Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,actin binding (GO:0003779),0.7231236051522731,2.1559359056366243,0.0,0.0009801323932678906,0.001,42/170,6.29%,PDLIM3;SYNPO2;TPM2;CAP2;DMD;KCNMA1;TPM1;LDB3;MYOZ2;TNNI2;SMTN;TNNC2;ABRA;PDLIM1;NRAP;PDLIM5;CALD1;LMOD2;ACTN4;TNNT3;MYL2;VCL;MICAL2;SYNPO2L;LMOD3;SYNE1;FERMT2;MYH9;MYL3;MYO9B;LCP1;MRTFA;ITGB1;MAP1B;FHL3;SLC6A2;PDLIM7;UTRN;SYNE2;GC;MAPT;SORBS1
prerank,alpha-actinin binding (GO:0051393),0.9142288825615402,2.110810872921695,0.0,0.002940397179803672,0.005,14/24,4.42%,PDLIM3;SYNPO2;PALLD;MYOT;LDB3;TTN;CACNA1C;PDLIM1;NRAP;PDLIM5;MYPN;KCNA5;KCNN2;PDLIM7
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.8013358867987904,-2.010472397853198,0.0,0.020813398184119203,0.02,4/13,2.30%,BMP6;BMP7;BMP4;CDH5
prerank,muscle alpha-actinin binding (GO:0051371),0.9480826634450584,1.9939890410043417,0.0,0.02384988823618534,0.058,9/15,0.96%,PDLIM3;SYNPO2;PALLD;LDB3;TTN;PDLIM1;NRAP;PDLIM5;MYPN
prerank,actinin binding (GO:0042805),0.8580509818388155,1.9721158689011085,0.003289473684210526,0.027933773208134883,0.091,9/21,4.09%,SYNPO2;MYOT;TTN;CACNA1C;PDLIM5;CSRP1;CSRP3;KCNA5;KCNN2
prerank,BMP receptor binding (GO:0070700),-0.8013373134055664,-1.958575719330279,0.0,0.029659092412369862,0.054,4/12,2.30%,BMP6;BMP7;BMP4;CDH5
prerank,myosin binding (GO:0017022),0.7194084441468145,1.906214283322794,0.0012547051442910915,0.08938807426603163,0.298,6/55,1.34%,MYBPC1;MYLK2;DMD;CALD1;ACTA1;MYL2
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.8732765842929088,1.8819499266842883,0.0016806722689075631,0.11549226700673312,0.421,2/15,0.33%,JPH2;OBSCN
prerank,retinoid binding (GO:0005501),-0.6475934078986622,-1.8603111082198307,0.0,0.09088517207065383,0.21,6/22,4.19%,ALDH1A2;RBP1;PTGDS;CYP26B1;ABCA4;RBP4
prerank,tropomyosin binding (GO:0005523),0.8492378452690915,1.8556772249863467,0.008361204013377926,0.15402080465638282,0.571,5/16,1.60%,LMOD1;CALD1;LMOD2;TNNT3;LMOD3
prerank,titin binding (GO:0031432),0.8800205397690936,1.8398777832495492,0.0017513134851138354,0.17091058607608842,0.659,5/13,3.16%,MYBPC1;OBSCN;TCAP;TRIM63;CAMK2D
prerank,voltage-gated calcium channel activity (GO:0005245),0.7215499519882419,1.8151932721122694,0.008185538881309686,0.21867842729799158,0.776,7/37,4.25%,CACNB2;RYR1;CACNA1S;CACNA1C;CACNA2D1;CACNA1H;CACNB4
prerank,cell-cell adhesion mediator activity (GO:0098632),0.7072479506267387,1.803348521898126,0.005291005291005291,0.23052713889660786,0.83,11/42,7.35%,NEXN;PALLD;PDLIM1;PDLIM5;MYPN;ROBO3;ANXA1;JAM3;DSCAM;CD200;CNN3
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.6652901041549166,1.7930772713600758,0.01139240506329114,0.23665742150177432,0.854,17/55,12.48%,CACNB2;RYR1;ATP2A1;RYR2;ATP2B4;ATP2A2;ITPR1;SLC8A2;PKD1L3;TRPV2;ATP2B1;TRPC5;ATP2A3;ANXA9;PANX1;CHRNA7;TRPM2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.8768300580780068,1.790723744351285,0.0017667844522968198,0.224123607260591,0.867,3/11,1.66%,RYR1;RYR2;ITPR1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.7560655496319568,1.7872458382970104,0.0167427701674277,0.2159307057168645,0.873,2/24,0.33%,JPH2;OBSCN
prerank,adenylate cyclase binding (GO:0008179),0.8797738024542915,1.7771798478473497,0.012704174228675136,0.223960251861713,0.901,6/10,7.26%,CAP2;AKAP6;ADCY5;ADCY2;CALM1;CAP1
prerank,cell adhesion mediator activity (GO:0098631),0.7678146449946334,1.7669820781868466,0.007309941520467836,0.2319646664067341,0.923,7/24,6.20%,NEXN;PALLD;MYPN;BCAM;ROBO3;JAM3;DSCAM
prerank,calcium activated cation channel activity (GO:0005227),0.7872482827900636,1.7588081082897606,0.01935483870967742,0.2368857477979333,0.934,7/17,8.74%,KCNMA1;ANO1;KCNMB1;ANO6;KCNN2;ANO10;TRPM4
prerank,high voltage-gated calcium channel activity (GO:0008331),0.899706641814587,1.7479503641628775,0.005607476635514018,0.24860769881006733,0.949,4/10,4.25%,CACNB2;CACNA1S;CACNA1C;CACNB4
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.7100556364851162,1.744757972333369,0.008571428571428572,0.24198379753791702,0.951,4/34,3.92%,JPH2;OBSCN;FERMT2;MYO1B
prerank,mannosyltransferase activity (GO:0000030),-0.5932751145798465,-1.727620570672957,0.005208333333333333,0.31584331744400884,0.664,9/21,21.60%,TMTC1;TMTC2;DPY19L4;TMTC4;DPY19L1;PIGV;ALG1;ALG12;POMT1
prerank,ligand-gated calcium channel activity (GO:0099604),0.7773486009081523,1.7275074613550345,0.009708737864077669,0.2744370701150094,0.976,4/19,2.87%,RYR1;RYR2;ITPR1;GRIN2C
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.5749025384825058,-1.7255278021318126,0.006006006006006006,0.2593349413741252,0.671,9/26,8.03%,SLC6A13;SLC16A12;ABCG2;SLC16A9;SLC6A1;SLC6A12;SLC6A6;SLC16A1;SLC16A11
prerank,miRNA binding (GO:0035198),-0.5324795357720629,-1.7146574217977912,0.006269592476489028,0.24334331376932697,0.709,17/30,34.49%,AGO3;PUM1;MATR3;ZC3H7A;TUT4;PNPT1;ZC3H12A;FMR1;TUT7;ZC3H7B;YBX1;RBM10;AGO4;ZC3H10;HNRNPA2B1;ELAVL1;SPOUT1
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.8217169291890764,1.713470333608867,0.01971326164874552,0.2977152144551218,0.987,6/12,11.98%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1;GABRB3
prerank,voltage-gated cation channel activity (GO:0022843),0.6081590893035411,1.707117226451964,0.004694835680751174,0.3013207014732144,0.99,13/97,5.58%,CACNB2;KCNMA1;RYR1;CACNA1S;CACNA1C;CACNA2D1;GRIN2C;KCNQ5;KCNA5;KCNQ4;CACNB4;KCNB1;KCNH1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.6752578617552001,1.6978311552679903,0.027137042062415198,0.31346415995603993,0.99,3/38,1.87%,JPH2;OBSCN;HIP1
prerank,P-type ion transporter activity (GO:0015662),0.8206604870807861,1.6954124828688175,0.017921146953405017,0.30614222231463156,0.991,5/12,10.32%,ATP2A1;ATP2B4;ATP2A2;ATP2B1;ATP2A3
prerank,GABA-A receptor activity (GO:0004890),0.7559567512273567,1.6920501030128385,0.024671052631578948,0.30179909942707134,0.992,6/18,11.98%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1;GABRB3
prerank,NADPH binding (GO:0070402),0.8080196972453715,1.6853742875111344,0.0216998191681736,0.3065462073184655,0.994,2/13,3.45%,KCNAB1;CRYZ
prerank,calcium-activated potassium channel activity (GO:0015269),0.8310713702542041,1.6847480196938667,0.02389705882352941,0.2965654437630191,0.994,3/11,4.09%,KCNMA1;KCNMB1;KCNN2
prerank,phosphatidic acid binding (GO:0070300),0.7472847686282436,1.68424735480818,0.024958402662229616,0.2866342732312321,0.994,5/19,7.68%,JPH2;PACSIN2;MARK1;RAPGEF6;OPA1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.8281733453013327,1.6618037005358213,0.03019538188277087,0.33559033050925957,1.0,4/10,9.21%,GABRE;GABRA4;GABRA5;GABRG1
prerank,anion transmembrane transporter activity (GO:0008509),-0.6765534863006356,-1.6552436490911764,0.016587677725118485,0.38222319093836044,0.888,5/12,8.18%,ABCG2;SLCO2B1;SLC39A8;SLC22A6;SLC4A2
prerank,potassium channel regulator activity (GO:0015459),0.6349922533794461,1.6498024863803151,0.014304291287386216,0.3555514750751107,1.0,8/49,8.12%,KCNAB1;FLNA;KCNMB1;SLC5A3;KCNE4;KCNIP3;ENSA;WNK2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.720429891841936,1.648257505301507,0.026771653543307086,0.34814302608875475,1.0,4/23,6.54%,JPH2;HIP1;CLVS1;PHLDA3
prerank,cation channel activity (GO:0005261),0.5755894008993497,1.6470476002228625,0.016374269005847954,0.33960006568033596,1.0,23/94,12.48%,CACNB2;RYR1;RYR2;TMEM38B;ASIC3;TRPC6;ANO1;ANO6;KCNQ4;PKD1L3;TRPV2;CALHM5;ANO10;TRPM4;TRPC5;ABCC8;TMEM38A;ANXA9;PANX1;KCNK3;KCNA2;CHRNA7;TRPM2
prerank,diacylglycerol kinase activity (GO:0004143),0.8082328637326462,1.6365335549403839,0.029250457038391225,0.3575032904444631,1.0,2/11,0.44%,DGKB;DGKG
prerank,calcium channel activity (GO:0005262),0.5791987395404574,1.6351755955527816,0.010625737898465172,0.35029337715762127,1.0,18/84,12.48%,CACNB2;RYR1;RYR2;CACNA1S;CACNA1C;TRPC6;CACNA2D1;CACNB4;PKD1L3;TRPV2;NCS1;TRPM4;TRPC5;ANXA9;PANX1;CACNA1B;CHRNA7;TRPM2
prerank,calcium ion binding (GO:0005509),0.5305038773325735,1.6334874559053,0.0,0.34448770881033214,1.0,40/323,5.70%,ASPN;SLIT3;SLIT1;RYR1;ATP2A1;TTN;CDH6;RYR2;AOC3;TNNC2;SPARCL1;MYL2;ESYT2;CASQ1;HRC;ATP2A2;ITPR1;FER1L5;PPP3CA;S100G;RASGRP2;DYSF;ASTN2;CDH13;SLC8A1;ANXA1;ASPH;LOXL2;ITSN1;LPL;LCP1;PADI2;STIM1;PITPNM3;CDH4;CAMKK2;SYT10;NUCB1;TESC;CDHR3
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.591539228847271,1.6293824515850823,0.019801980198019802,0.3443625154290072,1.0,17/72,11.78%,JPH2;OBSCN;HIP1;CGAS;MYO1B;MARK1;SYTL2;TTPA;PHLDA3;PLCB1;AMER1;PLCD1;ACTN2;SNX18;ANXA9;GRAMD2A;OSBPL2
prerank,alkali metal ion binding (GO:0031420),-0.6440040820364071,-1.6135638421260978,0.026570048309178744,0.5035541523170339,0.964,3/13,7.62%,ATP1A2;HDAC4;PDXK
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.7974442378614697,1.611603315631118,0.03597122302158273,0.38252389237260737,1.0,1/10,0.36%,NCF2
prerank,vinculin binding (GO:0017166),0.7939544970069159,1.6102839908574473,0.0429553264604811,0.37573507746248,1.0,5/11,7.36%,DMD;ACTN1;UTRN;TLN1;RTCB
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7773175888575653,1.609922206154829,0.04291044776119403,0.3664663432513208,1.0,5/11,8.87%,SLC5A3;SLC2A10;SLC23A2;SLC23A1;SLC5A11
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.625603040598782,-1.608934936810707,0.029484029484029485,0.46471692945541704,0.967,5/15,7.39%,PIK3CA;PI4KA;PIK3R3;PI4K2A;PIK3CB
prerank,filamin binding (GO:0031005),0.7772064733442162,1.606323438748736,0.04036697247706422,0.366167409484953,1.0,2/11,2.54%,SYNPO2;DPYSL4
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.5657800578682896,1.6022836839847243,0.01527614571092832,0.36713309120832016,1.0,22/91,11.87%,JPH2;OBSCN;HIP1;CGAS;MYO1B;MARK1;TTPAL;KCNH1;SYTL2;TTPA;MAPT;CLVS1;PHLDA3;PLCB1;AMER1;PLCD1;ACTN2;SNX18;ANXA9;GRAMD2A;OSBPL2;WDR45
prerank,MAP kinase kinase kinase activity (GO:0004709),0.7725891994378061,1.5908880665620555,0.04964539007092199,0.38882569210981077,1.0,2/11,1.23%,MAP3K20;MAP3K5
prerank,cation:chloride symporter activity (GO:0015377),-0.6827148311737199,-1.5840134283557639,0.048458149779735685,0.5209593565485036,0.984,5/10,18.20%,SLC12A2;SLC6A1;SLC12A7;SLC12A6;SLC12A8
prerank,gated channel activity (GO:0022836),-0.6154474753550877,-1.5814177387235955,0.02771362586605081,0.4839115077807714,0.986,9/14,25.67%,PIEZO1;PIEZO2;TMEM63A;TMC7;TMEM266;TMC4;TMC6;TMEM63B;PACC1
prerank,R-SMAD binding (GO:0070412),-0.5725672127378727,-1.5783104428858983,0.036011080332409975,0.4544258603532692,0.986,10/18,18.22%,LDLRAD4;SMAD3;DDX5;SMAD6;RANBP3;RGCC;TRIM33;SMAD2;SMAD4;PMEPA1
prerank,"DNA binding, bending (GO:0008301)",-0.608225222749065,-1.5719942821941812,0.0327455919395466,0.4404435261885532,0.986,8/14,26.97%,LEF1;FOXD1;HMGB1;FOXL1;HMGA2;SAP30L;HHEX;HMGB2
prerank,BMP binding (GO:0036122),0.7778845346206443,1.568922304388679,0.057432432432432436,0.43949603243843294,1.0,3/11,3.01%,TCAP;HJV;GREM2
prerank,sialyltransferase activity (GO:0008373),-0.5568169815856143,-1.558047043179537,0.01971830985915493,0.4606451019535238,0.991,9/20,11.00%,ST3GAL4;ST3GAL6;ST8SIA4;ST3GAL1;ST3GAL5;ST6GALNAC3;ST8SIA1;ST3GAL3;ST8SIA2
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.5728979544557251,1.5570771251958127,0.032418952618453865,0.46412687887722764,1.0,8/73,5.49%,LHCGR;EDNRA;HCRTR1;CRHR2;EDNRB;VIPR2;TSHR;CYSLTR2
prerank,histone demethylase activity (GO:0032452),-0.5143191006622981,-1.5513577058728611,0.02373887240356083,0.453107678468275,0.992,12/27,26.46%,KDM7A;KDM5C;KDM5B;KDM2A;KDM3B;JMJD6;RIOX2;KDM4D;KDM1A;KDM6A;FBXL19;HR
prerank,damaged DNA binding (GO:0003684),-0.4531427003673602,-1.5501099970483363,0.011538461538461539,0.42921129567813315,0.993,27/44,36.06%,HMGB1;ERCC5;XRCC1;DDB1;NBN;EP300;CRY2;XPA;DCLRE1A;ERCC2;ERCC1;RAD1;ERCC4;DCLRE1B;HMGB2;OGG1;RPA3;TDG;SDE2;APTX;FANCG;RAD18;NEIL3;RPA2;ERCC3;DCLRE1C;RPA1
prerank,mechanosensitive ion channel activity (GO:0008381),-0.6329434236638589,-1.5481655922920827,0.0262582056892779,0.4102075918581846,0.994,7/12,21.48%,PIEZO1;PIEZO2;TMEM63A;TMC7;TMC4;TMC6;TMEM63B
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.6646947115841594,1.5447841697324416,0.05446293494704992,0.49142501654279397,1.0,6/22,13.12%,ATP2A1;ATP2A2;ATP6V0A2;ATP6V1C1;ATP2A3;ATP6V0D2
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.5860422546965365,-1.5321493659192655,0.0225,0.4378329568009297,0.998,5/15,7.75%,ALDH1A2;ALDH1A1;ALDH3A2;ALDH4A1;ALDH7A1
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.423804497916067,-1.529129627743363,0.017857142857142856,0.4239360577502174,0.998,19/51,18.57%,SLC22A8;SLCO2B1;SLCO1C1;SLCO2A1;SLC7A5;SLC25A3;MCU;SLC35E2A;SLC35E2B;SLC22A6;CLCN4;SLCO3A1;SLC25A14;SLC22A4;SLC5A5;SLC25A30;SLC25A11;SLC35D2;SLC35D1
prerank,Wnt-activated receptor activity (GO:0042813),0.7021321739123239,1.5279878591391043,0.06642728904847396,0.5356532432808275,1.0,7/15,11.54%,FZD5;ROR1;FZD4;FZD8;FZD9;LRP5;TSPAN12
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.6578908756712971,-1.5219659769143437,0.0389908256880734,0.4265705957835231,0.998,4/10,12.38%,ANKRD13A;PML;FAN1;DNAJB2
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.6488587376943877,-1.5215063295450022,0.059734513274336286,0.4073479358891901,0.998,4/10,12.38%,ANKRD13A;FAN1;DNAJC2;DNAJB2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.5508527859561827,1.5176298596352593,0.0364963503649635,0.5592720664890346,1.0,14/75,10.96%,KCNAB1;HSD17B10;DHRS4;HIBADH;MDH1;ME3;HSD17B7;DHRS3;HSD17B4;LDHD;CBR1;HADHB;NSDHL;PTGR1
prerank,glucuronosyltransferase activity (GO:0015020),0.6572448892855949,1.5139096297883932,0.0903010033444816,0.559968404766583,1.0,3/19,3.73%,LARGE1;CSGALNACT1;EXT2
prerank,calcium-release channel activity (GO:0015278),0.7029470909681699,1.5129737095507467,0.05921052631578947,0.551283632363469,1.0,3/17,1.66%,RYR1;RYR2;ITPR1
prerank,GABA receptor activity (GO:0016917),0.6607452322036648,1.5062602085767283,0.06349206349206349,0.5623559613129281,1.0,6/21,11.98%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1;GABRB3
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.5926734136033286,-1.5044915666042293,0.04964539007092199,0.4396357334618269,1.0,7/13,17.61%,ALDH1A2;ALDH1A1;ALDH3A2;ALDH4A1;ALDH7A1;ADH5;ALDH1L1
prerank,phospholipase C activity (GO:0004629),0.6238621585284281,1.5026834774141864,0.08395802098950525,0.5626351990314999,1.0,7/25,9.48%,EDNRA;PLCE1;PLCB4;PLCL1;CCL5;PLCB1;PLCD1
prerank,sodium channel regulator activity (GO:0017080),0.6010416947180186,1.4991403709013535,0.06573426573426573,0.5633839433068277,1.0,7/37,7.25%,FGF13;ATP2B4;FGF14;SNTA1;CAMK2D;NEDD4;PRSS8
prerank,calcium channel regulator activity (GO:0005246),0.5976279690849228,1.4956764132895641,0.05851063829787234,0.5635195800294256,1.0,10/37,10.49%,PRKG1;ITPR1;INAFM2;PACSIN3;RRAD;STIM1;GEM;CALM1;SRI;REM1
prerank,glucose transmembrane transporter activity (GO:0005355),0.6586042279951313,1.494847589430482,0.08520900321543408,0.5554576710225351,1.0,4/17,8.87%,SLC2A4;SLC5A3;SLC2A10;SLC5A11
prerank,protein heterodimerization activity (GO:0046982),0.5014014240902103,1.4923913491083645,0.013742071881606765,0.5540652117943635,1.0,38/178,11.59%,TPM2;TPM1;AGTR1;AOC3;MEF2C;RALGAPA2;UBA2;HIP1;PDGFB;ITGA3;NR4A1;FZD4;ITGB1;EXT2;BCL2;KCNB1;MEF2A;ATP1B1;SAE1;TAF1;TP53;TUBB2B;BCL2L2;FZD9;ADD2;RALGAPA1;TPM4;GCA;NR4A2;RALGAPB;DGKD;HIF1A;SRI;TOP2B;PDGFA;ATF3;ABCG1;BOK
prerank,voltage-gated chloride channel activity (GO:0005247),0.7345222195114252,1.4913149855428365,0.09340659340659341,0.5471633636890421,1.0,3/10,5.96%,ANO1;ANO6;CLCN6
prerank,lysine-acetylated histone binding (GO:0070577),-0.5324971752974992,-1.4911723033150481,0.036211699164345405,0.4426316013822683,1.0,7/20,7.54%,MLLT3;CARM1;ATAD2B;BRD9;ZMYND8;TRIM24;BRDT
prerank,acetylation-dependent protein binding (GO:0140033),-0.5324971752974992,-1.4911723033150481,0.036211699164345405,0.4426316013822683,1.0,7/20,7.54%,MLLT3;CARM1;ATAD2B;BRD9;ZMYND8;TRIM24;BRDT
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.6896407454249709,1.4874825126874158,0.085667215815486,0.5397090425877067,1.0,5/16,9.82%,ANO1;ANO6;TTYH1;ANO10;ANO3
prerank,intracellular chloride channel activity (GO:0061778),0.6896407454249709,1.4874825126874158,0.085667215815486,0.5397090425877067,1.0,5/16,9.82%,ANO1;ANO6;TTYH1;ANO10;ANO3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.7457870759715864,1.4838111801375966,0.06486486486486487,0.5415062484461429,1.0,2/11,3.36%,PADI3;PADI2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.5613839890842387,-1.4790319161646728,0.0705596107055961,0.4633478703748617,1.0,9/14,31.80%,SLC7A11;SLC1A3;SLC17A6;SLC38A7;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6
prerank,ion gated channel activity (GO:0022839),0.6372747147687442,1.4689112300433866,0.09451219512195122,0.5804377257759339,1.0,8/24,9.82%,ANO1;ANO6;TTYH1;KCNT2;ANO10;TRPM4;KCNT1;ANO3
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.6576318312788504,1.4677355530128777,0.08507223113964688,0.5747986420319545,1.0,5/18,9.06%,PDLIM1;PDLIM5;ANXA1;CNN3;PPP1CA
prerank,actin monomer binding (GO:0003785),0.6225044378395893,1.4677102001132702,0.08157099697885196,0.5654881876831171,1.0,5/22,3.40%,LMOD2;MYL2;LMOD3;MYL3;MRTFA
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.6325403138859202,1.4662710402029073,0.07357357357357357,0.5608096234061036,1.0,5/24,6.38%,MYLK2;CAMK2G;CAMK2D;PHKA2;MAPKAPK2
prerank,metal ion binding (GO:0046872),0.4737703253122324,1.459246051898347,0.0,0.5739997563431559,1.0,71/477,10.26%,ASPN;SLIT3;SLIT1;RYR1;ATP2A1;TTN;MAP3K20;CDH6;RYR2;AOC3;TNNC2;SPARCL1;STK38L;MAP3K5;MYL2;ESYT2;UBA2;CASQ1;HRC;DYRK2;ATP2A2;ITPR1;FER1L5;PPP3CA;S100G;ADCY2;RASGRP2;DYSF;ASTN2;CDH13;SLC8A1;ANXA1;ASPH;LOXL2;CSGALNACT1;ITSN1;LPL;LCP1;PADI2;STIM1;PITPNM3;GEM;CDH4;CAMKK2;SYT10;MARK1;NUCB1;TESC;CDHR3;TPPP;EML1;CALB1;CALM1;STK26;RASGRP1;OPA1;PAPOLA;PRKACB;DIS3L2;NCS1;TPM4;CDH2;TRPM4;GCA;BRSK1;AASDHPPT;TPD52;RAP2A;AGRN;SRI;AOAH
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5874823449991153,-1.4583469500359014,0.06264501160092807,0.5111690542488199,1.0,6/12,14.29%,IGF1;ARRB1;GNAS;SOCS2;IGF2;INSR
prerank,NADP binding (GO:0050661),0.595625010262795,1.4514834020272336,0.08866279069767442,0.5908360583168003,1.0,3/32,4.65%,KCNAB1;CRYZ;ME3
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5264407098625725,-1.450862302233008,0.05929919137466307,0.5172514882053327,1.0,4/18,6.30%,ALDH1A2;ALDH1A1;FAR2;ALDH3A2
prerank,hexose transmembrane transporter activity (GO:0015149),0.6826829519011809,1.4465858875341808,0.1076388888888889,0.5979712336527919,1.0,2/12,2.86%,SLC2A4;SLC5A3
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.6066749778314963,1.4396680855806232,0.10785824345146379,0.6121966330314473,1.0,6/23,9.48%,EDNRA;PLCE1;PLCB4;CCL5;PLCB1;PLCD1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.6606299490874512,1.4336507055981307,0.11409395973154363,0.6224133274084916,1.0,2/14,6.78%,NCF2;KMO
prerank,death receptor binding (GO:0005123),0.6716082450119693,1.4329393127314174,0.09572649572649573,0.6153357647205813,1.0,3/15,6.25%,NTF3;MYD88;DAB2IP
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.5101236955363796,1.4323039313869088,0.056753688989784334,0.6086906258539476,1.0,19/100,12.02%,JPH2;OBSCN;HIP1;FERMT2;MYO1B;TTPAL;KCNH1;TTPA;MAPT;DAB2IP;CLVS1;PHLDA3;ANKFY1;FCHSD2;GAP43;DENND1A;MYO10;WDR45;SNX13
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.6786001282758078,1.4309471564269467,0.12284069097888675,0.604405641254311,1.0,3/12,8.44%,TENT5B;PAPOLA;TENT4A
prerank,chemoattractant activity (GO:0042056),0.5940511922153056,1.429058376757375,0.09049773755656108,0.6022844533223212,1.0,5/26,6.86%,NTF3;PDGFB;CCL5;VEGFA;GDNF
prerank,growth factor activity (GO:0008083),0.5145038512497496,1.426832731880892,0.08518518518518518,0.6004808333255546,1.0,9/74,7.13%,NTF3;FGF1;PDGFB;THPO;JAG1;IL2;VEGFA;GDNF;AREG
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.6765236633877297,1.4235780881489013,0.12811387900355872,0.6022846424275484,1.0,4/13,8.72%,RYR2;SOX9;PKIA;PRKAR1B
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.38389689572987,-1.4229223859304845,0.04,0.5981250303161255,1.0,26/53,30.27%,SLC7A11;SLC1A3;SLC47A1;SLC3A2;SLC7A5;CTNS;SLC6A9;SLC43A2;SLC17A6;SLC66A1;SLC38A5;SLC38A6;SLC25A38;SLC38A7;SLC7A7;SLC15A4;SLC1A4;SLC36A1;SLC43A1;SLC1A1;SLC25A22;SLC1A2;SLC25A15;SLC7A6;SLC25A18;SLC38A9
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.5267272019750074,-1.4189435473491436,0.07989690721649484,0.5725418950481457,1.0,6/16,10.86%,PTPRB;PTPRG;PTPRN2;PTPRM;PTPRZ1;PTPRD
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.5267272019750074,-1.4189435473491436,0.07989690721649484,0.5725418950481457,1.0,6/16,10.86%,PTPRB;PTPRG;PTPRN2;PTPRM;PTPRZ1;PTPRD
prerank,voltage-gated anion channel activity (GO:0008308),0.6530035128615397,1.4147296036381594,0.12393887945670629,0.6211655267496964,1.0,4/15,8.75%,ANO1;ANO6;CLCN6;VDAC1
prerank,E-box binding (GO:0070888),-0.44223629472035353,-1.4141015779912796,0.054982817869415807,0.5699178402770833,1.0,14/34,26.21%,TCF4;ZEB1;MAX;AHR;HES1;BHLHE41;PER1;BHLHE40;PPARG;ATOH8;TAL1;TFAP4;SNAI1;TWIST1
prerank,transaminase activity (GO:0008483),0.7017015260795021,1.412546383228355,0.14754098360655737,0.6200840257089085,1.0,3/11,7.85%,BCAT2;GOT1;GOT2
prerank,motor activity (GO:0003774),0.5279556280658859,1.412271529910841,0.06962025316455696,0.6127246070598783,1.0,20/60,14.53%,MYO1E;MYL6;KIF27;MYH9;KIF2A;DYNLRB1;KIF3B;DNAH17;KIF1A;PIN1;KIF5B;CENPE;KIF1C;DYNC1I2;KIF5C;KIF5A;APPBP2;KIF20B;KIF18A;KIF6
prerank,phosphatidylglycerol binding (GO:1901611),-0.5695387919259991,-1.4095311988581531,0.08068459657701711,0.5682382913611169,1.0,6/13,14.96%,PITPNA;PLTP;GSDME;PITPNC1;GSDMD;STOML2
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6013261704033634,-1.4045603471193375,0.09502262443438914,0.5666920687403364,1.0,5/10,8.85%,SLCO2B1;SLCO1C1;SLCO2A1;SLC22A6;SLCO3A1
prerank,antiporter activity (GO:0015297),-0.5056693573576215,-1.4035135497843019,0.10164835164835165,0.5532078805584859,1.0,11/20,29.35%,SLC35E2A;SLC35E2B;CLCN4;SLC25A14;SLC25A30;SLC25A11;SLC35D2;SLC35D1;SLC35E3;SLC35E4;SLC35C2
prerank,potassium channel activity (GO:0005267),0.5080036365162446,1.4015112302040702,0.08470588235294117,0.6388553855288592,1.0,18/89,11.35%,KCNMA1;TMEM38B;KCNMB1;KCNQ5;KCNA5;KCNQ4;KCNN2;KCNB1;CCDC51;KCNH1;KCNT2;GRIK5;KCNT1;ABCC8;TMEM38A;KCNH8;KCNK3;KCNA2
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.5443100906906171,-1.39881463292961,0.11576354679802955,0.5534282577157296,1.0,5/14,15.21%,ATXN3;MINDY3;OTUD7B;USP7;MINDY1
prerank,androgen receptor binding (GO:0050681),-0.46812371325405566,-1.3964839837491954,0.07878787878787878,0.5455422924037465,1.0,11/25,19.27%,NSD1;PRKCB;FOXP1;DDX5;RNF6;PRMT2;SNW1;EP300;CALR;KDM1A;PARK7
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.6678722950119508,1.3962782397854174,0.14768683274021352,0.6473146167538734,1.0,3/10,7.01%,PRDM16;SUV39H2;ASH1L
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.6065381623007293,1.3856090321735899,0.13578274760383385,0.6733013272184197,1.0,2/21,0.93%,RYR2;AKAP6
prerank,microtubule plus-end binding (GO:0051010),0.6182352695421832,1.382786588144573,0.14332784184514002,0.6735347289987785,1.0,11/20,17.37%,CLASP2;STIM1;DST;MAPRE2;CLIP3;FBXW11;CLASP1;KIF18A;MAPRE3;KNSTRN;DCTN1
prerank,protein homodimerization activity (GO:0042803),0.44695900379257564,1.3825640709975953,0.003003003003003003,0.6659334090259889,1.0,119/589,15.02%,MYOM1;TPM2;SOX6;PLN;FLNA;TPM1;ATP2A1;RBPMS;ACTN1;RBPMS2;TRPC6;CAMK2G;ACTN4;MAP3K5;RBM44;MYOM3;ANO1;CHMP4C;HIP1;HSPB6;PDGFB;SYNE1;PDGFC;MYH9;PIP4K2A;MYO9B;CAMK2D;FZD4;LPL;PADI2;CCL5;ACP3;EXT2;NACC2;KCNN2;NR2F2;BCL2;BMPR1A;TBX18;LHPP;TYW5;ATG7;TESC;HSD17B4;ZDHHC2;CRPPA;TPPP;DAB2IP;TERT;VEGFA;GRHL1;ZBTB38;GDNF;SFPQ;STK26;PLEK;BCL2L2;FZD9;GLA;ADD2;TGFB2;RELA;MAP3K10;DAPK3;TRIM68;TPM4;MVD;GCA;MGLL;LRRFIP1;PTH1R;DGKD;HOOK1;TPD52;ST6GAL1;RAB11FIP3;RAB11FIP4;DNM1L;S100A6;PDGFA;GGCT;ATF3;TERF2;ABCG1;BOK;DUSP29;TSG101;GSTA4;AIMP1;GBP2;DROSHA;CHRNA7;KIF20B;SNX9;NR6A1;PDCD10;POU3F3;HPS4;ST3GAL2;CEP43;TMEM192;MKLN1;PDK2;MTCL1;DGCR8;STK10;MCL1;ZBTB4;EPRS1;HM13;SPPL2B;LRRK2;TNNC1;GLB1;KNSTRN;MLXIPL;KARS1;SNX1;EXD2
prerank,cAMP response element binding (GO:0035497),-0.5967336824182947,-1.3817429289466285,0.09230769230769231,0.5785280908772269,1.0,6/10,20.06%,CREB5;ATF2;CREB1;CREB3L1;ATF7;HMGA2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5760112941268194,1.3809960589450962,0.13075780089153047,0.6625694978490941,1.0,9/27,10.32%,ATP2B4;CNNM2;ITPR1;SLC8A2;SLC4A8;ATP2B1;SLC23A1;MRS2;ATP2A3
prerank,solute:anion antiporter activity (GO:0140323),-0.5254366921421155,-1.380251391129948,0.10436893203883495,0.5688904216825108,1.0,4/14,11.17%,SLC7A11;SLC26A7;SLC4A2;SLC26A2
prerank,solute:sodium symporter activity (GO:0015370),0.5671270475564415,1.3780140212166616,0.14434523809523808,0.663892086138805,1.0,5/27,8.87%,SLC5A3;SLC4A8;SLC20A2;SLC4A7;SLC5A11
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.5554006910274041,-1.3772161267158478,0.09669811320754718,0.5643899807593656,1.0,5/12,18.12%,PIK3CA;PIK3R3;PIK3CB;PIK3R6;ATM
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.6150404048293288,1.3753339374912799,0.12267080745341614,0.6642963977800899,1.0,3/21,5.14%,PDE3A;PDE5A;PDE4A
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5542518628831634,1.3750076188769498,0.12867132867132866,0.6574612784347684,1.0,3/38,3.37%,SERPINB8;SERPINI1;SERPINE2
prerank,chemorepellent activity (GO:0045499),-0.45881798257619844,-1.3745469550585954,0.10355029585798817,0.5581372890548866,1.0,9/25,13.75%,SEMA3D;EPHA7;SEMA3C;SEMA6A;SEMA7A;SEMA3A;SEMA4D;SEMA6D;DPP4
prerank,transforming growth factor beta binding (GO:0050431),0.6021499461256676,1.374251448152103,0.12759170653907495,0.6519931855124359,1.0,5/23,3.63%,LTBP1;VASN;CD36;LRRC32;TGFB3
prerank,fatty acid synthase activity (GO:0004312),-0.5884521348481746,-1.3724761026599157,0.12184873949579832,0.551783491615326,1.0,7/10,34.39%,ELOVL7;ELOVL4;ELOVL6;ELOVL1;OXSM;ELOVL5;MCAT
prerank,ankyrin binding (GO:0030506),0.6048972625542266,1.3678955036169016,0.1393841166936791,0.664574826193941,1.0,3/19,4.31%,OBSCN;SLC8A1;FLNC
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.6681902591997968,1.3677208263970728,0.17157712305025996,0.6574794921249643,1.0,2/12,5.14%,PDE3A;PDE4A
prerank,bHLH transcription factor binding (GO:0043425),-0.4906141331068008,-1.3625741835803316,0.1,0.5692216624806791,1.0,9/19,26.21%,SMAD3;FHL2;PSMD9;BHLHE41;BHLHE40;KDM1A;LMO2;USF1;TWIST1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.4341164117273062,-1.3576368984331844,0.10204081632653061,0.5707469411349804,1.0,15/29,31.80%,SLC13A3;SLC26A7;SLC25A14;SLC26A2;SLC25A30;SLC25A11;SLC38A7;SLC1A4;SLC1A1;SLC25A22;SLC26A6;SLC25A21;SLC25A18;SLC13A5;SLC1A6
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.581010482150489,1.3547603132024884,0.15337423312883436,0.6893194032788436,1.0,6/25,9.76%,OBSCN;HIP1;TTPA;PHLDA3;PLEK;FCHSD2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.5893639948570143,1.3528409873592562,0.13513513513513514,0.6875519835175001,1.0,3/23,5.14%,PDE3A;PDE5A;PDE4A
prerank,glutamate receptor activity (GO:0008066),-0.47667888508133394,-1.350297146565834,0.09141274238227147,0.5798187005496389,1.0,7/19,19.56%,GRM3;GRM7;GRIK3;GRIN2D;GRM5;GRID2;GRIK1
prerank,mannose binding (GO:0005537),0.6418491784055198,1.3485149093750743,0.1733102253032929,0.6942783963741563,1.0,2/12,7.74%,CLN5;MBL2
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5560068527142369,-1.3452918287028774,0.1291759465478842,0.5830064091351612,1.0,2/11,0.83%,SRRM2;LEF1
prerank,metalloaminopeptidase activity (GO:0070006),0.6196037706893182,1.3448567808059848,0.16086235489220563,0.6982697549125799,1.0,4/16,7.40%,MMP17;LNPEP;RNPEP;ENPEP
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.5812100159565095,-1.344769703572633,0.10087719298245613,0.5720064779209455,1.0,7/10,36.38%,B4GALT1;B4GALT6;B4GALT7;B3GALT2;B3GALT1;A3GALT2;B3GALT6
prerank,FMN binding (GO:0010181),-0.5620580843880831,-1.3403628104344316,0.13876651982378854,0.5732319846687893,1.0,3/11,9.33%,POR;PPCDC;NOS3
prerank,ligand-gated anion channel activity (GO:0099095),0.5971235209886291,1.3369176838354655,0.1893687707641196,0.7156758110714263,1.0,6/17,11.98%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1;GABRB3
prerank,cholesterol binding (GO:0015485),-0.37898788380431037,-1.3349507162800727,0.0796812749003984,0.5788726369958153,1.0,17/47,23.59%,OSBPL8;ABCA1;PTCH1;OSBPL10;GRAMD1C;ANXA6;APOD;SCARB2;SIDT1;PROM1;SOAT1;GRAMD1A;STARD4;SYP;STARD3NL;STARD5;NPC1
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.6272683082961671,1.3218321922867582,0.18588640275387264,0.7570271505151986,1.0,7/13,10.74%,PDGFB;PDGFC;PDGFD;VEGFA;ITGB3;PDGFRB;PDGFA
prerank,Toll-like receptor binding (GO:0035325),0.6518143702321122,1.3210065553179502,0.18244406196213425,0.7517512284533852,1.0,3/11,6.25%,CD36;MYD88;DAB2IP
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.5476358961909866,1.315455782196574,0.1815431164901664,0.7617670638177485,1.0,6/27,8.16%,ASIC3;SLC8A2;SLC8A1;SLC4A8;SLC23A1;SLC9A8
prerank,amino acid:sodium symporter activity (GO:0005283),-0.5468820037241942,-1.3146453538284484,0.1545253863134658,0.6298176766837295,1.0,4/11,3.69%,SLC6A13;SLC1A3;SLC6A1;SLC6A12
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.5656780697815942,-1.3139201477544296,0.14573991031390135,0.6194275433575716,1.0,3/10,7.39%,PIK3CA;PIK3R3;PIK3CB
prerank,ephrin receptor activity (GO:0005003),-0.4794914903961052,-1.313534385427943,0.15463917525773196,0.5967841671638795,1.0,8/17,22.01%,EPHA7;EPHA4;EPHA3;EPHA8;EPHA10;EPHB4;EFNB3;EPHB2
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.4794914903961052,-1.313534385427943,0.15463917525773196,0.5967841671638795,1.0,8/17,22.01%,EPHA7;EPHA4;EPHA3;EPHA8;EPHA10;EPHB4;EFNB3;EPHB2
prerank,leak channel activity (GO:0022840),-0.48243180319856965,-1.3116880837069305,0.15404699738903394,0.591041602585068,1.0,3/18,6.56%,KCNK2;NALCN;KCNK5
prerank,GTPase inhibitor activity (GO:0005095),-0.5149232680543256,-1.3065489866188293,0.17402597402597403,0.5951282864109121,1.0,3/13,3.94%,CPEB2;SLIT2;PDE6D
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.5125482839773525,-1.3064504279397866,0.15402298850574714,0.584515906094373,1.0,5/14,17.16%,SLC26A7;SLC25A14;SLC26A2;SLC25A30;SLC25A11
prerank,ATPase activator activity (GO:0001671),-0.46022803882403285,-1.3042968083698987,0.16062176165803108,0.58045222525086,1.0,7/20,12.41%,ATP1B3;DNAJC10;TOR1AIP2;TOR1AIP1;ATP1B2;DNAJB2;DNAJC19
prerank,voltage-gated potassium channel activity (GO:0005249),0.4730803923576043,1.3000702656715335,0.14268585131894485,0.8052444400443788,1.0,12/80,9.71%,KCNMA1;KCNJ12;KCNQ5;KCNA5;KCNQ4;KCNN2;KCNE4;KCNB1;KCNH1;KCNT2;KCNT1;KCNH8
prerank,sodium channel activity (GO:0005272),0.521880842118184,1.2974831158448377,0.18636995827538247,0.8057388367228681,1.0,3/37,1.95%,SCN4A;ASIC3;CACNA1H
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.47997582862980115,-1.2923828361587126,0.14925373134328357,0.6047935335501164,1.0,11/16,31.80%,SLC13A3;SLC25A14;SLC25A30;SLC25A11;SLC38A7;SLC1A4;SLC1A1;SLC25A22;SLC25A18;SLC13A5;SLC1A6
prerank,alanine transmembrane transporter activity (GO:0022858),-0.5112848890488464,-1.2880820995507642,0.15529411764705883,0.6068899829134895,1.0,6/12,21.66%,SLC6A6;SLC3A2;SLC38A5;SLC38A7;SLC1A4;SLC36A1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.4685906987419558,1.2871474300029895,0.14631197097944376,0.8334095440938488,1.0,7/74,4.76%,DGKB;DGKG;NMRK2;FAM20A;HK2;GNE;ADPGK
prerank,hyaluronic acid binding (GO:0005540),-0.5617795060754353,-1.285069146634891,0.15172413793103448,0.6048937943442236,1.0,4/10,14.43%,CEMIP;CD44;LAYN;IMPG2
prerank,DNA-binding transcription factor binding (GO:0140297),0.4328609037401547,1.283464221423121,0.11029411764705882,0.8370134612029133,1.0,26/189,9.18%,MYOCD;PRDM16;MEF2C;HEY2;CRTC1;GABPA;PRRX1;RUNX1T1;TEAD3;CRTC3;HDAC9;ANKRD2;BCL2;PIAS4;MEF2A;MTDH;TAF1;TP53;AR;YAP1;RELA;MAP3K10;DAPK3;PPARA;MTA3;SKI
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.357705496614073,-1.280029225693222,0.09859154929577464,0.6092948873416029,1.0,19/54,19.80%,NGLY1;ASPA;ACER2;NAAA;HDAC4;PIGL;SIRT7;HINT1;ASAH2;SUDS3;UPB1;ASRGL1;NTAQ1;ASPG;HINT3;HDAC2;NADSYN1;AMDHD2;MIER1
prerank,kinase binding (GO:0019900),0.4157619440910276,1.2786774156632015,0.04909819639278557,0.8446412202500067,1.0,60/434,11.36%,MYOM1;ACTA2;FLNA;ARHGEF7;TTN;PPP1R12A;INKA2;MYOM2;PRKAB2;LIMS1;CCNA2;FERMT2;FZD5;CCND2;CSPG4;FAM83D;KCNA5;BCAR3;RHOBTB3;LAX1;PARN;TSKS;ACTB;UTRN;DOK7;LYST;CAV1;MAPT;DAB2IP;DUSP3;TP53;PPP2R5A;PARP1;PTPN1;CALM1;TPX2;BTG1;RAD9A;ADD2;RELA;TRIM68;CCND1;RHOF;VDAC1;PPP1CB;SKI;PAK2;TOM1L2;ADCY6;DGKD;HIF1A;CEP192;PDGFRB;GYS1;ANKRA2;RB1;PFKM;PRKCD;UNC5C;RHOH
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.33466658067852384,-1.278264346708546,0.10396039603960396,0.6043562546495268,1.0,12/71,5.83%,EYA2;PTPN13;EYA1;PTPRB;EYA4;PTPRG;PTPN14;CDC14B;PTPN11;PTPRN2;PTPRM;PTPRZ1
prerank,I-SMAD binding (GO:0070411),-0.5020500360032649,-1.2755697596013658,0.17942583732057416,0.6031521373775317,1.0,7/13,17.38%,SMAD3;SMAD6;SMAD9;CTNNB1;TGFBR1;SMAD2;SMAD4
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.579030139799425,1.2743610987564582,0.21226415094339623,0.8504089882765521,1.0,5/19,9.21%,GABRE;GABRA4;GABRA5;GRIK5;GABRG1
prerank,histone acetyltransferase binding (GO:0035035),0.566245469709509,1.2742167290572786,0.2112,0.8425712876651661,1.0,11/21,20.78%,MEF2A;TP53;TRIM68;HIF1A;SIRT2;ZBTB7A;CITED2;KANSL1;STAT1;EGR1;KANSL1L
prerank,carboxy-lyase activity (GO:0016831),-0.4332072023020239,-1.2738647020647262,0.15954415954415954,0.598467790643364,1.0,9/23,21.19%,PPCDC;UXS1;ECHDC1;AMD1;PCK2;AZIN1;DDC;ODC1;GAD1
prerank,water transmembrane transporter activity (GO:0005372),-0.534182544502751,-1.2706596240697008,0.16589861751152074,0.5985803234014031,1.0,1/11,1.63%,PDPN
prerank,adenylyltransferase activity (GO:0070566),0.5427887570009067,1.2701526760945951,0.22169811320754718,0.847588335778279,1.0,7/21,14.97%,NMNAT2;PAPOLA;TENT4A;NMNAT1;COASY;OASL;KARS1
prerank,receptor antagonist activity (GO:0048019),0.5741478750353618,1.2692429645052954,0.23778501628664495,0.8424844668761923,1.0,3/17,6.02%,FST;CCL5;PXDN
prerank,regulatory RNA binding (GO:0061980),-0.3689184405132172,-1.2679769347825385,0.13382899628252787,0.5971043732897889,1.0,17/38,34.49%,AGO3;PUM1;MATR3;ZC3H7A;TUT4;PNPT1;ZC3H12A;FMR1;TUT7;ZC3H7B;YBX1;RBM10;AGO4;ZC3H10;HNRNPA2B1;ELAVL1;SPOUT1
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.4281494228289417,1.2679688744785587,0.12249208025343189,0.8387806584010392,1.0,29/181,11.65%,MYOCD;HEY2;ACTN4;SMARCD3;NR1H4;PRRX1;TEAD3;ARID1A;ANKRD2;ACTB;PIAS4;SETD6;MEF2A;NCOA7;MTDH;TAF1;SMARCB1;TP53;AR;PPARGC1A;MED1;RELA;PPARA;MTA3;HIF1A;RB1;TACC2;PIAS2;BAZ2A
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5334714577388342,-1.267257178421101,0.1934156378600823,0.5901229094233675,1.0,7/11,38.51%,CASP8;CASP9;CASP4;CASP12;CASP6;PYCARD;CASP1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5063124964400878,1.2604495750399727,0.19247467438494936,0.8559578631450914,1.0,6/32,5.58%,KCNQ5;KCNA5;KCNQ4;KCNE4;KCNB1;KCNH1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.6030682285592417,1.2591685093632858,0.24329159212880144,0.8523430948456205,1.0,6/12,21.18%,TAF1;RELA;STAT1;HDAC1;POU2F1;H3-3A
prerank,protein kinase C activity (GO:0004697),-0.4882991565266267,-1.2590556479198662,0.16478555304740405,0.6040234541671846,1.0,4/14,7.71%,PRKCB;PRKCH;SMG1;PRKCE
prerank,receptor tyrosine kinase binding (GO:0030971),0.4720645650847476,1.2559945997406687,0.18306351183063513,0.8545045981638016,1.0,10/56,6.82%,ANGPT2;ANGPT1;ANGPT4;SOCS5;PITPNM3;ARHGEF16;IRS1;DUSP3;TP53;PTPN1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.5059350899220658,-1.2554251851560376,0.20665083135391923,0.6056545831886158,1.0,9/12,44.77%,B3GALNT1;B3GNT2;B3GALT2;B3GALT1;B3GNT9;B3GNT3;B3GNT8;B3GNT6;B4GAT1
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.2919502793735049,-1.2549068755342492,0.047058823529411764,0.598143883031872,1.0,27/134,9.92%,SLC6A13;SLC16A12;SLC1A3;SLC13A3;ABCG2;PDPN;GJA1;SLCO2B1;SLC6A1;SLC6A6;SLC26A7;SLC16A1;SLCO1C1;SLC25A17;SLCO2A1;SLC3A2;SLC25A32;SLC52A1;SLC7A5;SLC39A8;CTNS;SLC22A6;SLC16A11;SLC6A9;SLCO3A1;ABCC4;SFXN2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.6020679773591002,1.2546707550524485,0.24518388791593695,0.850719276178592,1.0,4/13,9.21%,GABRE;GABRA4;GABRA5;GABRG1
prerank,carbohydrate kinase activity (GO:0019200),0.5972621950377356,1.254553779965322,0.24818840579710144,0.8433465292668736,1.0,3/11,7.54%,HK2;GNE;FGGY
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.5305794403757411,-1.2534317011559664,0.1935483870967742,0.5933156486642952,1.0,8/11,36.44%,SLC25A17;SLC35B3;LRRC8A;SLC25A24;SLC35B2;SLC17A9;SLC25A25;SLC19A1
prerank,calcium channel inhibitor activity (GO:0019855),0.6322670281156391,1.2490681818844387,0.25486725663716814,0.8543954091029526,1.0,3/11,7.02%,ITPR1;PACSIN3;CALM1
prerank,transferrin receptor binding (GO:1990459),0.6304699376414694,1.2479840923376084,0.2643478260869565,0.8506681799765938,1.0,1/10,0.59%,HJV
prerank,glycine binding (GO:0016594),-0.5202532805224329,-1.24657360582158,0.18259023354564755,0.603573890016792,1.0,5/11,20.84%,GLRB;GRIN3A;GLRA2;SRR;GLRA1
prerank,voltage-gated sodium channel activity (GO:0005248),0.5480569933350496,1.2455260613362704,0.21543408360128619,0.8508580891873994,1.0,2/22,1.95%,SCN4A;CACNA1H
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.5342071082259328,1.24385826340821,0.21091445427728614,0.8487861296796171,1.0,8/28,16.82%,GABRE;GABRA4;GABRA5;GRIK5;GABRG1;CHRNA7;CHRNA4;GRIK4
prerank,acid-thiol ligase activity (GO:0016878),0.585367830759901,1.2396191164554933,0.24686940966010734,0.8550472212856679,1.0,1/13,0.89%,ACSS1
prerank,endopeptidase inhibitor activity (GO:0004866),0.443763379597774,1.2392206169837086,0.1872749099639856,0.8490459685682672,1.0,7/82,6.81%,SERPINB8;SERPINI1;ROCK1;ITIH4;SERPINE2;LXN;TIMP4
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.444238489550029,-1.2390763218043808,0.18478260869565216,0.6162789387322739,1.0,7/20,15.28%,SLC39A10;SLC30A10;SLC39A11;SLC39A8;SLC30A1;SLC39A1;SLC39A6
prerank,chloride channel inhibitor activity (GO:0019869),-0.5330949351662085,-1.236321769605133,0.22247706422018348,0.6157914712063103,1.0,6/10,17.84%,WNK1;WNK4;WNK3;STX1A;VAMP8;STX8
prerank,5'-3' exonuclease activity (GO:0008409),-0.479943539277917,-1.2356551277143246,0.2160919540229885,0.6092278531988027,1.0,7/14,25.84%,MRE11;FAN1;TRIR;DCP2;DCLRE1A;DCLRE1B;EXOG
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.509855920962055,-1.2348095260722942,0.21770334928229665,0.6033804133576157,1.0,8/12,36.44%,SLC25A17;SLC35B3;LRRC8A;SLC25A24;SLC35B2;SLC17A9;SLC25A25;SLC19A1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.38148036521822204,-1.2337543276035683,0.17218543046357615,0.5981113372910044,1.0,14/32,22.84%,SLC6A6;SLC3A2;SLC7A5;SLC6A9;SFXN2;SLC43A2;SLC38A5;SLC38A6;SLC25A38;SLC38A7;SLC1A4;SLC36A1;SLC43A1;SLC1A1
prerank,aminopeptidase activity (GO:0004177),0.5255357975924007,1.2335231752784763,0.2240117130307467,0.859617639929553,1.0,5/26,7.40%,MMP17;LNPEP;RNPEP;BLMH;ENPEP
prerank,SH2 domain binding (GO:0042169),0.5050817768421287,1.2314521958302893,0.24651810584958217,0.8588101230759911,1.0,7/31,11.25%,DLC1;LAX1;NUP62;IRS1;INPPL1;PAG1;ARHGAP5
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5588444695813074,1.231250565641667,0.24566929133858267,0.8522251159464309,1.0,4/18,5.14%,HJV;LTBP1;ACVR2A;BMPR1A
prerank,CXCR chemokine receptor binding (GO:0045236),-0.5169547967909272,-1.230481640667192,0.20993227990970656,0.5989528359257211,1.0,2/11,8.89%,ITCH;YARS1
prerank,potassium ion leak channel activity (GO:0022841),-0.47305999729039877,-1.2303184016209527,0.21052631578947367,0.5916875529931528,1.0,2/15,6.56%,KCNK2;KCNK5
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.5697207821545889,1.2290592596539884,0.2578512396694215,0.8525450765210927,1.0,3/15,15.00%,PLA2G3;PLA2G4A;PLA2G4C
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.4376646345490655,-1.2262774563851941,0.21374045801526717,0.5951446307343806,1.0,7/18,11.77%,TGFBR3;SMAD3;SMAD6;ENG;FKBP1A;TGFB1;TGFBR1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5263031720167175,-1.224807821806507,0.2396039603960396,0.5917509271222391,1.0,6/10,38.51%,CASP8;CASP9;CASP4;CASP12;CASP6;CASP1
prerank,WW domain binding (GO:0050699),0.5177902179776136,1.2239865955897307,0.23338485316846985,0.8620907108557176,1.0,7/26,19.99%,ENAH;WBP1;KIF20B;TCEAL3;TCEAL6;TCEAL9;NDFIP2
prerank,sterol transfer activity (GO:0120015),-0.4594396787930788,-1.223683105023462,0.22506393861892582,0.5875416742950341,1.0,7/17,23.46%,PLTP;ABCA1;GRAMD1C;GRAMD1A;STARD4;OSBP;STARD5
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.49476345073041134,-1.2193830335870355,0.23214285714285715,0.5912020372006151,1.0,4/12,17.73%,KDM7A;KDM3B;KDM4D;KDM1A
prerank,ADP binding (GO:0043531),0.523987592709596,1.2179849645226744,0.25,0.8745490257004147,1.0,8/25,11.57%,ACTA1;MYH9;MYO9B;MYO18A;COQ8A;MIEF1;LONP1;ABCG1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5508725973447166,1.2162931093679354,0.24519230769230768,0.8728790348465035,1.0,2/18,4.70%,HSD17B10;HSD17B7
prerank,gamma-tubulin binding (GO:0043015),0.538186275764634,1.215211169622073,0.25386996904024767,0.8693460685920343,1.0,4/21,9.13%,ARHGEF7;TUBGCP6;NDRG1;BRSK1
prerank,tau-protein kinase activity (GO:0050321),0.52943076345789,1.2133890605460245,0.26080246913580246,0.868101704951667,1.0,5/20,10.88%,ROCK1;MARK1;DYRK1A;BRSK1;ROCK2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.5193690240197811,-1.2129967444999206,0.2383073496659243,0.6006420722953194,1.0,3/10,12.77%,KDM7A;KDM2A;RIOX2
prerank,lipoprotein particle binding (GO:0071813),0.5470017493155851,1.2126709600759729,0.2601880877742947,0.8633577220668163,1.0,4/20,6.17%,CD36;CDH13;LPL;MAPT
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.5258134111761034,1.2039844404036446,0.26099706744868034,0.8840947332962822,1.0,5/25,9.92%,ART1;SIRT3;PARP1;ART4;SIRT2
prerank,Hsp70 protein binding (GO:0030544),-0.38289947826882165,-1.2036594072299251,0.23376623376623376,0.6184057046181511,1.0,8/31,14.15%,DNAJB12;DNAJC10;PRKN;DNAJC2;STUB1;ERN1;DNAJB2;SNCA
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.4468791890701192,1.2022691183130527,0.23580246913580247,0.8825978232494418,1.0,10/60,10.19%,LRRC2;CAMK2G;PPM1L;PPM1J;PPP3CA;PPM1E;PPM1A;PPP1CB;PPP1CA;CTDSP2
prerank,nucleoside-diphosphatase activity (GO:0017110),0.5691495194962033,1.2022517680184062,0.2764811490125673,0.8758538461041354,1.0,2/12,7.16%,ENTPD1;ENTPD7
prerank,monocarboxylic acid binding (GO:0033293),0.5289272606102203,1.2021995889757564,0.27447833065810595,0.8693250593419559,1.0,2/18,4.32%,NR1H4;NR2F2
prerank,microtubule binding (GO:0008017),0.4025575752111736,1.2014924135457548,0.16579770594369134,0.8651153419669843,1.0,71/222,18.90%,FGF13;KIF27;CLASP2;FAM83D;KIF2A;HOOK2;STIM1;MAP1B;TOGARAM2;HAUS8;DST;KIF3B;MAP7D3;ARHGEF2;CEP290;MAPRE2;TUBGCP6;KIF1A;MAPT;NDRG1;TPPP;EML1;EML5;HDGFL3;TPX2;RMDN3;TOGARAM1;OPA1;KIF5B;SUN2;WHAMM;CCDC170;HOOK1;CENPE;CCDC181;KIF1C;DNM1L;FHDC1;KIF5C;CLIP3;FBXW11;KIF5A;KIF20B;CLASP1;MAST1;MTCL1;MAP4;KIF18A;HAUS7;LRRK2;KIF6;MAPRE3;UXT;KNSTRN;DNM2;CCDC66;ABRAXAS2;MAP9;GAS2L3;KIF7;S100A8;S100A9;STARD9;DCTN1;SGIP1;MAP1A;MAP1S;MAP6;CEP295;HAUS4;HDAC6
prerank,beta-tubulin binding (GO:0048487),0.48250211586026637,1.1989418838814336,0.2539454806312769,0.8667244428919539,1.0,4/31,5.50%,FGF13;DLEC1;TTLL7;GABARAP
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.5863788570959011,1.198509929221513,0.2830188679245283,0.86151443041994,1.0,2/11,1.66%,TRPC6;ITPR1
prerank,MAP kinase activity (GO:0004707),-0.4628330096988702,-1.1934123738150129,0.23170731707317074,0.6386162721657892,1.0,7/14,26.73%,MAPK14;MAPK4;MAPK9;MAPK6;MAPK7;MAPK10;MAPK8
prerank,chloride channel activity (GO:0005254),0.44628685231078247,1.1926153688156527,0.2453066332916145,0.8731454973627377,1.0,11/59,11.98%,ANO1;GABRE;ANO6;CLCN6;GABRA4;TTYH1;GABRA5;GABRB2;GABRG1;ANO3;GABRB3
prerank,exonuclease activity (GO:0004527),-0.3352885154376224,-1.1900274370385129,0.18352059925093633,0.6400482966003587,1.0,22/46,27.20%,REXO5;MRE11;ENPP2;RAD50;FAN1;ENPP3;TRIR;EXOSC1;REXO1;ENPP1;ISG20L2;EXOSC9;ZC3H12A;EXOSC2;RAD1;AEN;DCLRE1B;EXOSC7;EXOSC3;EXOG;EXD1;EXOSC5
prerank,histone deacetylase binding (GO:0042826),0.42238454280734306,1.1887466444165737,0.22482435597189696,0.8788760688163181,1.0,21/88,14.12%,MEF2C;HEY2;GMNN;NACC2;PRDM1;HDAC9;MEF2A;TP53;SFPQ;RAD9A;RELA;CCND1;MTA3;PKN2;SIRT2;TOP2B;ANKRA2;KPNA2;CHD4;MEF2B;MTA1
prerank,protein phosphatase binding (GO:0019903),0.40999723614481315,1.1879174566219872,0.23666666666666666,0.8749505943932592,1.0,13/117,7.70%,MYOZ2;ATP2B4;PPP1R3A;MAP3K5;ITGA1;STRN3;MFHAS1;AKAP11;MAPT;DAB2IP;TP53;TRAF3;ENSA
prerank,sequence-specific mRNA binding (GO:1990825),0.6025655191177094,1.1856877353916166,0.31135531135531136,0.8753363536833421,1.0,1/10,0.82%,RBM24
prerank,CoA-ligase activity (GO:0016405),0.5605775225402782,1.1850155248452243,0.29609929078014185,0.8708582083867934,1.0,1/14,0.89%,ACSS1
prerank,tubulin binding (GO:0015631),0.3891577118632883,1.18190199423332,0.1712538226299694,0.8745721345129388,1.0,78/295,17.50%,ARHGEF7;FGF13;AGBL1;DLEC1;KIF27;CLASP2;FAM83D;KIF2A;HOOK2;TTLL7;MAP1B;TOGARAM2;HAUS8;DST;KIF3B;PRUNE1;MAP7D3;ARHGEF2;GABARAP;MAPRE2;TUBGCP6;KIF1A;MAPT;NDRG1;TPPP;RABGAP1;IFT81;EFHC1;EML1;EML5;HDGFL3;TPX2;RMDN3;TOGARAM1;OPA1;KIF5B;SUN2;WHAMM;CCDC170;WASHC1;BRSK1;HOOK1;CENPE;CCDC181;KIF1C;DNM1L;NCALD;ALDOA;FHDC1;TBCD;KIF5C;UNC5C;CLIP3;KIF5A;KIF20B;CLASP1;MAST1;MTCL1;MAP4;KIF18A;STMN2;LRRK2;KIF6;MAPRE3;UXT;DNM2;CCDC66;ABRAXAS2;MAP9;GAS2L3;INO80;KIF7;S100A8;S100A9;STARD9;DCTN1;SGIP1;MAP1A
prerank,GDP binding (GO:0019003),0.4423416383856852,1.1801002048859364,0.2474747474747475,0.874041750813603,1.0,8/63,9.85%,RASL12;RAP1A;RERG;GEM;RAP2C;RRAS;MIEF1;RAP2A
prerank,protein serine/threonine kinase activity (GO:0004674),0.3893329287446841,1.179915381962657,0.16395112016293278,0.8684732261841254,1.0,81/334,17.80%,MYLK2;MYLK;TTN;MAP3K20;MYLK4;CAMK2G;STK38L;MAP3K5;ROCK1;MAST4;KALRN;PRKAB2;DYRK2;CDK6;FAM20A;CAMK2D;ACVR2A;MARK1;BMPR1A;DYRK1A;PRKCQ;MAP4K3;MAP4K5;TAF1;RPS6KA2;MAPKAPK2;DYRK1B;CHEK1;NUAK1;MAP3K10;WNK2;DAPK3;MAP2K1;BRSK1;PKN2;PAK2;CDK7;STK33;STK24;EIF2AK2;ROCK2;PRKCD;ACVR1B;CDK12;DMPK;BMPR1B;TNIK;BCR;CDC42BPB;STK36;PRKD3;TAOK3;CDK15;MAST1;CPNE3;CSNK1E;SGK1;STK10;MAPK1;LRRK2;PRKAA2;PRKCA;PRKACA;SRPK2;MAPK12;CSNK1A1;RAF1;PLK4;HIPK2;MAST3;ATP23;MAP3K13;EIF2AK3;CDK14;MAP3K2;MARK2;BRD4;MASTL;EIF2AK4;STK35;DAPK2
prerank,kinase activity (GO:0016301),0.41519169381847737,1.1788652614968083,0.23387096774193547,0.865162178130299,1.0,21/109,14.40%,DGKB;DGKG;CKM;NMRK2;CKMT2;SEPHS2;ADPGK;SEPHS1;TAF1;COQ8A;PSTK;PKN2;DGKD;ITPKC;COASY;PRKD3;PIK3C3;DGKZ;CHKB;CKB;LRRK2
prerank,ribosomal large subunit binding (GO:0043023),-0.4930449120492978,-1.1785507064102794,0.2713936430317848,0.6627273063177817,1.0,4/11,13.62%,CPEB2;NMD3;LTN1;NEMF
prerank,microtubule motor activity (GO:0003777),0.44683268922756764,1.1756901984325625,0.26295336787564766,0.8685334299344162,1.0,18/51,17.28%,KIF27;KIF2A;DYNLRB1;KIF3B;DNAH17;KIF1A;KIF5B;CENPE;KIF1C;DYNC1I2;KIF5C;KIF5A;APPBP2;KIF20B;KIF18A;KIF6;KIF7;STARD9
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.5066465948635854,-1.1741756328142126,0.2607758620689655,0.667436011428127,1.0,3/10,3.69%,SLC6A13;SLC6A1;SLC6A12
prerank,protein tyrosine kinase activity (GO:0004713),0.40781050669550173,1.1739089103913416,0.23728813559322035,0.8680390451467773,1.0,11/108,5.45%,TTN;NTRK3;DYRK2;MERTK;MST1R;ROR1;FRK;MUSK;CAMKK2;PEAK1;DYRK1A
prerank,cholesterol transfer activity (GO:0120020),-0.4432267590330853,-1.172860363730987,0.288135593220339,0.664052638356356,1.0,5/16,17.17%,PLTP;ABCA1;GRAMD1C;GRAMD1A;STARD4
prerank,MAP kinase phosphatase activity (GO:0033549),0.5608956070097518,1.1711079556191415,0.30935251798561153,0.8703307122796055,1.0,4/12,12.82%,DUSP5;DUSP3;DUSP29;DUSP16
prerank,metalloexopeptidase activity (GO:0008235),0.44705412644076864,1.1675175192018792,0.2897800776196636,0.8749448515250725,1.0,7/51,7.40%,MMP17;AGBL1;LNPEP;RNPEP;CPA4;CPA3;ENPEP
prerank,store-operated calcium channel activity (GO:0015279),0.5852291321581515,1.1650587358366304,0.3339285714285714,0.876536372809177,1.0,2/10,8.89%,TRPC6;TRPC5
prerank,voltage-gated ion channel activity (GO:0005244),0.5470576431277332,1.1559938555923994,0.31208053691275167,0.8980183485352525,1.0,3/14,8.75%,CACNA1H;ANO6;VDAC1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4452464573286392,1.1550675830835915,0.3021978021978022,0.8950372988843723,1.0,7/44,9.03%,PRDM16;SMYD1;SUV39H2;ASH1L;KMT2D;SETD3;NSD3
prerank,pentosyltransferase activity (GO:0016763),0.47584736920267634,1.1524011163921213,0.31471389645776565,0.8972170873632281,1.0,8/36,13.71%,ART1;LARGE1;SIRT3;PARP1;ART4;SIRT2;PPAT;SIRT4
prerank,wide pore channel activity (GO:0022829),0.48669751968100944,1.1518350923826457,0.2986217457886677,0.89320367752023,1.0,4/23,11.42%,GJD3;GJC1;PANX1;GJA4
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.399971960325409,-1.1508007073246778,0.2571428571428571,0.7161196535215947,1.0,13/22,32.96%,OTUD7B;PARP10;OPTN;IKBKG;TAB2;ATRIP;WDR81;PRPF8;ZBTB1;IKBKE;SQSTM1;TNFAIP3;MINDY2
prerank,potassium ion antiporter activity (GO:0022821),-0.4396523748497405,-1.1492430485552891,0.3073286052009456,0.7127788362746053,1.0,7/15,27.33%,SLC24A3;SLC9A2;SLC9A6;SLC9A9;SLC9A5;SLC24A2;SLC24A4
prerank,MHC class I protein binding (GO:0042288),-0.4609668207634912,-1.1473898690797462,0.25790754257907544,0.7103250828097551,1.0,7/13,44.88%,DERL1;ABCB9;TAP1;TAPBP;ATP5F1B;TAP2;LILRB1
prerank,gap junction channel activity (GO:0005243),0.49030739124345496,1.147127430772859,0.29876160990712075,0.901292593503525,1.0,4/22,11.42%,GJD3;GJC1;PANX1;GJA4
prerank,syntaxin-1 binding (GO:0017075),0.49179777406789693,1.1465630271480227,0.31937984496124033,0.8971139066588882,1.0,2/22,1.34%,STXBP2;SYPL2
prerank,transmitter-gated ion channel activity (GO:0022824),0.48146932508943907,1.146185790194888,0.30029154518950435,0.8924769401357648,1.0,7/29,11.98%,GABRE;GABRA4;GABRA5;GRIK5;GABRB2;GABRG1;GABRB3
prerank,frizzled binding (GO:0005109),-0.36287033860463097,-1.1455039504981182,0.22847682119205298,0.7078345782444324,1.0,13/34,33.22%,WNT4;WNT5A;WNT9A;SDCBP;RNF43;WNT6;MYOC;ZNRF3;WNT16;DVL2;WNT11;CCDC88C;BAMBI
prerank,growth factor receptor binding (GO:0070851),0.40375576367361243,1.1435543330252609,0.2767962308598351,0.8942074534580722,1.0,16/95,10.74%,FGF1;HIP1;PDGFB;PDGFC;IL2;PDGFD;ATXN2;VEGFA;IL12RB1;AREG;PIBF1;ITGB3;ADAM17;PDGFRB;HBEGF;PDGFA
prerank,protein phosphatase 1 binding (GO:0008157),0.4976845933103156,1.1434641261514913,0.3269537480063796,0.888717879671574,1.0,2/21,5.81%,PPP1R3A;AKAP11
prerank,N-acetyltransferase activity (GO:0008080),0.5198017958114105,1.1426758920435784,0.3164983164983165,0.8855123971000733,1.0,8/19,18.44%,NAT10;SAT2;NAT8L;NAT8;NAT14;NAT2;NAT1;ESCO1
prerank,cadherin binding (GO:0045296),0.37826179020150535,1.1416566578467853,0.2231237322515213,0.8831362724624173,1.0,48/315,10.23%,CTNNA3;FLNA;NOTCH3;CDH6;PDLIM1;PDLIM5;CALD1;VASN;VCL;ESYT2;PFKP;CNN2;MYH9;PHLDB2;COBLL1;CDH13;ANXA1;PACSIN2;BZW2;ITGB1;TAGLN2;MYO1B;CDH4;ARHGEF16;CDHR3;MPP7;EPN2;NDRG1;DAB2IP;CHMP5;KTN1;PTPN1;TLN1;CNN3;KIF5B;CDH2;PPP1CA;ANLN;PKN2;PAK2;ARHGAP1;LRRFIP1;EPHA2;BAG3;PARVA;IST1;STK24;EIF3E
prerank,leucine zipper domain binding (GO:0043522),0.5764077274884754,1.1414674738836883,0.34942084942084944,0.8780883594737874,1.0,5/10,18.00%,MRTFA;DAPK3;PAWR;PMF1;DDIT3
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.5266519772033227,1.141314464958456,0.3284552845528455,0.8730605390269237,1.0,4/16,8.59%,ALOX5;ETHE1;HGD;ADI1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5461545735599037,1.1377840167542317,0.3508771929824561,0.8774060481734739,1.0,3/12,8.49%,CRYZ;DHRS4;CBR1
prerank,carboxylic acid binding (GO:0031406),-0.3330955460986291,-1.1376705303772947,0.24305555555555555,0.7213835242963869,1.0,14/38,25.67%,GRM7;UBR2;GLRB;NOS3;GRIN3A;GLRA2;PHYH;SRR;HIF1AN;EPDR1;GLRA1;PSAP;SESN2;GCLC
prerank,U6 snRNA binding (GO:0017070),0.5335225083615713,1.1348241739023956,0.34915254237288135,0.8807120927139562,1.0,3/14,10.93%,LSM8;EIF5A;PRPF4
prerank,double-stranded DNA binding (GO:0003690),-0.2177673632358125,-1.1293895280532669,0.0,0.7368600222384012,1.0,120/531,20.10%,TCF4;FLI1;NFAT5;ZBTB20;HLF;RBMS1;LEF1;NFATC3;HOXB6;FOXP1;ZIC1;ELF1;HMGB1;KDM5B;PKNOX2;CREM;ZIC4;KLF12;E2F3;GLI2;EGFR;ERG;CREB5;PKNOX1;RUNX2;JDP2;PRKDC;XRCC5;CUX1;HOXB4;MTF1;ARNT2;ELK3;PRRX2;TBX15;HOXA5;MRE11;WDR48;MEOX2;ELK4;MBD1;POLR3F;CRY1;KLF3;ZFP1;GLIS1;FOXC2;POU6F1;RAD50;FBH1;TFEB;MAU2;HSF2;TFCP2;CAMTA1;ERCC5;MAX;NR3C1;RFX2;AHR;MEIS2;OSR1;ESR1;MAFG;ATF2;ZNF740;SIX1;ZNF177;DDX60;HES1;TEAD2;ZIC5;IRF9;CREB1;TARDBP;XRCC6;SOX4;BHLHE41;ZNF76;KLF2;GMEB2;CEBPB;ELF2;ELK1;MAF;KLF10;ARNT;TEF;BHLHE40;CREB3L1;ATF7;GLIS2;KLF5;VSX1;KLF13;RARA;NFIB;TFE3;SMAD2;LHX6;PPARG;NPAS2;XPA;RORB;TFCP2L1;KLF11;E2F4;HOXB8;TGIF1;HSF1;CAMTA2;PARK7;MECP2;THRB;SATB1;HOXB9;HOXA9;MSH6;ONECUT2;NFATC2
prerank,telomeric DNA binding (GO:0042162),-0.36171568253144676,-1.1282402532899942,0.26480836236933797,0.7324798517192366,1.0,12/32,17.92%,UPF2;XRCC5;STN1;SMG1;RAD50;BLM;XRCC6;HNRNPD;CTC1;TERF2IP;KDM1A;SMG6
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.4209358335967269,-1.127365362001932,0.2878411910669975,0.7271922383081358,1.0,9/15,31.80%,SLC1A3;SLC17A6;SLC38A7;SLC1A4;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6
prerank,galactosyltransferase activity (GO:0008378),-0.4746464570711712,-1.1261897925337088,0.32954545454545453,0.7228195855084825,1.0,8/11,36.38%,B4GALT1;B4GALT6;B4GALT4;B4GALT7;B4GALT3;B4GALT2;A3GALT2;B3GALT6
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.35307522641186306,-1.1238918443903094,0.2651006711409396,0.7210581052725539,1.0,9/32,12.77%,KDM7A;KDM2A;TET3;TET2;EGLN3;BBOX1;PHYH;EGLN2;RIOX2
prerank,cation transmembrane transporter activity (GO:0008324),-0.3150105503134219,-1.121194021950897,0.2916666666666667,0.7213091274688351,1.0,18/48,22.84%,SLC41A1;SLC6A6;SLC3A2;SLC7A5;SLC6A9;SFXN2;SLC39A1;SLC66A1;SLC38A5;SLC38A6;SLC25A38;SLC8B1;SLC38A7;MMGT1;SLC15A4;SLC1A4;SLC36A1;SLC1A1
prerank,nuclear localization sequence binding (GO:0008139),0.5038221965980311,1.1112194967332933,0.36492890995260663,0.9446264996800582,1.0,7/18,14.38%,CABP1;KPNA4;NUP153;RANBP6;KPNA2;KPNA3;IPO4
prerank,amino acid binding (GO:0016597),-0.33994363336063543,-1.1083723760331665,0.3081761006289308,0.7490453503915413,1.0,11/31,21.40%,GRM7;GLRB;NOS3;DDAH1;GRIN3A;GLRA2;SRR;AARS1;DDAH2;GLRA1;ASS1
prerank,active ion transmembrane transporter activity (GO:0022853),-0.3282107892731376,-1.108030552031843,0.3090909090909091,0.7427220331418262,1.0,11/37,12.30%,SLC22A8;SLCO2B1;SLCO1C1;SLCO2A1;CYB5A;SLC22A6;UQCRC1;SLCO3A1;SLC22A4;COX10;ATP13A3
prerank,ferrous iron binding (GO:0008198),-0.3842265221621607,-1.1068359196123825,0.34324324324324323,0.7387745996227165,1.0,11/21,26.20%,TET2;EGLN3;FTL;FTH1;PHYH;EGLN2;SNCA;CDO1;HIF1AN;ISCU;FECH
prerank,solute:proton symporter activity (GO:0015295),-0.4131446885163907,-1.10300314608863,0.3399503722084367,0.7417975164351561,1.0,4/16,7.67%,SLC2A13;SLC25A3;SLC39A8;CTNS
prerank,pyridoxal phosphate binding (GO:0030170),0.4861055211562332,1.0996162449086124,0.3667711598746082,0.9741030940002126,1.0,3/20,10.83%,PYGM;PYGB;ACCS
prerank,protein tyrosine kinase activator activity (GO:0030296),0.4961601094749539,1.0979380938931311,0.34548335974643424,0.9734663121112676,1.0,5/19,13.57%,ANGPT4;CCL5;ERCC6;PAK2;GAS6
prerank,ubiquitin protein ligase activity (GO:0061630),-0.2447210809540069,-1.096195323640431,0.2,0.7528503457455687,1.0,58/228,15.38%,RNF220;KCMF1;RNF145;NEDD4L;SH3RF1;TRIP12;AREL1;ITCH;RNF38;CUL3;RNF185;MYCBP2;PPIL2;UBE2D3;RNF135;RC3H2;RNF144B;SHPRH;RNF217;TRIM24;RNF6;UBR2;BIRC2;RNF25;RNF13;HERC2;LTN1;MDM2;PELI1;TOPORS;TRIM25;WWP1;SH3RF3;SMURF2;RNF144A;PRKN;UBE3A;MGRN1;MKRN2;RNF181;UBE4B;TRIM5;RNF34;STUB1;DTX1;VPS18;TRIM14;RNF125;DTX3L;RNF166;SH3RF2;SIAH1;RNF115;HECW1;BIRC3;RNF10;NHLRC3;RNF43
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.3698964560128435,1.09614703628213,0.3199577613516367,0.9731658235025675,1.0,20/188,8.05%,SOX6;PRDM16;SOX5;MEF2C;GABPA;ARID5B;HINFP;MTERF3;TBX18;KLF15;SUV39H2;JUND;ARID5A;TP53;GRHL1;SFPQ;AR;YAP1;RELA;KMT2D
prerank,copper ion binding (GO:0005507),0.42713222112801336,1.095946812646289,0.3360655737704918,0.968009089022589,1.0,11/42,18.02%,AOC3;LOXL2;RNF7;TP53;SUMF1;ATP7B;SNCG;MT3;SOD3;SNCB;P2RX4
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.306596787705461,-1.0948923143684643,0.3209302325581395,0.74938051103482,1.0,14/55,9.67%,SLC6A13;SLC16A12;SLC13A3;PDPN;SLC16A9;SLC6A12;SLC6A6;SLC16A1;SLC7A14;SLC25A32;SLC7A5;SLC16A11;SLC38A10;SLC22A4
prerank,peptide hormone receptor binding (GO:0051428),-0.46220323012873243,-1.0941467855226632,0.3617021276595745,0.7442735028223,1.0,5/11,37.67%,PSMC5;PTHLH;ADCYAP1;GNRH1;CCK
prerank,thyroid hormone receptor binding (GO:0046966),-0.3593931737989749,-1.0930725551161244,0.3373860182370821,0.7396657738006288,1.0,6/28,6.47%,NSD1;MED13;TRIP12;TACC1;MED17;PRMT2
prerank,G protein-coupled receptor activity (GO:0004930),0.3649007856914442,1.092842184513979,0.3215400624349636,0.9716533781261293,1.0,18/239,10.07%,AGTR1;LHCGR;GPR20;HCRTR1;CRHR2;S1PR3;VIPR2;ADRA1D;TSHR;TAPT1;CYSLTR2;CXCR6;GPR17;NTSR2;XPR1;PTH1R;ADGRL2;PDGFRB
prerank,protein kinase binding (GO:0019901),0.3556335332334112,1.0923507187954749,0.25925925925925924,0.9675059818487336,1.0,62/479,10.14%,ACTA2;ARHGEF7;TTN;PPP1R12A;RYR2;INKA2;PDLIM5;PRKAB2;LIMS1;CCNA2;FERMT2;FZD5;CCND2;CSPG4;FAM83D;DUSP5;KCNA5;ITGB1;RHOBTB3;LAX1;HDAC9;PARN;ANKRD2;TSKS;ACTB;UTRN;DOK7;IRS1;LYST;CAV1;MAPT;DAB2IP;MAPKAPK2;DUSP3;TP53;PARP1;PIN1;PTPN1;CALM1;TPX2;PLEK;RAD9A;SOX9;ADD2;RELA;PKIA;TNIP1;TRIM68;CCND1;RHOF;PRKAR1B;VDAC1;GSTP1;PPP1CB;SKI;PAK2;TOM1L2;ADCY6;HIF1A;CEP192;PDGFRB;GYS1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.4539597206535203,-1.091196859410752,0.3937947494033413,0.7377203964627095,1.0,2/11,5.36%,SASH1;STK38
prerank,poly-purine tract binding (GO:0070717),0.4545099453853784,1.0899861453475659,0.37091988130563797,0.9688465413243557,1.0,7/27,11.06%,RBPMS;RBMS3;MCRS1;ATXN1;PPIE;HNRNPU;DDX1
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.43903858894920234,-1.0895687753593173,0.3530701754385965,0.7349116292457107,1.0,6/12,25.69%,SLC9B2;SLC9A2;LETM1;SLC9A6;SLC9A9;SLC9A5
prerank,sterol binding (GO:0032934),-0.2992690219792297,-1.0863473460482342,0.33183856502242154,0.7368974251682815,1.0,19/56,23.59%,OSBPL8;ABCA1;PTCH1;OSBPL10;GRAMD1C;ANXA6;APOD;SCARB2;SIDT1;PROM1;SOAT1;GRAMD1A;INSIG1;STARD4;OSBP;SYP;STARD3NL;STARD5;NPC1
prerank,translation elongation factor activity (GO:0003746),0.5046035422309832,1.083954548675566,0.39636363636363636,0.9810555412196895,1.0,7/14,18.09%,EEFSEC;GFM2;EIF5AL1;EIF5A;TSFM;GTPBP2;EEF2
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.24035982976792278,-1.083944306932421,0.16666666666666666,0.7369243794564705,1.0,98/346,19.46%,RNF220;TTC3;KCMF1;RNF145;NEDD4L;SH3RF1;TRIP12;FBXL5;RNF146;AREL1;ITCH;RNF38;FBXO10;CUL3;SEL1L;RNF185;MYCBP2;RNF20;PPIL2;UBE2D3;RNF135;BIRC6;RC3H2;RNF144B;SHPRH;RNF217;TRIM24;RNF6;PML;UBR2;BIRC2;RNF25;RNF13;FBXO9;HERC2;LTN1;RNF213;MDM2;PELI1;FBXO4;TOPORS;UBE2E2;CDC23;UBE2E3;FBXO7;RBCK1;TRIM25;WWP1;SH3RF3;SMURF2;RNF144A;RNF31;PRKN;UBE3A;MGRN1;FBXO25;MKRN2;RMND5B;RNF181;TRIM5;FBXO3;RNF34;STUB1;RMND5A;DZIP3;DTX1;VPS18;TRIM14;RNF125;DTX3L;RNF166;FBXW8;SH3RF2;SIAH1;UBE2H;RNF115;HECW1;BIRC3;RNF10;OBI1;NHLRC3;RNF43;TRIM56;DTX3;BCOR;CDC42;UBE2S;ANAPC4;UBA7;SIAH2;SYVN1;RNF130;CHFR;NEURL2;RNFT1;ARIH1;RNF41;BTRC
prerank,ATP binding (GO:0005524),0.36094296787246705,1.0799979522485088,0.31794871794871793,0.9874295639183476,1.0,44/266,13.66%,RYR1;MAP3K20;STK38L;MAP3K5;ACTA1;UBA2;DYRK2;PFKP;CDK6;MYH9;PDK4;MYO9B;RHOBTB3;MYO1B;KSR1;PEAK1;MARK1;BMPR1A;MYO18A;MAP4K3;MAP4K5;ABCE1;STK26;ERCC6;WNK2;DAPK3;PAPOLA;PRKACB;ABCD4;LONP1;BRSK1;HNRNPU;PFKM;DDX25;ABCG1;ACVR1B;DMPK;BMPR1B;CDC42BPB;SMARCA5;STK36;MAST1;ATP7B;PDK2
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.4469307808936283,1.0749134234229163,0.38472622478386165,0.9966538203337225,1.0,6/31,11.35%,TMEM38B;KCNQ4;ABCC8;TMEM38A;KCNK3;KCNA2
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.35075060640962386,1.0695672314165428,0.33768844221105526,1.0,1.0,71/431,14.41%,RYR1;RASL12;MAP3K20;RAP1A;STK38L;MAP3K5;TUBA1C;ACTA1;UBA2;DYRK2;PFKP;CDK6;MYH9;PDK4;RRAD;MYO9B;RERG;GEM;RHOBTB3;MYO1B;MFHAS1;KSR1;PEAK1;MARK1;SEPHS1;BMPR1A;MYO18A;MAP4K3;MAP4K5;RAP2C;RRAS;RANBP17;TUBB2B;RHOJ;ABCE1;STK26;ERCC6;WNK2;DAPK3;PAPOLA;PRKACB;RHOF;ABCD4;LONP1;BRSK1;RRAGB;RAP2A;HNRNPU;REM1;PFKM;DDX25;RHOH;ABCG1;ACVR1B;DRG2;DMPK;BMPR1B;GBP2;CDC42BPB;SMARCA5;STK36;ADSS1;MAST1;LSG1;ATP7B;PDK2;TUBD1;SARS2;RAB14;LRRK2;DIRAS2
prerank,TBP-class protein binding (GO:0017025),-0.3793174911147968,-1.0685998190241524,0.3891891891891892,0.7701601990899718,1.0,11/21,26.88%,YEATS2;AHR;ESR1;DR1;PSMC5;PSMC2;TAF12;TAF13;GTF2A2;DRAP1;HHEX
prerank,magnesium ion binding (GO:0000287),0.3650562214740597,1.0679534056310511,0.37458926615553123,1.0,1.0,18/135,9.85%,MAP3K20;STK38L;MAP3K5;UBA2;DYRK2;ADCY2;GEM;MARK1;TESC;TPPP;STK26;OPA1;PAPOLA;PRKACB;DIS3L2;BRSK1;AASDHPPT;RAP2A
prerank,MAP-kinase scaffold activity (GO:0005078),-0.4391687782282846,-1.0674134786072274,0.40229885057471265,0.7663712299794627,1.0,4/11,11.08%,AKAP13;SH3RF1;MAPK8IP3;MAP2K2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.4436564077228079,-1.0661564159205574,0.4022727272727273,0.7630282267333682,1.0,9/11,50.53%,HMCES;HMGA2;NEIL1;NEIL3;NTHL1;NEIL2;APEX1;APEX2;APLF
prerank,low-density lipoprotein particle binding (GO:0030169),0.4987652549379388,1.0653538154844633,0.41788617886178864,1.0,1.0,2/16,2.68%,CD36;CDH13
prerank,iron ion binding (GO:0005506),-0.3027115939708878,-1.0651530916252532,0.3545816733067729,0.7590520719655781,1.0,13/48,15.10%,AGMO;KDM7A;FBXL5;AOX1;TET2;JMJD6;EGLN3;FTL;FTH1;PHYH;EGLN2;SNCA;CDO1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.5018698360431152,1.0645382178545393,0.3944153577661431,1.0,1.0,3/13,5.56%,WDR4;FTSJ1;TRMT10C
prerank,platelet-derived growth factor binding (GO:0048407),0.5171358824113128,1.0637617310270933,0.414721723518851,1.0,1.0,5/11,12.43%,COL4A1;PDGFB;PDGFRB;PDGFA;COL3A1
prerank,nuclear import signal receptor activity (GO:0061608),0.4971993768110315,1.0623002976062652,0.39965986394557823,1.0,1.0,8/15,20.74%,KPNA4;RANBP6;KPNA2;TNPO3;KPNA3;IPO4;IPO9;HIKESHI
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.30125829030224033,-1.0613192940195244,0.3729508196721312,0.7623218396444958,1.0,20/49,24.55%,UBQLN1;OTUD7B;UBL7;UFD1;PARP10;OPTN;IKBKG;TAB2;BRCC3;EPS15;DZIP3;MINDY1;UBXN1;ATRIP;UBQLN2;WDR81;SHARPIN;PRPF8;ZBTB1;RAD23B
prerank,retinoid X receptor binding (GO:0046965),-0.44511199269476254,-1.0609920365024492,0.4019138755980861,0.7566199394118451,1.0,3/11,8.25%,NSD1;TACC1;MED25
prerank,deubiquitinase activity (GO:0101005),-0.26447033231619066,-1.058601693753729,0.31097560975609756,0.7562259641065227,1.0,24/88,19.25%,ATXN3;USP53;USP46;USP11;MINDY3;OTUD7B;USP45;UFD1;USP19;USP7;USP12;BRCC3;USP3;USP29;MINDY1;PAN2;VCPIP1;USP37;OTUD3;EIF3F;USP24;ZC3H12A;USP10;USP32
prerank,ligand-gated cation channel activity (GO:0099094),0.38704709822888145,1.0568451564453747,0.4146341463414634,1.0,1.0,9/75,12.48%,ASIC3;KCNJ12;GRIN2C;KCNN2;CCDC51;TRPM4;GRIK5;CHRNA7;TRPM2
prerank,estrogen receptor binding (GO:0030331),-0.328540474690965,-1.0568344574556157,0.3654485049833887,0.7540867607091255,1.0,8/32,10.50%,NSD1;LEF1;TACC1;NCOA1;PRMT2;CTNNB1;ESR1;TRIP4
prerank,inward rectifier potassium channel activity (GO:0005242),0.459465513131888,1.0548016229332067,0.41297935103244837,1.0,1.0,3/24,9.37%,KCNJ12;KCNN2;ABCC8
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3013180659531689,-1.0545591194493682,0.3522267206477733,0.7533246061764466,1.0,17/47,18.62%,SLC7A11;SLC6A13;SLC47A1;PDPN;SLC6A1;SLC6A6;SLC7A14;SLC3A2;SLC7A5;SLC38A10;SLC22A4;SLC43A2;SLC66A1;SLC38A5;SLC38A6;SLC38A7;SLC7A7
prerank,nucleotidyltransferase activity (GO:0016779),0.4691098298260773,1.0540825231324806,0.4067524115755627,1.0,1.0,4/19,8.44%,CGAS;CRPPA;TERT;TENT4A
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.4908985396029705,1.051316502405017,0.40460526315789475,1.0,1.0,3/15,9.35%,NDST3;HS2ST1;HS6ST1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.49601284950796565,1.0508375139182686,0.4027072758037225,1.0,1.0,2/13,2.62%,PIP5K1B;PIP4K2A
prerank,anion channel activity (GO:0005253),0.38852218886253836,1.04834419699545,0.38729763387297633,1.0,1.0,10/61,11.98%,ANO1;GABRE;ANO6;GABRA4;GABRA5;VDAC1;GABRB2;GABRG1;ANO3;GABRB3
prerank,protein tyrosine kinase binding (GO:1990782),0.38841858894657216,1.0449246935458147,0.41019417475728154,1.0,1.0,10/71,6.82%,ANGPT2;ANGPT1;ANGPT4;SOCS5;ITGB1;PITPNM3;ARHGEF16;DUSP3;TP53;PTPN1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.43939866161887636,1.0444202504475686,0.42074074074074075,1.0,1.0,5/29,8.72%,INKA2;PKIB;HEXIM1;PKIA;PRKAR1B
prerank,nucleoside-triphosphatase activity (GO:0017111),0.34508643881563267,1.0438834171440325,0.4139344262295082,1.0,1.0,56/248,16.94%,RASL12;RAP1A;MYO1E;MYL6;MYH9;KIF2A;RERG;GEM;RHOBTB3;GNAO1;GNAZ;MYO18A;NKIRAS2;KIF1A;RAP2C;TPPP;RRAS;ABCA3;PIN1;RHOJ;RAB3A;ENTPD7;OPA1;ATP2B1;RHOF;GNA12;GNG11;RRAGB;RAP2A;GFM2;ATAD1;KIF1C;DNM1L;GSPT1;MFN2;RHOH;RUVBL1;DRG2;KIF5A;GBP2;CLU;KIF20B;LSG1;GNAQ;RAB14;LRRK2;DIRAS2;RAB8B;RHOG;DNM2;VWA8;RHOT1;AGAP2;RAB8A;DHX9;RAB38
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5146770706304152,1.0431453786070068,0.4288354898336414,1.0,1.0,1/10,3.53%,DCTD
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.454854507154901,1.0430843948157704,0.4080370942812983,0.997646486766442,1.0,5/22,13.20%,RBM24;RBMS3;CPEB1;CPEB3;ZFP36L1
prerank,adenyl ribonucleotide binding (GO:0032559),0.3469002148718082,1.0428333808845132,0.39734422880490294,0.9932008251781291,1.0,46/291,13.01%,RYR1;MAP3K20;STK38L;MAP3K5;ACTA1;UBA2;DYRK2;PFKP;CDK6;MYH9;PDK4;MYO9B;RHOBTB3;MYO1B;KSR1;PEAK1;MARK1;BMPR1A;PDE4A;MYO18A;MAP4K3;MAP4K5;COQ8A;ABCE1;STK26;ERCC6;MIEF1;WNK2;DAPK3;PAPOLA;PRKACB;ABCD4;LONP1;BRSK1;HNRNPU;PDE4D;PFKM;DDX25;ABCG1;ACVR1B;DMPK;BMPR1B;CDC42BPB;SMARCA5;STK36;MAST1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.4961454610040916,1.0421082008151152,0.42786069651741293,0.9900200501056762,1.0,2/14,4.10%,KCNA5;KCNE4
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.36953969868531333,-1.0420590665068603,0.3828125,0.7801697587367731,1.0,4/20,7.73%,SENP1;SENP3;COPS2;USP7
prerank,lipase activator activity (GO:0060229),0.5175121674839744,1.0414517360717934,0.42015209125475284,0.9866346117737451,1.0,2/10,4.86%,CCL5;ARHGAP6
prerank,cyclic nucleotide binding (GO:0030551),0.45832119596598064,1.0402545477235363,0.4319620253164557,0.9847867655559218,1.0,4/21,11.18%,PDE5A;PDE4A;KCNH1;PDE4D
prerank,nuclear receptor binding (GO:0016922),0.3599793132860075,1.0378106387764081,0.4126984126984127,0.9864882517977044,1.0,24/111,11.69%,ACTN4;SMARCD3;NR1H4;NR4A1;RERG;PADI2;ARID1A;TGFB1I1;NCOA7;ASXL1;TAF1;ARID5A;HMGN3;PPARGC1A;MED1;PPARGC1B;MED12;TRIM68;NR4A2;HIF1A;MED14;TACC2;BAZ2A;ZBTB7A
prerank,retinoic acid receptor binding (GO:0042974),0.4708955494192044,1.0338290942356299,0.4372937293729373,0.9920681171838788,1.0,5/17,9.10%,ACTN4;ASXL1;ARID5A;MED1;NR4A2
prerank,serine-type peptidase activity (GO:0008236),0.3646932281913626,1.0298341470485848,0.4308571428571429,0.9978638792915552,1.0,7/96,10.51%,TMPRSS4;HTRA1;KLK2;APEH;PRSS8;MASP2;MBTPS1
prerank,metal ion:proton antiporter activity (GO:0051139),-0.40762756549803525,-1.0296484537307207,0.4125560538116592,0.8058423211570866,1.0,6/13,25.69%,SLC9B2;SLC9A2;LETM1;SLC9A6;SLC9A9;SLC9A5
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.2612972329212465,-1.0295119983234677,0.3575757575757576,0.7996876852306379,1.0,22/83,19.25%,ATXN3;USP53;USP46;USP11;MINDY3;OTUD7B;USP45;UFD1;USP19;USP7;USP12;BRCC3;USP3;USP29;PAN2;VCPIP1;USP37;OTUD3;USP24;ZC3H12A;USP10;USP32
prerank,semaphorin receptor binding (GO:0030215),-0.3542727414620691,-1.026023577285143,0.4388059701492537,0.8023564999977951,1.0,7/23,11.12%,SEMA3D;SEMA3C;SEMA6A;SEMA7A;SEMA3A;SEMA4D;SEMA6D
prerank,hormone receptor binding (GO:0051427),-0.37792727477440924,-1.0259179249216626,0.43243243243243246,0.7962528883874522,1.0,6/14,37.67%,SOCS2;PTHLH;ADCYAP1;NCOA6;NPPC;CCK
prerank,PDZ domain binding (GO:0030165),0.38462621685861326,1.024574818906008,0.4271604938271605,1.0,1.0,14/61,14.25%,ATP2B4;SDC2;CRIM1;FZD4;ARHGEF16;FZD8;SYNJ2;ATP2B1;ADAM17;SLC22A5;TMEM88;NSF;TMEM88B;PLEKHA1
prerank,chloride channel regulator activity (GO:0017081),-0.4053407331980444,-1.02455348656036,0.4351145038167939,0.7932854638600708,1.0,6/14,17.84%,WNK1;WNK4;WNK3;STX1A;VAMP8;STX8
prerank,double-stranded RNA binding (GO:0003725),0.36805988079405066,1.0232199356132816,0.43333333333333335,1.0,1.0,21/70,19.70%,ACTN1;VIM;MTDH;DICER1;EIF4A1;LRRFIP1;MBNL1;HNRNPU;EIF2AK2;DROSHA;OASL;DHX30;DGCR8;STAU2;RFTN1;DHX9;CLTC;PRKRA;ILF3;AGO1;ADARB1
prerank,cytokine receptor binding (GO:0005126),0.3624509424738861,1.0226727477559294,0.4206730769230769,1.0,1.0,12/83,10.34%,LIFR;CRLF1;IL2;CCL5;PXDN;VEGFA;IL12RB1;PIBF1;IL22;TGFB2;ADAM17;IL13RA1
prerank,metalloendopeptidase activity (GO:0004222),0.36914005037102504,1.022660098255656,0.4186320754716981,0.9974302743669008,1.0,15/76,15.09%,MMP17;ADAMTS14;ADAMTS5;ADAMTS19;AFG3L2;TRABD2B;ADAM17;MIPEP;THSD4;PHEX;ADAMTS20;ADAMTS16;PMPCB;ADAM19;ADAMTSL4
prerank,GTP binding (GO:0005525),0.34495936056708065,1.021800244840288,0.4488697524219591,0.9949116309811568,1.0,34/172,16.94%,RASL12;RAP1A;TUBA1C;RRAD;RERG;GEM;RHOBTB3;MFHAS1;SEPHS1;RAP2C;RRAS;RANBP17;TUBB2B;RHOJ;RHOF;RRAGB;RAP2A;REM1;RHOH;DRG2;GBP2;ADSS1;LSG1;TUBD1;RAB14;LRRK2;DIRAS2;RHOG;DNM2;RHOT1;AGAP2;RAB8A;ARL4D;RAB38
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.510551117454593,1.0210148316427328,0.46113989637305697,0.9921822562204193,1.0,6/12,19.82%,CDK6;CDK7;CDK12;MAPK1;BRD4;CDK13
prerank,endoribonuclease activity (GO:0004521),-0.3167043298145017,-1.0190191257055872,0.4098939929328622,0.8008605370033116,1.0,12/32,25.89%,AGO3;ZC3H12B;TSNAX;ERN1;ZC3H12C;SMG6;ZC3H12A;RNASEL;INTS11;KHNYN;EXOG;SND1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.4184129506174773,1.0189374423100648,0.43731778425655976,0.9926637445008426,1.0,7/28,15.38%,MYD88;DAB2IP;TRAF3;TRAF5;CASP8AP2;FEM1B;STAT1
prerank,semaphorin receptor activity (GO:0017154),-0.43248931532523055,-1.0182456538857292,0.47149122807017546,0.7965561770154768,1.0,4/11,8.24%,PLXNA2;NRP2;NRP1;PLXNA4
prerank,5'-nucleotidase activity (GO:0008253),0.4826222861893464,1.0172337559378193,0.4688026981450253,0.9923792902595001,1.0,5/13,19.79%,ACP3;NT5C2;NT5M;NT5C3A;NT5C
prerank,sulfotransferase activity (GO:0008146),-0.31583713050624573,-1.0168736655396555,0.4212218649517685,0.7940391458772953,1.0,5/33,8.17%,UST;CHST11;HS3ST3A1;CHST9;TPST1
prerank,ribonuclease activity (GO:0004540),-0.2771045580565562,-1.0168168910714217,0.4380952380952381,0.788096939028141,1.0,22/56,27.90%,AGO3;ZC3H12B;TSNAX;SAMHD1;EXOSC1;RNASE4;ERN1;ZC3H12C;EXOSC9;SMG6;ZC3H12A;EXOSC2;RNASEL;INTS11;PPP1R8;KHNYN;EXOSC7;EXOSC3;EXOG;SND1;EXOSC5;ELAC2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.4260200765828085,-1.0144353809070925,0.47404063205417607,0.7876846310505808,1.0,3/11,7.55%,CARM1;PRMT2;PRMT3
prerank,endonuclease activity (GO:0004519),-0.28363125889770574,-1.0131643624448339,0.4336283185840708,0.7848607261858813,1.0,18/49,27.55%,AGO3;ZC3H12B;MRE11;N4BP2;TSNAX;ERCC5;DIS3;ERN1;ZC3H12C;SMG6;ZC3H12A;RNASEL;INTS11;KHNYN;ERCC4;EXOG;SND1;OGG1
prerank,poly(A) binding (GO:0008143),0.4405775193389626,1.0126174800253531,0.46226415094339623,1.0,1.0,5/21,11.06%,RBPMS;RBMS3;PPIE;HNRNPU;DDX1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.44029218193605063,1.010837895907648,0.454983922829582,0.999923528131954,1.0,1/21,1.46%,FGF1
prerank,nuclear receptor coactivator activity (GO:0030374),0.3826684447342408,1.0093418753314927,0.46455696202531643,0.9990128383171565,1.0,9/52,10.58%,ACTN1;ACTN4;NCOA7;PPARGC1A;MED1;PPARGC1B;MED12;SFR1;MED14
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.49982175809610585,1.0070081809013027,0.4690909090909091,1.0,1.0,2/10,11.27%,DPYSL4;OPLAH
prerank,omega peptidase activity (GO:0008242),-0.25244140328096093,-1.0028373359536296,0.4489795918367347,0.8048727466439349,1.0,29/89,24.98%,ATXN3;USP53;USP46;USP11;MINDY3;OTUD7B;USP45;UFD1;USP19;USP7;USP12;BRCC3;USP3;ASRGL1;USP29;PAN2;VCPIP1;USP37;OTUD3;USP24;ZC3H12A;USP10;USP32;MPND;USP25;CYLD;GGT7;OTUD1;UCHL1
prerank,metallopeptidase activity (GO:0008237),0.349200760417087,1.0023685057556897,0.4633596392333709,1.0,1.0,17/113,11.91%,MMP17;PAPPA2;ADAMTS14;ADAMTS5;ADAMTS19;LNPEP;RNPEP;AFG3L2;TRABD2B;ADAM17;MIPEP;THSD4;ADAM18;PHEX;ADAMTS20;ADAMTS16;EIF3H
prerank,hexosaminidase activity (GO:0015929),-0.3963656545289662,-1.0009829900405451,0.4794520547945205,0.8033432092450423,1.0,4/12,20.45%,CEMIP;HEXA;CEMIP2;NAGA
prerank,SUMO binding (GO:0032183),0.47080295857348153,0.9989723120004134,0.4778156996587031,1.0,1.0,3/13,11.10%,UBA2;CBX4;CASP8AP2
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3359435235237769,0.9982965399366831,0.502127659574468,1.0,1.0,24/173,11.71%,PRDM16;HEY2;ZFHX3;TBX2;ZEB2;ETS2;HEYL;ZNF436;NACC2;PRDM1;OSR2;TBX18;KCNIP3;SNAI2;RELA;PPARA;SKI;NR1D1;LRRFIP1;ZBTB33;ZNF3;SREBF2;ATF3;NFX1
prerank,tRNA binding (GO:0000049),0.3968141242478387,0.9978826443352735,0.4596774193548387,1.0,1.0,15/43,17.63%,HSD17B10;NAT10;TYW5;TRMT10C;TERT;PSTK;SEPSECS;AIMP1;NSUN2;RPUSD4;SARS2;KARS1;SARS1;FARS2;EIF2AK4
prerank,ATPase regulator activity (GO:0060590),0.3954095730772084,0.9974075883091983,0.4606896551724138,1.0,1.0,11/38,19.22%,PLN;ATP1B1;BAG3;DNAJC1;FNIP2;BAG2;HSPBP1;DNAJA2;DNAJB6;BRSK2;SIL1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.331365450432657,-0.9966259794291131,0.4553072625698324,0.8077128892363553,1.0,6/25,9.33%,POR;CYP27A1;CYP26B1;FMO1;FMO2;NOS3
prerank,lysophospholipase activity (GO:0004622),-0.3516455306759732,-0.9926060388561264,0.47527472527472525,0.8115098375203732,1.0,9/20,25.78%,LYPLA1;ENPP2;PLA2G6;GDPD1;ABHD12;ASPG;GDE1;PNPLA6;LYPLA2
prerank,snRNA binding (GO:0017069),0.3906173016616352,0.9922458813185165,0.466484268125855,1.0,1.0,10/42,15.95%,LSM8;HEXIM1;SF3B3;CCNT1;HNRNPU;EIF5A;PRPF4;SNRPB2;RBM41;LSM10
prerank,phosphatidylcholine transporter activity (GO:0008525),0.4458953632724076,0.9918024512111252,0.4807692307692308,1.0,1.0,8/17,15.17%,ATP8B1;ABCB4;PITPNB;ABCA3;ATP10A;ABCG1;MTTP;PITPNM2
prerank,exoribonuclease activity (GO:0004532),-0.4069316589582346,-0.9913003957583885,0.47757847533632286,0.8085024853311492,1.0,7/12,27.20%,EXOSC1;EXOSC9;ZC3H12A;EXOSC2;EXOSC7;EXOSC3;EXOSC5
prerank,telomerase RNA binding (GO:0070034),0.439161911353187,0.9909771608670934,0.4820359281437126,1.0,1.0,8/22,18.89%,PARN;TERT;NAF1;HNRNPU;HNRNPC;TEP1;SNRPD3;EXOSC10
prerank,protein phosphatase 2A binding (GO:0051721),0.4270569451475516,0.9872419900559464,0.493993993993994,1.0,1.0,6/23,7.70%,STRN3;MFHAS1;MAPT;DAB2IP;TP53;ENSA
prerank,peptidoglycan binding (GO:0042834),-0.4178681334856881,-0.9861116291801574,0.4989106753812636,0.8153761041136885,1.0,8/10,52.55%,NOD1;PGLYRP1;NOD2;RNASE7;JCHAIN;NLRP3;TLR2;HK1
prerank,CARD domain binding (GO:0050700),-0.3825789584468585,-0.9854732110541234,0.47126436781609193,0.8110832605221366,1.0,5/14,18.82%,NOD1;CARD10;IRGM;CARD14;CASP4
prerank,5'-3' RNA polymerase activity (GO:0034062),0.4047589448727993,0.9838955294510554,0.48125937031484256,1.0,1.0,7/27,14.44%,POLR2L;POLR2I;POLR2G;TERT;POLR1H;POLR2J;POLR3K
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.4195736944651997,-0.9837987864170216,0.5143540669856459,0.8097961827529697,1.0,4/11,16.78%,STN1;RAD50;CTC1;TERF2IP
prerank,small GTPase binding (GO:0031267),0.33649479754184397,0.9818219430371106,0.5149572649572649,1.0,1.0,40/169,14.68%,FLNA;RNF152;PLCE1;MYO9B;RHOBTB3;STRN3;UNC13D;TBC1D20;TNFAIP1;BICD2;ARHGEF16;KIF3B;ARHGEF2;MTSS2;RUSC2;CAV1;NDRG1;RABGAP1;CYFIP1;RAPGEF6;PEX5L;EVI5;DAPK3;WHAMM;DENND10;PAK2;ARHGAP1;ANKFY1;RAB11FIP3;RAB11FIP4;DNM1L;SH3BP4;RHOH;XPO5;HPS4;MYO5B;TNPO3;LRRK2;ANKRD27;RAB34
prerank,insulin-like growth factor I binding (GO:0031994),-0.39532529054918214,-0.9798176527305381,0.5011709601873536,0.8136353097884148,1.0,6/13,14.29%,IGFBP2;ITGA6;IGFBP3;ITGAV;IGFBP6;INSR
prerank,death domain binding (GO:0070513),-0.40384945679870343,-0.9779342309214084,0.5114155251141552,0.8125812637910425,1.0,6/11,17.39%,DAP;BCL2L1;IRGM;DAPL1;BAX;CRADD
prerank,microtubule minus-end binding (GO:0051011),0.47639290648294097,0.977911064710465,0.5025041736227045,1.0,1.0,5/13,19.60%,CEP290;TUBGCP6;HAUS7;HAUS4;CAMSAP1
prerank,cardiolipin binding (GO:1901612),-0.4192290869608045,-0.9769841530990258,0.49122807017543857,0.8094099293824133,1.0,5/10,25.66%,GSDME;GSDMD;STOML2;PLEKHN1;MME
prerank,Tat protein binding (GO:0030957),0.47740830312002736,0.9751928413131672,0.48114901256732495,1.0,1.0,2/10,6.18%,ACTB;SMARCB1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.41561403878206116,-0.9735100323574791,0.5,0.8121675052797576,1.0,4/10,12.81%,DSE;RENBP;DSEL;GLCE
prerank,guanyl ribonucleotide binding (GO:0032561),0.3252528080700124,0.973419596944049,0.5406546990496304,1.0,1.0,37/196,16.94%,RASL12;RAP1A;TUBA1C;PDE5A;RRAD;RERG;GEM;RHOBTB3;MFHAS1;SEPHS1;RAP2C;RRAS;RANBP17;TUBB2B;RHOJ;MIEF1;RHOF;RRAGB;RAP2A;REM1;RHOH;DRG2;GBP2;ADSS1;LSG1;TUBD1;RAB14;LRRK2;DIRAS2;RAB8B;RHOG;DNM2;RHOT1;AGAP2;RAB8A;ARL4D;RAB38
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.41430687737880467,0.9697801374719532,0.4821705426356589,1.0,1.0,8/22,18.74%,DUSP5;DUSP3;DUSP29;SBF1;DUSP16;DUSP23;MTMR3;DUSP12
prerank,ephrin receptor binding (GO:0046875),-0.33221258054025476,-0.9695377636109125,0.5169491525423728,0.8164340552764374,1.0,5/21,13.87%,EFNB2;GRB2;ANKS1A;LYN;EFNB1
prerank,serine-type endopeptidase activity (GO:0004252),0.3529188076320643,0.9689102251451138,0.5095923261390888,1.0,1.0,5/80,10.51%,TMPRSS4;KLK2;APEH;MASP2;MBTPS1
prerank,glycerophospholipid flippase activity (GO:0140333),0.4639534900310956,0.9657817117083967,0.4851138353765324,1.0,1.0,4/11,11.17%,ATP8B1;ABCB4;ABCA3;ATP10A
prerank,DNA secondary structure binding (GO:0000217),0.4017131670734542,0.9650588430900224,0.5073746312684366,1.0,1.0,3/31,6.17%,MEF2C;RAD51AP1;MAPT
prerank,ATPase binding (GO:0051117),0.35132425649162086,0.9648697916109292,0.5146341463414634,1.0,1.0,8/71,7.14%,PLN;HRC;PPP3CA;SNTA1;ATP1B1;CAV1;ATP6V0A2;AR
prerank,Notch binding (GO:0005112),-0.3350862570917198,-0.9624708064923156,0.5196629213483146,0.8280900722424459,1.0,9/22,19.81%,SNED1;AAK1;CUL3;CCN3;SNW1;DTX1;JAG2;NOTCH4;HIF1AN
prerank,cytokine activity (GO:0005125),-0.2249703236129172,-0.9622790608968503,0.5151515151515151,0.8228745729374101,1.0,10/131,6.82%,BMP6;WNT4;BMP7;HMGB1;IL15;BMP4;IL18;WNT5A;CXCL16;WNT9A
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.357086153541416,0.9619074593227421,0.5063613231552163,1.0,1.0,10/60,10.07%,NTRK3;MERTK;CRIM1;MST1R;ROR1;MUSK;IGF2R;EPHA2;AXL;PDGFRB
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3216241269467617,0.9609406777634004,0.5188374596340151,1.0,1.0,27/147,12.75%,ARHGEF7;RAP1A;KALRN;ABR;PLCE1;ARHGEF17;RASGRP2;DOCK8;ITSN1;DOCK10;ARHGEF16;ARHGEF2;NUCB1;RCC1L;RAPGEF6;RASGRP1;DNMBP;RIN2;DENND10;ARHGEF4;DOCK1;VAV1;DENND1A;FRMD7;BCR;SBF1;HPS4
prerank,UDP-glycosyltransferase activity (GO:0008194),0.3495643015239822,0.9559702979922212,0.5133079847908745,1.0,1.0,7/70,6.60%,LARGE1;CHSY3;CSGALNACT1;EXT2;GCNT2;HAS2;RFNG
prerank,ion channel inhibitor activity (GO:0008200),0.38875023891789395,0.954434812327494,0.5084507042253521,1.0,1.0,7/35,8.12%,ITPR1;PACSIN3;CAMK2D;CALM1;NEDD4;ENSA;WNK2
prerank,neuropeptide receptor activity (GO:0008188),0.3925352262755163,0.9526228520504136,0.5286144578313253,1.0,1.0,2/29,4.13%,NPY1R;TACR3
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.3656411979978401,-0.9484551774608849,0.5408653846153846,0.8500177849670669,1.0,8/15,30.15%,AGPAT4;ABHD5;LPCAT2;AGPAT5;AGPAT1;ABHD8;LCLAT1;AGPAT2
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.364080647462883,0.9480072709414948,0.532345013477089,1.0,1.0,6/48,8.74%,ASIC3;TRPC6;PKD1L3;TRPV2;CALHM5;TRPM4
prerank,ATP hydrolysis activity (GO:0140603),0.36879089599497894,0.9468875765723901,0.516914749661705,1.0,1.0,9/41,12.58%,MYO1E;RHOBTB3;MYO18A;ABCA3;ATP2B1;ATAD1;RUVBL1;CLU;KIF20B
prerank,neuropeptide binding (GO:0042923),-0.3357804736088928,-0.9449801412852026,0.543424317617866,0.8528844929894419,1.0,11/18,54.64%,GPR149;GPR37;NMUR2;OPRL1;SSTR2;SORL1;MC4R;SSTR1;OPRD1;NMUR1;OPRM1
prerank,kinase activator activity (GO:0019209),0.3930787254824505,0.9437702820286632,0.5361890694239291,1.0,1.0,3/30,7.13%,FGF13;IL2;TPX2
prerank,sodium:proton antiporter activity (GO:0015385),-0.38848421497531777,-0.9433654481428857,0.5387931034482759,0.8512817694378821,1.0,5/11,25.69%,SLC9B2;SLC9A2;SLC9A6;SLC9A9;SLC9A5
prerank,hormone activity (GO:0005179),-0.2601642442231061,-0.9427460679671273,0.5694444444444444,0.847146385169015,1.0,21/54,40.74%,IGF1;CHGB;METRNL;PPY;PTHLH;EDN3;ADCYAP1;SST;PENK;VGF;INHBB;INHA;GNRH1;EDN1;NPPC;C1QTNF12;CCK;SPX;GRP;NPFF;PNOC
prerank,protease binding (GO:0002020),0.33149838364726786,0.9427216425475312,0.5715922107674685,1.0,1.0,16/99,12.43%,TTN;ITGA3;ADRM1;STIM1;ITGB1;BCL2;TP53;TIMP4;ITGB3;AMFR;SRI;ANXA9;LONP2;NFRKB;POLG;COL3A1
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.20871858830978077,-0.9414357933527332,0.8235294117647058,0.8449219398135527,1.0,85/269,24.02%,SNCAIP;SMAD3;ARRB1;UBXN7;FZD6;ATXN3;ITCH;SMAD6;POLR2A;CUL3;EGFR;XRCC5;RNF20;FOXO1;NFKBIA;NAE1;SHPRH;PML;DERL1;HSPA5;CASP8;PRR5L;HSP90AB1;SLF2;PCBP2;USP7;HERC2;BAG4;PRKAR2B;UQCRC1;PTPN22;MDM2;FBXO7;IKBKG;RNF31;PRKN;BAG1;TRIP4;AMBRA1;SLF1;UBC;BLZF1;RNF34;STUB1;STAT2;RTN4;DTX1;DTX3L;DBT;SLC22A18;PER1;CALR;SYT11;UBXN1;HGS;SMAD2;NEK6;GABARAPL2;HSPA9;WRAP53;CHEK2;RALB;PRKAR2A;SPOPL;ARRDC1;TRIB1;RPL11;ARIH1;SCAMP3;SUMO3;SUMO2;ABI2;HSPD1;UBB;AXIN1;DET1;UBE2B;TXNIP;PTPRN;YWHAZ;MAGEC2;USP25;TMBIM6;MAP1LC3A;CDKN1A
prerank,transcription cis-regulatory region binding (GO:0000976),0.30747638170450703,0.9409197307592475,0.6256306760847629,1.0,1.0,49/406,11.81%,SOX6;PRDM16;SOX5;MEF2C;ACTN4;NR1H4;ALX4;RORA;SIM2;GABPA;ARID5B;HINFP;ZNF436;FOSL2;RBAK;VEZF1;MTERF3;OSR2;TBX18;MEF2A;GBX1;DBP;KLF15;SUV39H2;JUND;ARID5A;TP53;GRHL1;SFPQ;AR;YAP1;SOX9;SNAI2;RELA;KMT2D;CUX2;BBX;LONP1;NR1D1;HIF1A;ZNF3;NR2C2;TEAD1;RUNX1;RB1;ATF3;HOXC8;NFX1;PSPC1
prerank,hydro-lyase activity (GO:0016836),0.372760303553032,0.9404302126626214,0.5445816186556928,1.0,1.0,8/41,9.77%,CA3;ENO3;TBXAS1;HSD17B4;HACD1;CDYL;ACO2;HADHB
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.2980578139100093,-0.9393125973609177,0.5523809523809524,0.8444563281429452,1.0,8/30,15.28%,SLC39A10;SLC30A10;SLC39A11;SLC39A8;SLC30A1;SLC25A28;SLC39A1;SLC39A6
prerank,calcium-dependent phospholipid binding (GO:0005544),0.36044895736620497,0.9387755933800633,0.5299600532623169,1.0,1.0,5/49,4.63%,ESYT2;FER1L5;DYSF;ANXA1;SYT10
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.4237800713647033,0.9385859109682472,0.5214408233276158,1.0,1.0,3/15,5.03%,SOCS5;SOCS6;SOCS4
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.3478019029538184,0.936998216865362,0.5366161616161617,1.0,1.0,11/60,12.19%,NTRK3;MERTK;MST1R;ROR1;ACVR2A;MUSK;EPHA2;AXL;PDGFRB;ACVR1B;BMPR1B
prerank,LRR domain binding (GO:0030275),0.44317194218492495,0.9365353376199573,0.5485008818342152,1.0,1.0,8/14,18.00%,MRTFA;DAPK3;ZXDC;PAWR;POLR2J;LRRFIP2;PMF1;DDIT3
prerank,phospholipase binding (GO:0043274),-0.36922831293765673,-0.9361786502052913,0.5686746987951807,0.8465950421381698,1.0,5/13,18.35%,PDPK1;PAFAH1B1;PRKN;DGKQ;BLNK
prerank,transcription coactivator binding (GO:0001223),-0.3194839651725304,-0.9354628803110827,0.5335120643431636,0.8427491685890905,1.0,10/20,19.38%,SMAD3;MED25;AHR;ESR1;TEAD2;CCNT2;CIT;SMAD4;ZBTB17;THRB
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.2377334751953104,-0.9339877206612649,0.6458333333333334,0.8410999115857495,1.0,28/85,26.91%,PAFAH1B2;DDHD2;LYPLA1;ABHD5;ENPP2;CA2;PLA2G6;PLAAT3;NOTUM;GDPD1;ABHD12;ASPG;PLA2G7;ABHD3;LIPE;AARS1;GDE1;TARS2;PLA2G12A;APMAP;PNPLA6;ABHD6;LIPA;DAGLB;ABHD8;LYPLA2;PGLS;PNPLA2
prerank,tau protein binding (GO:0048156),0.37888683533748535,0.9332342986451814,0.5378151260504201,1.0,1.0,15/40,19.40%,ROCK1;ACTB;MARK1;DYRK1A;PIN1;BRSK1;ROCK2;CLU;BAG2;MARK2;DCTN1;MAP1A;BRSK2;HDAC6;MARK3
prerank,acetylcholine receptor activity (GO:0015464),0.4007408178546045,0.9329619825891958,0.5132450331125827,1.0,1.0,5/22,15.30%,HRH3;ANXA9;CHRNA7;CHRFAM7A;CHRNA4
prerank,phosphatase binding (GO:0019902),-0.2275636506700662,-0.9327947287885976,0.6386554621848739,0.8386086973412737,1.0,30/105,20.81%,SMAD3;DLG1;MAPK14;CDH5;PXN;WNK1;EGFR;PTK2;MAGI2;CRY1;CTNNB1;MTMR4;PPME1;DZIP3;SIRPA;HSP90B1;SH3RF2;PDLIM4;SH3YL1;CRY2;PPP6R3;SMAD2;TERF2IP;SNX3;ANAPC4;STAT6;NFATC2;CEACAM1;CARHSP1;MVP
prerank,AMP binding (GO:0016208),-0.3942634974806748,-0.928167426112586,0.5502183406113537,0.8435447750835381,1.0,2/11,0.66%,MPPED2;PRKAG2
prerank,tumor necrosis factor receptor binding (GO:0005164),0.436645796821735,0.9277731431866822,0.5429553264604811,1.0,1.0,3/12,15.38%,TRAF3;TRAF5;STAT1
prerank,pyrophosphatase activity (GO:0016462),0.35855570892532423,0.9274399429874282,0.5509383378016086,1.0,1.0,8/50,8.91%,ENTPD1;NUDT7;NUDT4;PRUNE1;LHPP;BNIPL;ENTPD7;ATCAY
prerank,phospholipid transfer activity (GO:0120014),-0.33127263873190405,-0.9267900179050658,0.5771276595744681,0.8415247137055345,1.0,10/21,24.00%,PITPNA;PLTP;PITPNC1;CERT1;PLEKHA3;TNFAIP8L3;PRELID3B;C2CD2L;PRELID2;PRELID3A
prerank,G protein-coupled receptor binding (GO:0001664),0.3207663678852075,0.9259294169685002,0.5706462212486308,1.0,1.0,6/132,5.21%,FLNA;AGTR1;CCL5;GNAO1;SAG;GNAZ
prerank,phospholipase activator activity (GO:0016004),0.4619338358712386,0.9244405739324049,0.5478927203065134,1.0,1.0,2/10,4.86%,CCL5;ARHGAP6
prerank,hexosyltransferase activity (GO:0016758),-0.22849702874493485,-0.9240915194601056,0.6482758620689655,0.8423673493020493,1.0,30/101,25.35%,TMTC1;TMTC2;MGAT4C;B4GALT1;CHSY1;DPY19L4;B4GALT6;GBE1;TMTC4;DPY19L1;MGAT4B;OGT;HEXA;B3GALNT1;PIGV;B4GALT4;CHPF2;B4GALT7;ALG1;GBA2;ALG12;B3GNT2;POMT1;GYG1;B3GALT2;LFNG;B4GALT3;GCNT1;MFNG;MGAT4A
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.3704546955759089,-0.9230465536986716,0.5647321428571429,0.8394416073178324,1.0,6/12,32.37%,SULF1;ARSI;GALNS;SULF2;SGSH;ARSB
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.294559761032239,-0.9228929083830165,0.6,0.8345725758373859,1.0,11/27,19.32%,DCUN1D3;ZMYM2;RNF144B;RNF217;RNF144A;PRKN;RNF125;SIAH1;TOLLIP;SIAH2;ARIH1
prerank,protein phosphatase regulator activity (GO:0019888),0.35059938801625296,0.920651993234843,0.5723684210526315,1.0,1.0,12/53,12.78%,RCAN2;PPP2R1B;SET;SAG;PPP2R5A;CALM1;RCAN3;ENSA;EIF2AK2;DMPK;CABIN1;ARPP19
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.3590339961194729,-0.9177248105349698,0.5700712589073634,0.8412927839178425,1.0,3/14,5.34%,SPOCK2;COL4A3;RECK
prerank,GTPase binding (GO:0051020),0.3110516115359119,0.9175533565035797,0.6242105263157894,1.0,1.0,45/194,14.68%,FLNA;RNF152;PLCE1;MYO9B;LCP1;RHOBTB3;STRN3;UNC13D;TBC1D20;TNFAIP1;BICD2;ARHGEF16;KIF3B;ARHGEF2;MTSS2;RUSC2;CAV1;NDRG1;RABGAP1;CYFIP1;RAPGEF6;PEX5L;EVI5;DAPK3;WHAMM;DENND10;PAK2;ARHGAP1;RRAGB;ANKFY1;RAB11FIP3;RAB11FIP4;DNM1L;SH3BP4;RHOH;AIMP1;XPO5;HPS4;MYO5B;TNPO3;IARS1;EPRS1;LRRK2;ANKRD27;RAB34
prerank,phosphatidylinositol binding (GO:0035091),0.3289634246237696,0.9171905695300834,0.5919540229885057,1.0,1.0,24/91,18.15%,MYO1E;ESYT2;ITPR1;HIP1;PITPNB;MAPT;MREG;ANKFY1;GAP43;DENND1A;GRAMD2A;WDR45;SNX13;SNX9;SNX17;PARD3B;SNX1;PITPNM2;SNAP91;PHF12;SNX4;ESYT1;ZFYVE16;RPH3A
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.45381217613867475,0.915589667966268,0.5580589254766031,1.0,1.0,2/11,11.91%,SLC25A29;SLC22A5
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.3472320010443292,-0.9149434746881354,0.5847665847665847,0.8419271849090568,1.0,6/14,35.53%,POP1;TSEN34;ELAC2;POP4;RPP38;RPP21
prerank,pseudouridine synthase activity (GO:0009982),0.4389165745794229,0.9145244224906491,0.5671378091872792,1.0,1.0,5/13,18.22%,RPUSD3;PUS7L;RPUSD4;TRUB1;TRUB2
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3688707104250039,0.9141253702198492,0.5714285714285714,1.0,1.0,4/35,3.59%,PLCE1;PLCB4;PLCL1;PLCXD1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3647864522005439,-0.911397500978815,0.5878378378378378,0.8448609697834363,1.0,7/13,30.15%,AGPAT4;ABHD5;LPCAT2;AGPAT5;AGPAT1;LCLAT1;AGPAT2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.3682659025533215,0.9098003161604674,0.5724431818181818,1.0,1.0,9/34,14.67%,NDUFS1;NDUFA2;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFA1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.3682659025533215,0.9098003161604674,0.5724431818181818,1.0,1.0,9/34,14.67%,NDUFS1;NDUFA2;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFA1
prerank,ubiquitin binding (GO:0043130),-0.2394231533099597,-0.9086675218547914,0.6588235294117647,0.8457592899236605,1.0,35/73,31.88%,SMAD3;UBXN7;RNF185;WDR48;ILRUN;BIRC2;UBAP1;MDM2;FBXO7;IKBKG;RBCK1;RNF31;PRKN;DNAJB2;BUB3;TOLLIP;UBXN1;MVB12B;RNFT1;UBAP1L;SHARPIN;USP25;MVB12A;RAD23B;UCHL1;TRIM32;RNF19B;SQSTM1;USPL1;MARK4;TNFAIP3;GGA3;VPS28;OTULINL;PLAA
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.44176437699650595,0.9086618994310389,0.5512367491166078,1.0,1.0,2/11,4.45%,NUDT7;NUDT4
prerank,GTPase activity (GO:0003924),0.30289349016434514,0.9071955268640459,0.6410788381742739,1.0,1.0,39/192,16.94%,RASL12;RAP1A;RERG;GEM;RHOBTB3;GNAO1;GNAZ;NKIRAS2;RAP2C;TPPP;RRAS;RHOJ;RAB3A;ENTPD7;OPA1;RHOF;GNA12;GNG11;RRAGB;RAP2A;GFM2;DNM1L;GSPT1;MFN2;RHOH;DRG2;GBP2;LSG1;GNAQ;RAB14;LRRK2;DIRAS2;RAB8B;RHOG;DNM2;RHOT1;AGAP2;RAB8A;RAB38
prerank,symporter activity (GO:0015293),-0.38181350411238435,-0.9048057122657737,0.5991189427312775,0.848883117188545,1.0,3/10,28.37%,SLC5A5;MFSD2A;SLC5A6
prerank,lipoprotein particle receptor binding (GO:0070325),-0.2866399998130925,-0.9038079488879216,0.6309148264984227,0.845916848741718,1.0,4/27,12.92%,LRP1;APOE;SYT1;HSP90B1
prerank,ion channel activity (GO:0005216),0.32386307404599807,0.902177473730634,0.6169950738916257,1.0,1.0,11/80,12.48%,ASIC3;TRPC6;GRIN2C;PKD1L3;TRPV2;CALHM5;TRPM4;GRIK5;KCNK3;CHRNA7;TRPM2
prerank,carboxypeptidase activity (GO:0004180),0.36957722794102904,0.9007786563013288,0.5744089012517385,1.0,1.0,4/35,7.32%,AGBL1;BLMH;CPA4;CPA3
prerank,neurexin family protein binding (GO:0042043),-0.38616150248881886,-0.8998881809764091,0.6285097192224622,0.8491682811489597,1.0,4/10,17.13%,NLGN1;NLGN2;NLGN3;SYTL4
prerank,metallocarboxypeptidase activity (GO:0004181),0.3893443436471141,0.8968177431779003,0.5790273556231003,1.0,1.0,3/26,7.32%,AGBL1;CPA4;CPA3
prerank,calcium:sodium antiporter activity (GO:0005432),0.44049950752038464,0.8962824876190026,0.5730129390018485,1.0,1.0,2/10,2.70%,SLC8A2;SLC8A1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3453202257845214,0.8962569444710243,0.5868102288021534,1.0,1.0,5/46,6.60%,LARGE1;EXT2;GCNT2;PIGA;RFNG
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.2963417519506126,0.8957667970484698,0.6973415132924335,1.0,1.0,28/254,9.57%,PRDM16;MEF2C;SMARCD3;NR1H4;ALX4;NR4A1;GABPA;PRRX1;HINFP;FOSL2;VEZF1;OSR2;SP7;KLF7;MEF2A;DBP;FOXJ3;KLF15;TP53;GRHL1;HOXC4;AR;SOX9;RELA;ZFP62;PPARA;NR4A2;HIF1A
prerank,alpha-tubulin binding (GO:0043014),0.36745567223697845,0.8940912510490581,0.5906515580736544,1.0,1.0,4/31,8.93%,DLEC1;TTLL7;EFHC1;WASHC1
prerank,GTPase activator activity (GO:0005096),0.29212270902768583,0.8934307288521496,0.6907426246185148,1.0,1.0,52/313,11.68%,ARHGEF7;RAP1A;RALGAPA2;DLC1;TBC1D1;RGS6;KALRN;ABR;PLCE1;ARHGEF17;RASGRP2;DOCK8;MYO9B;ITSN1;ELMOD1;DOCK10;TBC1D20;ARHGAP10;ELMOD2;ARHGEF16;CHN1;ARHGEF2;LARS1;MTSS2;NUCB1;RABGAP1;RCC1L;RAPGEF6;RASGRP1;ARHGAP17;RALGAPA1;PLCB1;DNMBP;EVI5;RIN2;DENND10;ARHGAP39;ARHGAP30;ARHGEF4;RALGAPB;ARHGAP1;ASAP2;NPRL2;DOCK1;DNM1L;VAV1;DENND1A;TBCD;ARHGAP15;FRMD7;ARHGAP35;HTR2B
prerank,peptidase inhibitor activity (GO:0030414),-0.2721099751469659,-0.8931849442621961,0.6276923076923077,0.8584431308939481,1.0,6/33,10.66%,TFPI;PROS1;RECK;ITIH2;RENBP;SERPIND1
prerank,single-stranded DNA helicase activity (GO:0017116),0.4013157676522673,0.8922645799985583,0.5824,1.0,1.0,3/19,8.60%,WRNIP1;CHTF18;HELQ
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.3832206247946266,-0.8920440484013905,0.609271523178808,0.8556182279672143,1.0,4/11,12.19%,SGMS1;SGMS2;PTDSS2;GNPTAB
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.3550424847887347,0.8889373020590757,0.5985915492957746,1.0,1.0,9/34,15.16%,SMYD1;SETD6;SETD3;NSD3;ATPSCKMT;VCPKMT;N6AMT1;KMT5B;EEF1AKMT2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.44105071033106424,0.8886596785416591,0.582089552238806,1.0,1.0,2/10,12.82%,DUSP5;DUSP16
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.44105071033106424,0.8886596785416591,0.582089552238806,1.0,1.0,2/10,12.82%,DUSP5;DUSP16
prerank,histone methyltransferase binding (GO:1990226),-0.3715260147308787,-0.8884844848817391,0.5952941176470589,0.8577466070727574,1.0,2/11,7.19%,CTNNB1;HSP90AB1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.4349641856839024,0.8854750472375605,0.573076923076923,1.0,1.0,4/11,19.43%,AKR1B1;AKR1B10;RDH11;RDH13
prerank,protein phosphatase inhibitor activity (GO:0004864),0.3676192736703715,0.8852642679617818,0.5997001499250375,1.0,1.0,8/26,12.78%,PABIR1;SET;SAG;PPP1R14C;ENSA;PPP1R14A;CABIN1;ARPP19
prerank,palmitoyltransferase activity (GO:0016409),0.3611975466509715,0.8836403949402392,0.5911111111111111,1.0,1.0,11/28,18.76%,GOLGA7B;ZDHHC2;HHAT;ZDHHC1;ZDHHC14;ZDHHC17;ZDHHC13;ZDHHC4;ZDHHC5;ZDHHC8;ZDHHC3
prerank,mRNA 5'-UTR binding (GO:0048027),-0.2969686644456482,-0.8823964368071117,0.6274509803921569,0.865215354858454,1.0,6/24,18.72%,DDX3X;RPS13;RSL1D1;GNL3;FMR1;RPS7
prerank,cGMP binding (GO:0030553),0.4247531484714457,0.8822841253839784,0.5789473684210527,1.0,1.0,1/11,2.77%,PDE5A
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.41771725400447013,0.879707622560905,0.5701754385964912,1.0,1.0,3/11,10.33%,PABIR1;PPP1R14C;PPP1R14A
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.35934741343109133,-0.8780712610032604,0.6431718061674009,0.8688642272238492,1.0,3/12,3.31%,CISD2;AOX1;XDH
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.41105038182370807,0.8736263946877522,0.5916515426497277,1.0,1.0,7/14,21.32%,NDUFS1;ACO2;RSAD1;ISCA2;IREB2;NFU1;RSAD2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.34681566165706385,0.8729658760897648,0.6309192200557103,1.0,1.0,14/37,20.57%,NARS2;HARS2;LARS1;IARS2;IARS1;SARS2;EPRS1;KARS1;LARS2;SARS1;FARS2;GARS1;AARS2;CARS2
prerank,poly(U) RNA binding (GO:0008266),-0.31168722078961303,-0.8723944547236199,0.648,0.8761258056071904,1.0,6/20,10.44%,RBMS1;RBMS2;KHDRBS1;SSB;PABPC1;DAZAP1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.38575239360576274,0.871071736765228,0.6196013289036545,1.0,1.0,4/21,15.30%,ANXA9;CHRNA7;CHRFAM7A;CHRNA4
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.2258744804290772,-0.8694261925972072,0.7428571428571429,0.8771436256763252,1.0,19/78,23.53%,USP46;USP11;CAPNS1;CTSL;CTSH;CASP8;USP7;USP12;CTSB;USP29;CASP9;USP37;CAPN10;USP24;CASP4;USP10;CTSS;CASP12;USP25
prerank,thioesterase binding (GO:0031996),0.4299737150234765,0.8693008050075877,0.6097122302158273,1.0,1.0,4/11,17.43%,TRAF3;TRAF5;HAUS7;ADRA2A
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.3226505089180832,0.8659136147142521,0.6357868020304569,1.0,1.0,19/57,20.67%,NDUFS1;COX7A2L;NDUFA2;COX8A;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFA1;CYB561A3;UQCRFS1;UQCRH;COX5B;NDUFV3;UQCRQ;NDUFS4;COX6A1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.331197433207107,0.8658289763378451,0.6251621271076524,1.0,1.0,11/49,12.82%,DUSP5;PLCXD1;ACP3;PRUNE1;LHPP;DUSP3;SACM1L;PPP1CB;PPP1CA;SBF1;DUSP16
prerank,single-stranded DNA binding (GO:0003697),-0.21739477627766368,-0.8649320308426826,0.8083333333333333,0.8814240272567918,1.0,31/93,27.81%,RBMS1;HMGB1;STN1;TDP2;WDR48;FUBP1;FBH1;PCBP2;ERCC5;SAMHD1;PURB;BLM;RTF1;HMCES;CTC1;SSBP2;CRY2;PARK7;PMS2;HSPD1;POLR2H;POLR3C;NUCKS1;IGHMBP2;ERCC1;RAD23B;ERCC4;TOP1;HMGB2;RPA3;WBP11
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.35477229576649,0.8615989418212099,0.6296851574212894,1.0,1.0,6/27,14.44%,POLR2L;POLR2I;POLR2G;POLR1H;POLR2J;POLR3K
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.30658825424926806,-0.8591580553692943,0.6596858638743456,0.8883018813821064,1.0,9/20,31.75%,AGPAT4;LPGAT1;ABHD5;LPCAT2;AGPAT5;AGPAT1;LCLAT1;AGPAT2;DGAT2
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.35053358443188953,-0.8587700115799127,0.6602564102564102,0.8841762808593661,1.0,12/12,64.98%,ELOVL4;OPN3;GPR88;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4;GPR52
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.27867323513193465,-0.8576699603929673,0.676923076923077,0.8813669192923163,1.0,9/27,17.16%,SLC22A8;SLC26A7;SLC39A8;SLC22A6;SLC25A14;SLC5A5;SLC26A2;SLC25A30;SLC25A11
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.4135961333249639,0.8553850184651682,0.6138433515482696,1.0,1.0,11/11,58.67%,HCN2;CNGA1;KCNA10;CNGA3;CNGA4;CNGA2;HCN1;AQP1;CNGB3;HCN4;CNGB1
prerank,3'-5' DNA helicase activity (GO:0043138),-0.3323714863548196,-0.8531830785384162,0.6763925729442971,0.8851869632107486,1.0,3/16,11.84%,NAV2;FBH1;BLM
prerank,death receptor activity (GO:0005035),0.42472259540080054,0.8530641965375604,0.6283662477558348,1.0,1.0,3/11,13.74%,TNFRSF11A;TNFRSF25;TNFRSF10B
prerank,SH3 domain binding (GO:0017124),0.31545317150836266,0.8499690095096426,0.6609124537607891,1.0,1.0,6/62,7.61%,ENAH;MYPN;SYNJ2;MAPT;DAB2IP;RAD9A
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.3527092372587144,-0.8467473777814299,0.6690307328605201,0.8931336243729576,1.0,2/12,6.71%,GAB2;FRS2
prerank,cysteine-type peptidase activity (GO:0008234),0.3058570431791914,0.845346531211353,0.681265206812652,1.0,1.0,13/73,14.90%,TINAGL1;USP2;BLMH;CAPN2;USP1;ATG4D;USP13;USP50;ATG4A;USP35;USP20;USP30;USP42
prerank,acylglycerol lipase activity (GO:0047372),-0.35564809505647144,-0.8415364948363688,0.695852534562212,0.8980528851269519,1.0,4/11,23.17%,ABHD12;ABHD3;LIPE;ABHD6
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.3588507363302449,0.8401461647812797,0.6419753086419753,1.0,1.0,2/26,3.27%,CHSY3;CSGALNACT1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.3309173086773263,0.8383159808483474,0.6715817694369973,1.0,1.0,6/42,8.93%,CCNA2;CCND2;CCNQ;HEXIM1;CCND1;CCNT1
prerank,vitamin D receptor binding (GO:0042809),-0.3295812467792597,-0.8380399077175552,0.6931567328918322,0.8996338229161663,1.0,9/14,29.77%,MED13;MED17;SNW1;MED24;MED16;MED30;TAF7;RXRA;THRAP3
prerank,cytokine receptor activity (GO:0004896),0.30032018136821476,0.8372369286564236,0.6984318455971049,1.0,1.0,9/83,10.76%,LIFR;CRLF1;FZD4;IL12RB2;IL10RA;IL12RB1;GPR17;IL13RA1;GFRA1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.32060819445211136,0.8371900386620904,0.6577540106951871,1.0,1.0,10/42,13.44%,BCAR3;SHD;IRS1;FBXW7;PIN1;NEDD4;SAMSN1;VAV1;LDLRAP1;NCK2
prerank,rRNA binding (GO:0019843),0.3303502952104088,0.8355865208916667,0.6864864864864865,1.0,1.0,6/42,10.52%,CAVIN1;FASTKD5;RCC1L;CIRBP;RPL5;MRPL16
prerank,fibroblast growth factor binding (GO:0017134),-0.2922977343920428,-0.8346588240606987,0.6938202247191011,0.9011530013782191,1.0,10/21,30.40%,RPS19;ITGAV;FGFR2;FIBP;FGFR4;KL;GPC1;CEP57;FGFRL1;FGFBP3
prerank,transition metal ion binding (GO:0046914),0.27144083379495926,0.8346131393302567,0.8301314459049545,1.0,1.0,33/397,7.40%,AOC3;CRIP1;PAPPA2;TRIM54;MSRB3;CSRP1;DYRK2;POLR2L;LIMS1;TRIM2;ADCY2;LARGE1;LOXL2;RBAK;ITGB1BP2;SIRT3;ALOX5;ATAD3A;PIAS4;ARHGEF2;RNF7;ETHE1;KLF7;LNPEP;TYW5;RNPEP;SUV39H2;TP53;CALB1;PTPN1;ABCE1;RASGRP1;ENPEP
prerank,phospholipase activity (GO:0004620),0.30830088010608836,0.8343481262206185,0.6937046004842615,1.0,1.0,5/67,3.65%,PLCE1;PLCB4;LPL;PLCL1;PITPNM3
prerank,lipase activity (GO:0016298),-0.23814646986376475,-0.83213672614864,0.7637795275590551,0.9010921445386089,1.0,14/43,27.12%,DDHD2;PLA1A;LYPLA1;SEC23IP;ABHD5;DDHD1;ABHD12;ABHD3;LIPE;ABHD6;LIPA;DAGLB;PNPLA2;PNPLA8
prerank,poly-pyrimidine tract binding (GO:0008187),0.362880818986916,0.830539274998778,0.6829652996845426,1.0,1.0,7/23,11.70%,RBMS3;MCRS1;ATXN1;U2AF2;DIS3L2;HNRNPU;HNRNPC
prerank,receptor ligand activity (GO:0048018),0.274194368093291,0.8304092473095565,0.7854209445585215,1.0,1.0,17/245,7.86%,NTF3;FGF1;PDGFB;SEMA5A;CRLF1;THPO;GREM2;JAG1;IL2;TNFSF13B;TGFB3;CCL5;SEMA6C;VEGFA;GDNF;AREG;TGFB2
prerank,SUMO transferase activity (GO:0019789),0.3888200893211645,0.8298815736517563,0.6634768740031898,1.0,1.0,7/16,19.31%,PIAS4;CBX4;PIAS2;MUL1;TRIM28;PIAS1;UBE2I
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.38192107392354735,0.8289785918781619,0.637223974763407,1.0,1.0,5/16,17.85%,MTMR7;SACM1L;MTMR14;PTEN;MTMR3
prerank,four-way junction DNA binding (GO:0000400),-0.29655488639659544,-0.8289152343366754,0.7175572519083969,0.9019563599783422,1.0,6/17,28.16%,HMGB1;BLM;MSH6;RAD51C;HMGB2;XRCC2
prerank,methyltransferase activity (GO:0008168),-0.2349643550744982,-0.8286620319060694,0.7656903765690377,0.8976686488250712,1.0,23/46,38.03%,COQ5;PRMT3;AS3MT;METTL3;EEF1AKMT1;TRMT11;BUD23;ARMT1;NSUN3;RRP8;SUV39H1;FTSJ3;COQ3;AMT;NDUFAF7;METTL27;GCSH;MRM2;BCDIN3D;NTMT1;GAMT;DNMT3B;PRMT8
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.35534747033318753,-0.8275989954837487,0.7268518518518519,0.894762510725236,1.0,2/10,5.95%,GNAS;SHANK3
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.3902530764793924,0.8252351824354783,0.6649395509499136,1.0,1.0,4/13,17.14%,IDI1;SREBF2;ECI1;MIF
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.3052695049872711,-0.8238961901394354,0.7082228116710876,0.8965017113128203,1.0,4/17,12.98%,PPT1;ACOT8;ACOT9;PLA2G6
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.39089465325659656,0.8228876097815991,0.6440972222222222,1.0,1.0,2/14,15.73%,DHRS3;RDH11
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.3785760179276152,0.8214564857955307,0.6700507614213198,1.0,1.0,2/15,5.55%,SLC4A8;SLC4A3
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.3530581274994034,0.819496074931149,0.684931506849315,1.0,1.0,3/22,11.68%,HTR1B;HRH3;HTR2B
prerank,serotonin receptor activity (GO:0099589),0.3530581274994034,0.819496074931149,0.684931506849315,1.0,1.0,3/22,11.68%,HTR1B;HRH3;HTR2B
prerank,G protein-coupled amine receptor activity (GO:0008227),0.3530581274994034,0.819496074931149,0.684931506849315,1.0,1.0,3/22,11.68%,HTR1B;HRH3;HTR2B
prerank,nucleotidase activity (GO:0008252),0.3797871218810363,0.8192816356153331,0.6794019933554817,1.0,1.0,5/15,19.79%,ACP3;NT5C2;NT5M;NT5C3A;NT5C
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.3454370057888803,0.8177100141994903,0.6844444444444444,1.0,1.0,8/28,15.49%,RPS6KA2;MAP2K1;MAP2K3;SGK1;LRRK2;PRKAA2;PRKACA;MAP2K4
prerank,heme binding (GO:0020037),0.29907294464388806,0.8174822158989247,0.7019108280254777,1.0,1.0,15/65,16.60%,GUCY1B1;PTGIS;HMOX2;TBXAS1;SDHC;PXDN;HEBP2;NR1D1;THAP4;RSAD1;SLC48A1;DGCR8;NOS1;JAK2;PGRMC1
prerank,phospholipase A2 activity (GO:0004623),0.35128575985695126,0.8172777004201895,0.6808199121522694,1.0,1.0,6/26,17.31%,PLA2G3;PLB1;PNPLA3;PLA2G4A;PLA2G4C;PRDX6
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.3498957051642568,-0.8165187850974538,0.7042889390519187,0.9048245449641424,1.0,4/10,13.97%,ATF2;NAA50;EP300;NAA60
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.3570943298657944,0.813873915898559,0.666110183639399,1.0,1.0,3/18,5.03%,SOCS5;SOCS6;SOCS4
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.3966446661252231,0.8132005002594318,0.648936170212766,1.0,1.0,2/12,5.14%,LTBP1;BMPR1A
prerank,outward rectifier potassium channel activity (GO:0015271),-0.3408663302338822,-0.8126116071082098,0.7221006564551422,0.9070867157828073,1.0,3/11,9.85%,KCNK2;PKD2;KCND3
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.32906192072101526,0.8124937972634717,0.7040673211781207,1.0,1.0,6/33,8.61%,UBA2;DCUN1D2;AUP1;DCUN1D1;RNF180;PPARA
prerank,neuropeptide hormone activity (GO:0005184),-0.26986687022935896,-0.8100536437484326,0.7771587743732591,0.9067131619240464,1.0,19/22,64.22%,PPY;ADCYAP1;PENK;CCK;SPX;GRP;NPFF;PNOC;NMB;AGRP;VIP;CRH;GAL;CALCB;UCN;NPPA;GHRH;HCRT;QRFP
prerank,protein kinase regulator activity (GO:0019887),0.28231468567879836,0.8099161299325931,0.7282976324689966,1.0,1.0,21/95,17.25%,FGF13;CCNA2;CCND2;CCNQ;HEXIM1;TPX2;ANKRD54;CCND1;PRKAR1B;CCNT1;PARVA;TAOK3;DNAJC3;CCNJL;ELP3;AGAP2;MT3;KIDINS220;CCNF;MARK2;FAF1
prerank,protein kinase C binding (GO:0005080),0.31858211777772816,0.8078847279979889,0.7106666666666667,1.0,1.0,7/43,12.74%,PDLIM5;HDAC9;IRS1;PLEK;ADCY6;TOP2B;CAVIN3
prerank,nuclease activity (GO:0004518),-0.2234349294442432,-0.8076888096148496,0.8035714285714286,0.9060659274111256,1.0,19/52,29.27%,REXO5;MRE11;N4BP2;ERCC5;SAMHD1;DIS3;RNASE4;REXO1;ENPP1;ISG20L2;ZC3H12A;NME1;RNASEL;AEN;EXOG;SND1;OGG1;DNA2;PDE12
prerank,dynactin binding (GO:0034452),0.3891261552256796,0.8074821322632124,0.6666666666666666,1.0,1.0,2/12,6.17%,BICD2;MAPT
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.32056132383394287,-0.8073513609347416,0.7054631828978623,0.9020537392077969,1.0,2/12,4.81%,CYFIP2;DCPS
prerank,myosin II binding (GO:0045159),0.4035994770861892,0.8071808323267317,0.6685499058380414,1.0,1.0,1/10,2.58%,MYL3
prerank,peptide N-acetyltransferase activity (GO:0034212),0.39212123740028104,0.8020553847826488,0.6845018450184502,1.0,1.0,2/10,8.20%,NAA25;NAA20
prerank,acetyltransferase activity (GO:0016407),0.32517640197369546,0.8000048138422231,0.6886657101865137,1.0,1.0,5/31,10.39%,NAT10;SAT2;NAT8L;NAT8;NAT14
prerank,general transcription initiation factor binding (GO:0140296),-0.2698872748685921,-0.7996670585015053,0.7352941176470589,0.9106178660854446,1.0,8/25,15.24%,YEATS2;AHR;ESR1;DR1;PSMC5;PSMC2;TAF12;TAF13
prerank,nuclear export signal receptor activity (GO:0005049),0.39237493046205296,0.7993205642400515,0.6827956989247311,1.0,1.0,3/11,16.83%,RANBP17;XPO5;XPO1
prerank,retinoic acid binding (GO:0001972),0.37251810576009803,0.7965457964078942,0.6835443037974683,1.0,1.0,1/12,4.32%,NR2F2
prerank,zinc ion binding (GO:0008270),0.2597976959644845,0.7956952855204013,0.8539325842696629,1.0,1.0,23/293,7.40%,CRIP1;PAPPA2;TRIM54;MSRB3;CSRP1;POLR2L;LIMS1;TRIM2;RBAK;ITGB1BP2;SIRT3;ATAD3A;PIAS4;ARHGEF2;KLF7;LNPEP;RNPEP;SUV39H2;TP53;CALB1;PTPN1;RASGRP1;ENPEP
prerank,ubiquitin-specific protease binding (GO:1990381),-0.2841010852017831,-0.7955199702761795,0.753968253968254,0.9128830026275535,1.0,5/19,19.27%,DERL1;PRKN;SART3;SYVN1;PARK7
prerank,phosphotyrosine residue binding (GO:0001784),-0.24216571277830562,-0.7954994634293966,0.8093525179856115,0.9083113393466492,1.0,6/37,6.44%,GRB2;PTPN11;RASA1;PIK3R3;VAV2;PLCG2
prerank,glutamate receptor binding (GO:0035254),0.3663774088658548,0.7909574311710432,0.7007751937984497,1.0,1.0,5/17,14.84%,HIP1;NSF;HOMER1;SHANK2;SHISA6
prerank,nucleosomal DNA binding (GO:0031492),0.35292729340982226,0.7906216351185623,0.7021604938271605,1.0,1.0,7/21,18.88%,H1-0;ACTB;SMARCB1;HNRNPC;CHD4;HDAC1;ACTL6A
prerank,epidermal growth factor receptor binding (GO:0005154),0.3380456966441007,0.7900291662309147,0.7145015105740181,1.0,1.0,6/25,16.94%,HIP1;ATXN2;AREG;HBEGF;SNX1;SNX4
prerank,protein kinase inhibitor activity (GO:0004860),0.3069438454705952,0.7878798396639831,0.7506887052341598,1.0,1.0,6/42,13.59%,INKA2;HEXIM1;PARVA;TAOK3;CEP43;DNAJC3
prerank,organic cation transmembrane transporter activity (GO:0015101),0.3669431350992862,0.7871094357577579,0.7072,1.0,1.0,4/16,11.91%,SLC44A1;SLC7A8;SLC25A26;SLC22A5
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3433052057355328,0.7856379514398061,0.7001477104874446,1.0,1.0,7/21,19.82%,CDK6;CDK7;CDK12;CDK15;CDK14;CDKL2;CDK13
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3433052057355328,0.7856379514398061,0.7001477104874446,1.0,1.0,7/21,19.82%,CDK6;CDK7;CDK12;CDK15;CDK14;CDKL2;CDK13
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.3164234274999306,0.785071430343787,0.7132564841498559,1.0,1.0,12/34,19.35%,TAF1;UBE2W;UBE2F;UBE2E1;UBE2D1;AKTIP;UBE2J1;UBE2K;UBE2L6;UBE2A;UBE2I;UBE2Q1
prerank,lysine N-methyltransferase activity (GO:0016278),0.3423085820108364,0.7838650704671495,0.6951026856240127,1.0,1.0,5/20,15.16%,SETD6;SETD3;ATPSCKMT;VCPKMT;EEF1AKMT2
prerank,anion:anion antiporter activity (GO:0015301),-0.2875559041851563,-0.7831148662100166,0.7957559681697612,0.9235477142743753,1.0,4/17,17.16%,SLC26A7;SLC4A2;SLC26A2;SLC25A11
prerank,endodeoxyribonuclease activity (GO:0004520),-0.2726614797338573,-0.7830808615013097,0.7651933701657458,0.9189995466868554,1.0,9/20,35.57%,MRE11;RAD50;ERCC5;ERCC1;ERCC4;EXOG;DNA2;ENDOV;DCLRE1C
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.25302893277508565,0.7826561500112906,0.970970970970971,1.0,1.0,121/831,16.13%,SOX6;PRDM16;SOX5;MEF2C;HEY2;ACTN4;ZFHX3;TBX2;NR1H4;EBF1;ZEB2;ALX4;RORA;NR4A1;EBF2;SIM2;GABPA;PRRX1;ETS2;HEYL;TEAD3;IRX5;HINFP;ZNF436;FOSL2;RBAK;NACC2;PRDM1;NR2F2;NR2C1;VEZF1;OSR2;SP7;KLF7;TBX18;KCNIP3;MEF2A;GBX1;KLF16;DBP;FOXJ3;KLF15;JUND;TAF1;CHD2;TP53;RXRG;GRHL1;ZNF418;ZBTB38;HOXC4;AR;ZFP28;ZNF431;SOX9;SNAI2;HSF4;RELA;ZFP62;CUX2;ZKSCAN4;PPARA;BBX;CARF;NR4A2;SKI;NR1D1;LRRFIP1;ZBTB33;HIF1A;ZBTB41;HNRNPU;ZNF3;NR2C2;TEAD1;SREBF2;RUNX1;RB1;ATF3;HOXC8;NKX6-1;ZKSCAN1;ZBTB7A;NFX1;ESRRA;NR6A1;POU3F3;MED8;ZBTB10;ZNF83;ZFP69;MXD4;BCL6;IKZF1;CASZ1;MEF2B;FOXJ1;ZBTB5;RFX7;ZKSCAN7;CLOCK;MTA1;ZBTB4;SP4;RFX1;EBF3;MLXIPL;KLF6;HOXB2;ZSCAN22;STAT1;HOXC5;NR5A1;RFX3;SARS1;ZSCAN18;SP1;STAT3;IKZF4;ZBTB9;CALCOCO1
prerank,chloride transmembrane transporter activity (GO:0015108),0.36214157288826265,0.7822509177926029,0.7174280879864636,1.0,1.0,2/16,5.96%,SLC4A8;CLCN6
prerank,RNA binding (GO:0003723),0.25324647301130393,0.7803780520373527,0.988,1.0,1.0,328/1321,20.44%,FLNA;SORBS2;MAP3K20;RBPMS;ACTN1;NOL6;RBPMS2;XIRP1;LSM8;ACTN4;RPL3L;CSRP1;CAVIN1;TNS1;SYNE1;KHDRBS3;MYH9;HNRNPR;VIM;HSD17B10;NUDT7;RAVER2;FASTKD5;RBM38;SAMD4A;DENR;MRPS31;H1-0;MRPL13;NAT10;PRPF38B;RBMS3;PARN;MCRS1;UTP14A;HARS2;RPUSD3;DDX23;NUDT4;SRP68;WDR33;RAD51AP1;UPF1;PCF11;CSDE1;ZNF638;CNOT4;MYO18A;TYW5;SF3B5;MTDH;POLR2G;TRMT10C;APEH;ATXN2;U2AF2;FAM32A;MYBBP1A;EIF1;MAPT;CHD2;WDR46;TERT;PARP1;RCC1L;HEXIM1;KTN1;RPS27L;PTPN1;CIRBP;ZCCHC7;RPL8;SFPQ;YTHDF2;FKBP3;RPF1;RCAN3;PA2G4;PPARGC1A;RTCB;CLNS1A;WDR36;PPARGC1B;CELF1;REXO4;DICER1;GOT2;RPS19BP1;DUSP14;MRPL43;SRSF4;FASTKD1;NAF1;PYM1;SRRM3;API5;PSTK;GPKOW;MBNL2;MRM1;PWP2;EIF4A1;MRPS35;MRPS28;FUS;LONP1;TDRD3;PPIE;ZC3H11A;PKN2;SEPSECS;LRRFIP1;MRPL45;RBM19;SECISBP2L;RPL5;SAMSN1;HADHB;SRP72;MRPL21;DDX59;MRPL23;PTBP2;RBM8A;KIF1C;MBNL1;U2AF1;EIF3E;DHX8;HNRNPU;PPP1R10;RPS23;MRPL16;EIF2AK2;EIF5A;TFB2M;ROCK2;CCT3;OTUD4;SRSF10;ALDOA;DDX1;FNDC3B;GSPT1;DDX25;RBM3;DCP1A;SF3A3;BAZ2A;NOP58;HNRNPC;NFX1;PSPC1;RBM6;EIF3H;MRPL9;KPNA2;YTHDC2;MAK16;DRG2;ALG13;SRRM1;AIMP1;TSFM;XPO5;DROSHA;RBM27;CPEB3;COL14A1;SF3B2;SF3B1;DCP1B;ZCRB1;OASL;NUFIP2;PCBP3;ZC3H4;MRPL42;NSUN2;ZFP36L1;CPNE3;RBM25;DXO;RPUSD4;TRIM28;CSNK1E;DHX30;SON;MTCL1;DGCR8;SYNCRIP;RPL15;TMSB4X;MAP4;GIGYF2;NUP98;SARS2;G3BP1;DDX55;CCDC9B;SRP19;CWC22;GDI2;EPRS1;IMP4;DDX56;EDF1;BZW1;EIF4E;STAU2;UBA1;KARS1;GLRX3;FASTKD2;SRPK2;RBM15;TEP1;NOL4;SF1;NANOS1;LAS1L;DDX18;PELP1;RFTN1;IREB2;NELFCD;RPL22;SARS1;DHX32;LSM10;SF3A1;PUF60;STAT3;SEC61B;ANXA11;FARS2;FIP1L1;PRRC2C;WBP4;ETF1;RPL31;IMMT;RBM45;MRPL14;DHX9;WDR6;DDX49;ACIN1;MRPL4;RPS6;MARK2;EIF4G2;USP36;BOP1;FKBP4;LUC7L;EIF2AK4;PDCD11;RPS17;RBM33;FAM98B;CEBPZ;EEF2;DHX29;FAM120C;MRPS21;NAP1L4;TRUB2;NDUFV3;AKAP1;HNRNPUL2;RBM14;MDH2;HDLBP;SNRPD3;TEFM;FRG1;MRPL40;MRPL22;LGALS1;EXOSC10;CMSS1;RTCA;N4BP1;TRMT6;HABP4;NIFK;UCHL5;RPS27A;SUMO1;CLTC;UBE2I;NTPCR;RPS14;PKM;KIN;SNIP1;PRKRA;ILF3;AARS2;QKI;RPGR;AGO1;SLC4A1AP;ADARB1;ZRANB2;PRMT1;TIAL1;PPRC1;SPATS2L;CDK13;PNN;JUN;SRP14;SERBP1;NSUN5;MRPS14;DDX10;ERI1;YTHDC1;WDR43;DHX37;NSRP1;CS;C1QBP;PRR3;EIF2S1;EIF2A
prerank,NAD+ binding (GO:0070403),0.3751150055232527,0.7784988537564197,0.7078853046594982,1.0,1.0,4/12,16.51%,SIRT3;SIRT2;HADH;SIRT6
prerank,syntaxin binding (GO:0019905),0.2893701723138939,0.7759389228897471,0.7609511889862328,1.0,1.0,3/61,4.63%,STXBP2;SYPL2;SYT10
prerank,ribosomal small subunit binding (GO:0043024),-0.28576544907494883,-0.773354553681068,0.7653631284916201,0.9293439880770907,1.0,2/17,2.55%,CPEB2;DDX3X
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.3620914206162832,0.7707821846005991,0.7237762237762237,1.0,1.0,3/13,13.68%,DICER1;SLX4;DNASE1L1
prerank,DNA binding (GO:0003677),0.2506731179473495,0.7687652995429276,0.954954954954955,1.0,1.0,97/694,13.68%,SOX6;PRDM16;HEY2;TBX2;NR1H4;ZEB2;ALX4;TRNP1;RORA;MLF1;NR4A1;SIM2;ETS2;ARID5B;CGAS;HINFP;BRIP1;H1-0;CHRAC1;RAD51AP2;SIRT3;GTF2H4;ARID1A;NR2F2;NR2C1;BCL2;GTF3C4;RAD51AP1;OSR2;CBFB;SP7;ZNF638;MEF2A;POLR2G;FOXJ3;MYBBP1A;MBD5;TAF1;MAPT;SMARCB1;CHD2;ARID5A;TERT;TIPIN;TP53;GRHL1;HDGFL3;SFPQ;PPARGC1A;MBD4;TDP1;CHTF18;REXO4;ERCC6;SOX9;SNAI2;RELA;KMT2D;CUX2;PPARA;MSL3;CARF;CCNT1;LONP1;NR4A2;LRRFIP1;ZBTB33;HIF1A;CRLF3;DEDD2;ZDHHC1;SYCP2;HNRNPU;ZNF3;MCMDC2;NR2C2;TEAD1;POLD1;ZBTB7A;ESRRA;POLG;RBM6;TSG101;LIN9;CSRNP3;HDGFL2;DEDD;NR6A1;POU3F3;SMARCA5;OASL;BCL6;CHD4;IKZF1;FOXJ1;TRIM28;DNASE1L1
prerank,RNA stem-loop binding (GO:0035613),-0.3160087390479063,-0.7676626907704285,0.7801418439716312,0.9330297807153317,1.0,5/12,20.20%,DDX3X;RC3H2;ZC3H12A;FMR1;METTL16
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3204972942779789,0.7660642393135327,0.7259036144578314,1.0,1.0,8/24,18.76%,GOLGA7B;ZDHHC2;ZDHHC1;ZDHHC14;ZDHHC17;ZDHHC4;ZDHHC8;ZDHHC3
prerank,RNA polymerase II complex binding (GO:0000993),0.3128277181967871,0.7649766068859224,0.7325581395348837,1.0,1.0,11/32,22.32%,SCAF1;PCF11;HNRNPU;URI1;ELOF1;DHX9;BRD4;AGO1;WDR43;RPRD1A;CCAR2
prerank,N-acyltransferase activity (GO:0016410),0.312264575680959,0.7640446684696763,0.7452966714905933,1.0,1.0,6/32,10.39%,NAT10;SAT2;NAT8L;NAT8;CERS1;NAT14
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.24333912511782357,-0.7620181100914448,0.8517350157728707,0.9367559579778943,1.0,11/28,35.53%,AGO3;POP1;EDC3;DBR1;ELAC2;POP4;ENDOV;RPP38;NUDT16;MRPL44;RPP21
prerank,amyloid-beta binding (GO:0001540),0.2762365699178656,0.7613013919737998,0.8098676293622142,1.0,1.0,14/79,16.81%,CD36;APBA1;FZD5;FZD4;ITM2C;TGFB2;CACNA1B;CHRNA7;CLU;LDLRAP1;ATP1A3;HSPG2;PGRMC1;CLSTN1
prerank,ribonuclease P RNA binding (GO:0033204),-0.31942789739417776,-0.7609383870109976,0.7660044150110376,0.9337093482939134,1.0,5/10,43.55%,POP1;POP4;RPP38;RPP21;POP7
prerank,endopeptidase activity (GO:0004175),0.25113250153707517,0.7587329876608885,0.8943589743589744,1.0,1.0,32/257,15.09%,TMPRSS4;MMP17;ADAMTS14;ADAMTS5;KLK2;ADAMTS19;USP2;APEH;AFG3L2;TRABD2B;ADAM17;USP1;MASP2;MIPEP;PSMB1;MBTPS1;THSD4;PHEX;ADAMTS20;USP13;ADAMTS16;PSMB2;DDI2;PMPCB;USP35;USP20;USP30;ADAM19;PSMB7;USP42;PCSK4;ADAMTSL4
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.25261794515725944,0.7579493380747605,0.8830769230769231,1.0,1.0,31/232,11.71%,TRIM54;RNF152;TRIM55;TRIM63;TRIM2;FBXL22;RNF150;PDZRN3;RNF114;ASB2;UBR5;ASB1;PIAS4;RNF7;CBLL1;NEURL4;NEDD4;RNF180;TRIM68;CBX4;NEURL1B;UHRF2;AMFR;TRIM7;NHLRC1;FBXO6;PELI2;UBE2D1;PIAS2;TRIM35;NFX1
prerank,Hsp90 protein binding (GO:0051879),-0.23626162306394688,-0.7568142394100095,0.8571428571428571,0.9353248139793976,1.0,12/33,25.49%,SLC12A2;USP19;NR3C1;AHR;STUB1;ERN1;KDR;NPAS2;HSF1;TELO2;AHSA1;CSNK2A1
prerank,phosphatase inhibitor activity (GO:0019212),0.3276397974424549,0.756089910934933,0.768025078369906,1.0,1.0,7/20,15.29%,SET;SAG;TESC;ENSA;CABIN1;ARPP19;URI1
prerank,chemokine binding (GO:0019956),0.309277587929911,0.7555086063881707,0.7470059880239521,1.0,1.0,4/30,8.26%,ITGB1;CXCR6;ITGB3;ITGA4
prerank,chemokine receptor activity (GO:0004950),0.3179270851022625,0.7538562464635218,0.7762345679012346,1.0,1.0,2/24,7.60%,CXCR6;GPR17
prerank,insulin-like growth factor binding (GO:0005520),0.34867592899496197,0.7509675226750551,0.761986301369863,1.0,1.0,4/15,7.48%,IGFBP5;IGFBP4;IGF2R;ITGB3
prerank,signal sequence binding (GO:0005048),0.3027603266228662,0.7509445286518981,0.7708333333333334,1.0,1.0,8/35,14.38%,CABP1;KPNA4;PEX5L;NUP153;RANBP6;KPNA2;KPNA3;IPO4
prerank,pre-mRNA binding (GO:0036002),0.3162620672607026,0.7506457144414892,0.7496318114874816,1.0,1.0,5/28,10.29%,RBM24;U2AF2;CELF1;U2AF1;HNRNPU
prerank,GTPase regulator activity (GO:0030695),0.2509381952339489,0.7501387067671743,0.8967674661105318,1.0,1.0,49/212,16.77%,RALGAPA2;DLC1;TBC1D1;RGS6;ABR;MYO9B;ELMOD1;TBC1D20;ARHGAP10;ELMOD2;CHN1;LARS1;MTSS2;RABGAP1;ARHGAP17;RALGAPA1;PLCB1;EVI5;RIN2;ARHGAP39;ARHGAP30;RALGAPB;ARHGAP1;ASAP2;NPRL2;DOCK1;DNM1L;SH3BP4;TBCD;ARHGAP15;RHOH;ARHGAP35;HTR2B;BCR;ARHGAP32;GNAQ;RGS5;LRRK2;ARHGAP24;IPO7;RUNDC1;TBC1D22B;ARHGAP26;AGAP2;RASGRP3;RGS10;VAV3;PREB;TBC1D12
prerank,kinase inhibitor activity (GO:0019210),-0.23331926730063704,-0.7483471299441249,0.8551724137931035,0.9425050751617302,1.0,16/33,33.85%,MBIP;NCK1;SNCA;SH3BP5L;TRIB1;QARS1;MAPK8IP1;SMCR8;CDKN1A;CDKN1C;SPRY4;SH3BP5;DUSP19;GMFB;SOCS3;WARS1
prerank,single-stranded RNA binding (GO:0003727),-0.21824946638416254,-0.7479096000348212,0.9034749034749034,0.9384541099507786,1.0,6/43,11.36%,AGO3;DDX3X;AQR;STRBP;JMJD6;DDX60
prerank,DNA polymerase binding (GO:0070182),-0.27325793693778494,-0.7477546179660932,0.7941176470588235,0.9341381737635605,1.0,5/18,17.92%,HMGB1;HSP90AB1;FANCI;CDK2AP1;SMG6
prerank,protein kinase activator activity (GO:0030295),0.2808885134340157,0.7473823738088425,0.7868020304568528,1.0,1.0,7/60,9.22%,FGF13;FAM20A;CALM1;TPX2;ERCC6;MAP2K1;PAK2
prerank,FAD binding (GO:0071949),0.3201023502487073,0.7461218167287939,0.7360248447204969,1.0,1.0,4/24,14.48%,MICAL2;KMO;MICAL3;CYB5R3
prerank,manganese ion binding (GO:0030145),0.2798068897052785,0.7451807689167148,0.77431906614786,1.0,1.0,3/48,2.30%,DYRK2;ADCY2;LARGE1
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.2659187021436187,-0.7438291718312673,0.8083989501312336,0.9350766024185286,1.0,5/20,16.42%,TJP2;DLG1;MAGI3;CASK;DTYMK
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.2402172819584823,0.7420007894185656,0.9809619238476954,1.0,1.0,102/732,16.13%,SOX6;PRDM16;SOX5;MEF2C;HEY2;ZFHX3;TBX2;NR1H4;EBF1;ZEB2;RORA;NR4A1;EBF2;GABPA;PRRX1;ETS2;HEYL;TEAD3;IRX5;HINFP;FOSL2;NACC2;PRDM1;NR2F2;NR2C1;SP7;KLF7;TBX18;KCNIP3;MEF2A;KLF16;DBP;FOXJ3;KLF15;JUND;CHD2;TP53;RXRG;GRHL1;ZNF418;ZBTB38;HOXC4;AR;ZFP28;ZNF431;SOX9;SNAI2;HSF4;RELA;ZFP62;ZKSCAN4;PPARA;CARF;NR4A2;SKI;NR1D1;LRRFIP1;ZBTB33;HIF1A;ZBTB41;HNRNPU;NR2C2;TEAD1;SREBF2;RUNX1;ATF3;NKX6-1;ZKSCAN1;ZBTB7A;ESRRA;NR6A1;POU3F3;MED8;ZNF83;MXD4;BCL6;IKZF1;MEF2B;FOXJ1;ZBTB5;RFX7;ZKSCAN7;CLOCK;MTA1;ZBTB4;SP4;RFX1;EBF3;MLXIPL;KLF6;HOXB2;ZSCAN22;STAT1;HOXC5;NR5A1;RFX3;SARS1;ZSCAN18;SP1;STAT3;IKZF4;CALCOCO1
prerank,histone deacetylase activity (GO:0004407),0.3274252825715535,0.7369708502999479,0.7537942664418212,1.0,1.0,6/19,18.90%,HDAC9;SIRT3;SIRT2;SIRT6;HDAC1;HDAC6
prerank,RNA polymerase binding (GO:0070063),0.3370325402619335,0.7358219823169465,0.7678571428571429,1.0,1.0,5/18,12.06%,NEDD4;STOM;CCNT1;PKN2;YTHDC2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.2380562105660569,0.7357528202894941,0.984984984984985,1.0,1.0,102/731,16.13%,SOX6;PRDM16;SOX5;MEF2C;HEY2;ZFHX3;TBX2;NR1H4;EBF1;ZEB2;RORA;NR4A1;EBF2;GABPA;PRRX1;ETS2;HEYL;TEAD3;IRX5;HINFP;FOSL2;NACC2;PRDM1;NR2F2;NR2C1;SP7;KLF7;TBX18;KCNIP3;MEF2A;KLF16;DBP;FOXJ3;KLF15;JUND;CHD2;TP53;RXRG;GRHL1;ZNF418;ZBTB38;HOXC4;AR;ZFP28;ZNF431;SOX9;SNAI2;HSF4;RELA;ZFP62;ZKSCAN4;PPARA;CARF;NR4A2;SKI;NR1D1;LRRFIP1;ZBTB33;HIF1A;ZBTB41;HNRNPU;NR2C2;TEAD1;SREBF2;RUNX1;ATF3;NKX6-1;ZKSCAN1;ZBTB7A;ESRRA;NR6A1;POU3F3;MED8;ZNF83;MXD4;BCL6;IKZF1;MEF2B;FOXJ1;ZBTB5;RFX7;ZKSCAN7;CLOCK;MTA1;ZBTB4;SP4;RFX1;EBF3;MLXIPL;KLF6;HOXB2;ZSCAN22;STAT1;HOXC5;NR5A1;RFX3;SARS1;ZSCAN18;SP1;STAT3;IKZF4;CALCOCO1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.3454387750778224,0.7345060757885384,0.7479935794542536,1.0,1.0,4/14,17.85%,MTMR7;MTMR14;PTEN;MTMR3
prerank,clathrin adaptor activity (GO:0035615),-0.2808329397189851,-0.7341577193576444,0.8371501272264631,0.9433105537191087,1.0,4/15,13.14%,DAB2;AP1M1;STON2;AP2S1
prerank,potassium:proton antiporter activity (GO:0015386),-0.3124308218660178,-0.7338507518722993,0.7931034482758621,0.9392340459803374,1.0,4/10,25.69%,SLC9A2;SLC9A6;SLC9A9;SLC9A5
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.3633261202679712,0.7328382456724216,0.7406749555950266,1.0,1.0,5/11,18.81%,UBR5;UBE4A;AMFR;UBE2K;ANAPC11
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.27096819135293015,-0.731621737073069,0.821256038647343,0.9375556442585807,1.0,6/17,20.94%,LBR;BLVRB;BDH2;DPYD;DECR2;PECR
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.35954393214787317,0.7311073159057041,0.7680140597539543,1.0,1.0,3/12,7.48%,DAB2IP;VEGFA;ITGB3
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.24160368043812364,-0.7310067075853179,0.8333333333333334,0.9339817917383453,1.0,13/24,36.79%,IP6K1;IP6K2;PPIP5K2;DTYMK;ITPKB;NME1;PMVK;AK4;AK1;PPIP5K1;NME2;AK5;AK3
prerank,transcription corepressor binding (GO:0001222),0.3040318114563304,0.7303617249847896,0.7858197932053176,1.0,1.0,3/27,11.69%,RORA;NR1D1;ZBTB7A
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.2844376896650437,-0.7292422897834537,0.8282352941176471,0.9318013157275393,1.0,5/13,19.45%,SLC66A1;SLC38A5;SLC38A7;SLC7A7;SLC15A4
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3489071856867204,0.7254946351407436,0.7759856630824373,1.0,1.0,2/11,8.20%,NAA25;NAA20
prerank,RNA cap binding (GO:0000339),-0.2722130006422032,-0.7212035459107904,0.8571428571428571,0.9369160828413751,1.0,5/16,20.60%,CYFIP2;DCPS;LSM1;NCBP2;EIF3D
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.3504362800043155,0.7191888317537982,0.7621722846441947,1.0,1.0,3/10,9.03%,ASH1L;SETD3;NSD3
prerank,peptidase activator activity (GO:0016504),0.3155341576297884,0.718719940778349,0.7765273311897106,1.0,1.0,4/22,11.10%,ADRM1;CAV1;PSME4;CASP8AP2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.2321576578886185,0.7172142162394397,0.982,1.0,1.0,57/597,11.81%,SOX6;PRDM16;SOX5;MEF2C;HEY2;TBX2;ALX4;NR4A1;GABPA;ETS2;ARID5B;IRX5;HINFP;PRDM1;NR2C1;MTERF3;OSR2;TBX18;KLF16;DBP;FOXJ3;KLF15;SUV39H2;JUND;MLH3;ARID5A;TP53;RXRG;GRHL1;SFPQ;HOXC4;AR;MBD4;YAP1;SOX9;SNAI2;HSF4;RELA;KMT2D;CUX2;MBNL2;BBX;NR4A2;NR1D1;KAT7;ZBTB33;HNRNPU;MCMDC2;NR2C2;TEAD1;SREBF2;RUNX1;ATF3;HOXC8;ZBTB7A;ESRRA;PSPC1
prerank,O-acyltransferase activity (GO:0008374),0.295340082650768,0.7150206389307083,0.7864357864357865,1.0,1.0,9/30,20.64%,LPCAT3;DGAT1;PLA2G4A;PLA2G4C;PRDX6;MBOAT7;GPAT3;LPCAT1;PLA2G15
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.30729506591396355,-0.714182500910871,0.8257918552036199,0.9405354036565571,1.0,4/10,30.84%,ATXN3;CYLD;TNFAIP3;YOD1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.2590160725519417,-0.7140018560276702,0.8663101604278075,0.9364406119692494,1.0,4/18,14.62%,RPS6KA3;BIRC2;SNCA;BIRC3
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.3453627653216089,0.7139688529015109,0.7727272727272727,1.0,1.0,2/11,15.30%,CHRNA7;CHRNA4
prerank,transcription coregulator binding (GO:0001221),0.2708823991865875,0.7132548109844787,0.8284250960307298,1.0,1.0,7/50,11.69%,RORA;CHD6;TERT;AR;RELA;NR1D1;ZBTB7A
prerank,phosphatidate phosphatase activity (GO:0008195),-0.27862201996799923,-0.711851093462831,0.841726618705036,0.9346926474931231,1.0,8/13,45.62%,LPIN2;PLPP5;LPIN3;LPIN1;PLPPR3;PLPP2;PLPP1;PLPPR4
prerank,ribonuclease P activity (GO:0004526),-0.28980450353194803,-0.7118135649097247,0.8480725623582767,0.9304818870921254,1.0,4/11,35.53%,POP1;POP4;RPP38;RPP21
prerank,DNA polymerase activity (GO:0034061),0.3106094210387995,0.7114439353890644,0.7892234548335975,1.0,1.0,4/22,11.83%,CHRAC1;TERT;POLD1;POLG
prerank,mRNA binding (GO:0003729),0.23874418079031542,0.7105313455111584,0.9402061855670103,1.0,1.0,40/249,14.16%,RBPMS;RBPMS2;RBM24;KHDRBS3;HNRNPR;CRYZ;SAMD4A;DENR;MRPL13;RBMS3;PARN;PCF11;TP53;CPEB1;CIRBP;YTHDF2;CELF1;SRSF4;SRRM3;EIF4A1;PPIE;ZC3H11A;SECISBP2L;RPL5;PTBP2;RBM8A;HNRNPU;DCP1A;HNRNPC;XPO5;CPEB3;SF3B1;DCP1B;PCBP3;ZFP36L1;RBM25;DXO;SYNCRIP;NUP98;G3BP1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.34908298792935155,0.703252867238317,0.8010291595197255,1.0,1.0,1/11,4.10%,KCNE4
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.21762744148057117,-0.7023352827949619,0.9305555555555556,0.9365982093717478,1.0,16/34,30.62%,DDX3X;IGF2;MAP2K2;CAB39L;IRGM;SPRY2;TAOK1;CCNT2;CCNK;ALS2;CDK5R1;DBF4;CALM3;INCENP;PARP16;CALM2
prerank,endopeptidase activator activity (GO:0061133),0.34679642323618187,0.6987140333918451,0.7755474452554745,1.0,1.0,1/10,2.96%,ADRM1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.33956685771239054,0.6887591678004119,0.8029739776951673,1.0,1.0,4/10,15.79%,HSD17B4;HADHB;ECI1;HADHA
prerank,GABA receptor binding (GO:0050811),0.33611462675654424,0.6887268040470987,0.8146167557932263,1.0,1.0,2/11,8.64%,GABARAP;TRAK1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.28432437772970226,0.687269785894456,0.849645390070922,1.0,1.0,4/35,9.30%,FRK;PEAK1;DYRK1A;SLA
prerank,methylation-dependent protein binding (GO:0140034),-0.1871071023125692,-0.6868545449104283,0.9570815450643777,0.9478299652788247,1.0,12/57,19.92%,KDM7A;KMT2E;CBX5;ZMYND8;TRIM24;MORC4;CHD1;NCAPG2;MPHOSPH8;FMR1;RRP8;MSH6
prerank,cAMP binding (GO:0030552),0.33927634407930607,0.6854645182812745,0.7952898550724637,1.0,1.0,2/11,11.18%,PDE4A;PDE4D
prerank,mRNA 3'-UTR binding (GO:0003730),0.24688820142077184,0.6839931153776947,0.8802902055622733,1.0,1.0,14/79,13.20%,RBM24;CRYZ;RBMS3;PARN;TP53;CPEB1;CIRBP;CELF1;SECISBP2L;RPL5;HNRNPU;HNRNPC;CPEB3;ZFP36L1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.22068258546585737,-0.6834297000501626,0.9295302013422819,0.9469349504781084,1.0,5/30,14.62%,BIRC6;RPS6KA3;BIRC2;SNCA;BIRC3
prerank,3'-5' exonuclease activity (GO:0008408),0.2669441830813668,0.6831597034147419,0.8579088471849866,1.0,1.0,9/45,11.83%,PARN;ERI2;REXO4;RAD9A;DIS3L2;DIS3L;POLD1;CNOT7;POLG
prerank,endopeptidase regulator activity (GO:0061135),0.2694169053341899,0.6827920267020129,0.8518005540166205,1.0,1.0,2/40,2.96%,ITIH4;ADRM1
prerank,phospholipase inhibitor activity (GO:0004859),0.3334435871028695,0.6784411134600769,0.8252788104089219,1.0,1.0,2/10,10.89%,ANXA1;ANXA9
prerank,RNA methyltransferase activity (GO:0008173),0.3077834163755594,0.6782127995987213,0.8193343898573693,1.0,1.0,3/19,12.14%,TRDMT1;FTSJ1;TGS1
prerank,N-methyltransferase activity (GO:0008170),0.2964557748768279,0.6781926668486749,0.8359872611464968,1.0,1.0,5/20,14.56%,SETD3;TFB2M;ZCCHC4;N6AMT1;NNMT
prerank,phosphatase activity (GO:0016791),0.24440373814197786,0.6777508401462078,0.8906633906633906,1.0,1.0,12/73,13.93%,DUSP5;ACP3;PRUNE1;LHPP;DUSP3;SACM1L;PLPPR1;PPP1CB;PPP1CA;SBF1;DUSP16;NT5M
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2768025043336583,0.6757690387500986,0.8641063515509602,1.0,1.0,10/31,19.35%,TAF1;UBE2W;UBE2E1;UBE2D1;AKTIP;UBE2J1;UBE2K;UBE2L6;UBE2A;UBE2Q1
prerank,translation initiation factor activity (GO:0003743),0.2689229865231672,0.6755460169219525,0.8517482517482518,1.0,1.0,11/36,20.44%,EIF1;EIF3M;EIF2D;EIF4A1;EIF3E;EIF3H;EIF4E;EIF4E3;EIF4G2;EIF2S1;EIF2A
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.3265235820886601,0.6747188788952074,0.8191681735985533,1.0,1.0,3/10,8.72%,PKIB;PKIA;PRKAR1B
prerank,protein phosphatase activator activity (GO:0072542),0.3224763071809897,0.6738143423690798,0.8361486486486487,1.0,1.0,2/13,7.02%,PPP2R5A;CALM1
prerank,tRNA methyltransferase activity (GO:0008175),0.3126035496511825,0.6683888578436415,0.8294701986754967,1.0,1.0,2/16,5.49%,TRDMT1;FTSJ1
prerank,sequence-specific DNA binding (GO:0043565),0.216492564945821,0.6652250246334009,0.993993993993994,1.0,1.0,59/590,11.77%,PRDM16;MEF2C;HEY2;TBX2;NR1H4;ZEB2;ALX4;RORA;NR4A1;GABPA;ETS2;IRX5;PRDM1;SIRT3;NR2F2;NR2C1;BCL2;UPF1;OSR2;ZCWPW1;CBFB;TBX18;MEF2A;KLF16;DBP;FOXJ3;KLF15;MYBBP1A;JUND;TAF1;MAPT;ARID5A;TERT;RXRG;GRHL1;ZBTB38;HOXC4;PPARGC1A;SOX9;SNAI2;HSF4;CUX2;PPARA;MBNL2;BBX;LONP1;NR4A2;NR1D1;ZBTB33;HIF1A;HNRNPU;NR2C2;TEAD1;SREBF2;ATF3;HOXC8;TERF2;ZBTB7A;ESRRA
prerank,ribosome binding (GO:0043022),0.2536648645047964,0.6611451663314194,0.8883116883116883,1.0,1.0,15/46,21.24%,SRP68;CPEB1;PYM1;SRP72;CPEB3;SRP19;SEC61B;ETF1;EEF2;SERBP1;ERI1;C1QBP;EIF2S1;EIF2A;OXA1L
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.25658064055520546,-0.6610898322794334,0.8949880668257757,0.9624291862553459,1.0,4/14,16.66%,NOD1;CTSH;MAL;APAF1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.240799160356079,0.6559251560760974,0.9054545454545454,1.0,1.0,22/69,21.75%,ZDHHC2;LPCAT3;CERS1;HHAT;ZDHHC1;SCP2;ZDHHC14;ZDHHC17;DGAT1;PLA2G4A;PLA2G4C;ELP3;ZDHHC13;ZDHHC5;ZDHHC8;ESCO1;ZDHHC3;KAT8;MBOAT7;PLA2G15;KAT6A;NMT1
prerank,phosphatase activator activity (GO:0019211),0.30893498563794464,0.6531381654127274,0.8389830508474576,1.0,1.0,2/14,7.02%,PPP2R5A;CALM1
prerank,ubiquitin protein ligase binding (GO:0031625),0.215476950720831,0.6511353717598727,0.9642126789366053,1.0,1.0,47/254,15.53%,VCL;FZD5;FZD4;ACTG1;MFHAS1;BCL2;USP2;PIAS4;CUL2;FZD8;GABARAP;TP53;FBXW7;UBE2W;PA2G4;PPARGC1A;TRAF3;DIO2;RELA;AUP1;PRKACB;WASHC1;SKI;RPL5;HIF1A;TRAF5;UBE2D1;DNM1L;ANKRA2;RB1;MFN2;CCDC50;ACVR1B;NDUFS2;USP13;TSG101;CLU;SNX9;UBE2J1;MUL1;TRIM28;CKB;HM13;PRKACA;UBE2K;UBE2L6;HSPBP1
prerank,disordered domain specific binding (GO:0097718),0.2865057441607648,0.6510366169713399,0.8564814814814815,1.0,1.0,5/23,11.19%,TP53;CALM1;BCL2L2;PPIL1;RB1
prerank,lipid phosphatase activity (GO:0042577),0.30751406737567694,0.6483935704446855,0.839527027027027,1.0,1.0,2/14,9.88%,PLPPR1;PLPP7
prerank,cytochrome-c oxidase activity (GO:0004129),0.2997241619043615,0.647848434459925,0.8426395939086294,1.0,1.0,2/15,7.26%,COX7A2L;COX8A
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.2660387484495389,0.6472864265743419,0.9030898876404494,1.0,1.0,4/35,8.00%,TRDMT1;FTSJ1;GATB;FTO
prerank,O-methyltransferase activity (GO:0008171),-0.27565762779335795,-0.6409603882252313,0.8970917225950783,0.9742104162042692,1.0,5/10,38.21%,FTSJ3;CMTR1;COQ3;BCDIN3D;CMTR2
prerank,channel activity (GO:0015267),0.24852701516977882,0.6376138373120801,0.9058171745152355,1.0,1.0,5/41,12.38%,BCL2;TRPV2;PANX1;KCNK3;CHRNA7
prerank,kinesin binding (GO:0019894),0.26393782121334364,0.6366183504250786,0.8800599700149925,1.0,1.0,6/27,16.81%,FAM83D;ACTB;ATCAY;KIFAP3;SPAG9;CLSTN1
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.30059237424143953,0.6355704129667826,0.8486956521739131,1.0,1.0,4/13,19.09%,ARHGDIG;SH3BP4;GDI2;RANBP1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.3052350302101635,0.6354784402712086,0.8387681159420289,1.0,1.0,3/12,11.10%,RPS27L;ATP2A3;CASP8AP2
prerank,signaling receptor complex adaptor activity (GO:0030159),0.25375528433856687,0.6329204038146335,0.9052197802197802,1.0,1.0,10/38,15.88%,NUP62;IRS1;SORBS1;SAV1;DEDD2;SHANK2;LDLRAP1;NCK2;LRRK2;SPAG9
prerank,flavin adenine dinucleotide binding (GO:0050660),0.23795278570773193,0.630646308166357,0.9267015706806283,1.0,1.0,11/53,15.59%,MICAL2;LDHD;DLD;KMO;ETFA;FOXRED2;GFER;SDHA;MICAL3;CYB5R3;NOS1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.28674648199568753,0.6266442607401133,0.8552631578947368,1.0,1.0,3/16,13.12%,ATP6V0A2;ATP6V1C1;ATP6V0D2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.28674648199568753,0.6266442607401133,0.8552631578947368,1.0,1.0,3/16,13.12%,ATP6V0A2;ATP6V1C1;ATP6V0D2
prerank,steroid hydroxylase activity (GO:0008395),0.2823084069239915,0.625889771504977,0.8539898132427843,1.0,1.0,1/16,3.15%,CYP7B1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.2403466696183455,-0.6204169836240647,0.9147869674185464,0.984151402721031,1.0,1/15,4.69%,CCR9
prerank,histone methyltransferase activity (GO:0042054),0.24923475607830559,0.619228544801254,0.8923303834808259,1.0,1.0,3/32,9.03%,SMYD1;PRMT7;NSD3
prerank,MHC class II protein complex binding (GO:0023026),0.3102713553486138,0.6183565717857771,0.8917431192660551,1.0,1.0,3/11,19.37%,ATP1B1;ANXA11;PKM
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.31099347725904847,0.617512331034724,0.8513274336283185,1.0,1.0,3/10,16.55%,POLD1;EXD2;MGME1
prerank,NF-kappaB binding (GO:0051059),0.26021673572862525,0.6122623111292558,0.8805970149253731,1.0,1.0,3/24,7.89%,SETD6;MTDH;RELA
prerank,dipeptidyl-peptidase activity (GO:0008239),0.30440378394094136,0.6121570678628449,0.8736654804270463,1.0,1.0,2/10,12.98%,DPP10;DPP8
prerank,CoA hydrolase activity (GO:0016289),0.277021145818214,0.610795176280761,0.8804713804713805,1.0,1.0,1/16,3.02%,NUDT7
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.2484279925741358,0.6105887474641127,0.9182481751824818,1.0,1.0,10/33,22.32%,PCF11;AR;HNRNPU;URI1;ELOF1;DHX9;AGO1;WDR43;RPRD1A;CCAR2
prerank,ionotropic glutamate receptor activity (GO:0004970),0.2786442912530504,0.6099792241210461,0.8868852459016393,1.0,1.0,2/17,8.76%,GRIN2C;GRIK5
prerank,MHC protein binding (GO:0042287),0.26868135443942015,0.6056364737610733,0.9090909090909091,1.0,1.0,1/20,4.01%,LAG3
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.22653554156195993,-0.5986980355552242,0.9658536585365853,0.9923452329375019,1.0,10/16,46.41%,CD38;SMUG1;ADPRS;TDG;NEIL1;NEIL3;NTHL1;ADPRH;NEIL2;BST1
prerank,histone acetyltransferase activity (GO:0004402),0.2471069302503375,0.5976197147697455,0.922962962962963,1.0,1.0,10/30,20.94%,TAF1;EPC2;KAT7;MCM3AP;HAT1;CLOCK;TADA3;KAT8;KAT14;KAT6A
prerank,myosin V binding (GO:0031489),0.2748777110091255,0.5918494523214656,0.8911222780569514,1.0,1.0,3/15,16.59%,RAB3A;RAB14;RAB8A
prerank,NAD binding (GO:0051287),0.24641326817099732,0.5877331128956274,0.930780559646539,1.0,1.0,6/26,16.51%,CRYZ;SIRT3;SIRT2;QDPR;HADH;SIRT6
prerank,CCR chemokine receptor binding (GO:0048020),0.24112560878068273,0.58609688446592,0.9391691394658753,1.0,1.0,4/28,18.77%,CCL5;CCL14;CCL25;CCL19
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.2361741138833542,0.5860351764756389,0.9261363636363636,1.0,1.0,11/35,21.18%,TAF1;SMARCB1;TP53;RELA;BAZ2A;STAT1;HDAC1;AGO1;RRN3;POU2F1;H3-3A
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.2537148196150811,0.5854451735326148,0.9228395061728395,1.0,1.0,7/22,19.28%,ANKRA2;CLU;LDLRAP1;SNX17;HSPG2;LANCL1;CLTC
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.24258984463333536,-0.5835596570276368,0.9536423841059603,0.9911494725220414,1.0,3/11,13.52%,BAG4;BAG1;PFN1
prerank,adenyl nucleotide binding (GO:0030554),-0.24258984463333536,-0.5835596570276368,0.9536423841059603,0.9911494725220414,1.0,3/11,13.52%,BAG4;BAG1;PFN1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.27906785464854783,0.5792985891277291,0.9086294416243654,1.0,1.0,2/12,11.80%,PARN;CNOT7
prerank,methyl-CpG binding (GO:0008327),0.2544970835121457,0.578663173419067,0.9201277955271565,1.0,1.0,4/22,14.21%,ZCWPW1;ZBTB38;ZBTB33;ZBTB4
prerank,RNA polymerase core enzyme binding (GO:0043175),0.232574102120147,0.5753309371650904,0.9425287356321839,1.0,1.0,11/33,22.32%,PCF11;HNRNPU;URI1;ELOF1;DHX9;AGO1;RRN3;WDR43;ERBB2;RPRD1A;CCAR2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.24550822010500348,-0.5737456417230772,0.9455782312925171,0.9914733704111931,1.0,2/10,12.16%,CXADR;SIRPA
prerank,mitogen-activated protein kinase binding (GO:0051019),0.23752413835413802,0.5691153980480385,0.9271623672230652,1.0,1.0,3/29,8.19%,DUSP5;MAPKAPK2;TNIP1
prerank,MAP kinase kinase activity (GO:0004708),0.2646341567897559,0.565756423826783,0.93,1.0,1.0,4/15,15.49%,MAP2K1;MAP2K3;LRRK2;MAP2K4
prerank,glutathione transferase activity (GO:0004364),0.2477954356942909,0.5647295764286474,0.9459041731066461,1.0,1.0,3/23,12.11%,GSTT1;GSTP1;GSTA4
prerank,mRNA methyltransferase activity (GO:0008174),-0.2261637473617426,-0.5636028723683746,0.9657534246575342,0.9912133106636959,1.0,5/12,28.18%,METTL3;METTL14;METTL16;CMTR1;METTL8
prerank,triglyceride lipase activity (GO:0004806),0.24749588211094334,0.5621357544286156,0.9314194577352473,1.0,1.0,1/20,3.34%,LPL
prerank,chemokine receptor binding (GO:0042379),-0.17195495883169326,-0.5620521621020513,0.9932203389830508,0.9875778012518145,1.0,4/35,15.56%,ITCH;CXCL16;CX3CL1;CKLF
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.2271162832242762,0.5616219965659953,0.9409282700421941,1.0,1.0,9/33,20.12%,PARN;ERI2;DIS3L2;DIS3L;CNOT7;EXD2;REXO2;EXOSC10;ERI1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.2261455225003428,0.5612716337422134,0.9586206896551724,1.0,1.0,9/34,20.12%,PARN;ERI2;DIS3L2;DIS3L;CNOT7;EXD2;REXO2;EXOSC10;ERI1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.17037027957821724,-0.5593947993256035,0.9961389961389961,0.9843129439082741,1.0,10/40,23.17%,PCMTD1;HNMT;TARBP1;AS3MT;THUMPD3;ARMT1;RRP8;TPMT;SUV39H1;THUMPD2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.216529485016763,-0.5562490425275024,0.972027972027972,0.9811649374744397,1.0,3/14,17.61%,ALDH4A1;BLVRB;ALDH1L1
prerank,exopeptidase activity (GO:0008238),0.21226429962264196,0.5553446749420511,0.9682741116751269,1.0,1.0,12/50,21.37%,LNPEP;RNPEP;BLMH;ENPEP;DPP10;DPP8;CTSA;METAP1;TRHDE;CNDP2;KDM8;XPNPEP3
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.21356651975733887,-0.5536544112497279,0.9507389162561576,0.9779064427243597,1.0,2/14,16.75%,CAPNS1;CAPN10
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.2614372288673226,0.5527235812808357,0.9393414211438474,1.0,1.0,2/15,8.08%,KMT2D;SETD3
prerank,C-C chemokine receptor activity (GO:0016493),0.23289479905863758,0.5411753992681223,0.9648562300319489,1.0,1.0,1/21,5.56%,CXCR6
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.23308802034746448,0.5287351452724487,0.9568690095846646,1.0,1.0,3/21,11.83%,CHRAC1;POLD1;POLG
prerank,phosphate ion binding (GO:0042301),0.26524247836036124,0.5225273896698567,0.9401869158878504,1.0,1.0,3/10,18.15%,RELA;ADSS1;RPH3A
prerank,snoRNA binding (GO:0030515),0.21870882597017247,0.5219158653404412,0.9666666666666667,1.0,1.0,2/30,4.45%,NUDT7;NUDT4
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.26285049758160883,0.5206851112350346,0.9427083333333334,1.0,1.0,1/10,6.71%,HEXIM1
prerank,chemokine activity (GO:0008009),0.20627851402746722,0.5180586831793363,0.9617083946980854,1.0,1.0,2/31,10.43%,CCL5;CCL14
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.24131858915665275,0.5164694339402561,0.9480069324090121,1.0,1.0,3/14,18.40%,AK7;CMPK1;CMPK2
prerank,deoxyribonuclease activity (GO:0004536),0.23579621636514836,0.5090028340335945,0.9533678756476683,1.0,1.0,4/14,18.34%,MBD4;DNASE1L1;ZRANB3;MAP1S
prerank,nucleotide diphosphatase activity (GO:0004551),0.24081491487242512,0.5073244281977846,0.9636048526863085,1.0,1.0,2/14,10.22%,NUDT4;NUDT13
prerank,aspartic-type endopeptidase activity (GO:0004190),0.24349454717426816,0.5054193058740106,0.9535283993115319,1.0,1.0,3/12,14.38%,DDI2;HM13;SPPL2B
prerank,adrenergic receptor binding (GO:0031690),0.22683011803749437,0.49138070988410504,0.9744897959183674,1.0,1.0,3/16,11.18%,NEDD4;SAV1;PDE4D
prerank,methylated histone binding (GO:0035064),0.18359915132637963,0.4897127919920006,0.9936868686868687,1.0,1.0,7/62,9.37%,ZCWPW1;NCAPD3;TAF1;L3MBTL2;MSL3;TDRD3;CDYL
prerank,C-C chemokine binding (GO:0019957),0.20781314859010797,0.4880220020705928,0.9811912225705329,1.0,1.0,1/22,5.56%,CXCR6
prerank,proton transmembrane transporter activity (GO:0015078),0.1928824996053261,0.48661644888865485,0.9905149051490515,0.998939507666067,1.0,11/39,22.44%,COX7A2L;COX8A;UQCRFS1;UQCRH;COX5B;UQCRQ;SLC11A2;CLCN5;COX6A1;SLC9A1;ATP6V1F
prerank,ligand-gated channel activity (GO:0022834),0.1965757840524714,0.4760474753794706,0.9898255813953488,0.9998380975593864,1.0,4/29,16.82%,GRIN2C;GRIK5;CHRNA4;GRIK4
prerank,ligand-gated ion channel activity (GO:0015276),0.19450940520570403,0.47478727975499146,0.9913669064748202,0.9979738657390952,1.0,4/30,16.82%,GRIN2C;GRIK5;CHRNA4;GRIK4
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.19272020899482084,0.4687595397868924,0.987012987012987,0.9972923503803158,1.0,4/29,11.20%,NEU3;GLA;GANC;PARG
prerank,aspartic-type peptidase activity (GO:0070001),-0.20214768147219309,-0.4685679874128705,0.9932126696832579,0.9932709225362361,1.0,5/10,45.90%,BACE2;CTSD;PSEN1;CTSE;BACE1
prerank,purinergic nucleotide receptor activity (GO:0001614),0.20713254222389638,0.44918962054023054,0.9868852459016394,0.9995760418783406,1.0,15/15,79.31%,P2RX4;P2RY14;GPR34;P2RX6;P2RX7;P2RX2;P2RY13;GPR87;P2RX1;GPR171;P2RX3;P2RX5;PTAFR;P2RY12;P2RY1
prerank,DNA replication origin binding (GO:0003688),0.18956572617331438,0.4371937821886395,0.9968847352024922,0.9996242057628346,1.0,4/23,16.80%,KAT7;MCMDC2;ORC2;DHX9
prerank,neuropeptide receptor binding (GO:0071855),0.19782772476142657,0.4180447939246414,0.9880546075085325,1.0,1.0,14/14,80.23%,NTS;NPY;UCN3;APELA;QRFP;GHRH;NPPA;UCN2;GAL;AGRP;APLN;SHANK1;NMU;PPY
prerank,1-phosphatidylinositol binding (GO:0005545),0.1926833733081379,0.41088590168925454,0.9930434782608696,0.9990080555170497,1.0,4/15,21.46%,SNX9;SNAP91;ZFYVE16;ZFYVE9
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.18378927886365143,0.40897612260328986,0.9919484702093397,0.997017008791565,1.0,1/17,4.87%,AK7
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.17479491185122203,0.40195731565859943,0.989010989010989,0.9956400264528039,1.0,3/21,18.02%,CHRNA7;CHRNA4;P2RX4
